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Abstract 
Introduction: Disuse models, such as limb immobilisation, result in profound 
changes in skeletal muscle morphology and function. Exercise prescription would 
be the recommended intervention to prevent immobilisation-induced atrophy and 
declines in maximal voluntary strength. Nutritional supplementation may stand as 
a viable intervention to combat muscle atrophy with disuse, when exercise is an 
unpractical therapeutic option. 
Aims: To (1) investigate the multifactorial effects of short-term upper limb sling 
immobilisation and (2) determine whether three potential protein-sparing 
modulators (essential amino acids (EAA), omega-3 (-3) and vitamin D) would 
attenuate the anticipated deleterious effects of immobilisation. 
Methods: Measures of muscle and sub-cutaneous adipose thickness (Brightness 
mode ultrasonography), body composition (dual-energy x-ray absorptiometry), arm 
girth (anthropometry), isometric and isokinetic elbow torque (dynamometry), co-
contraction (electromyography (EMG)), muscle fatigability (dynamometry and 
EMG), arterial blood flow (Doppler ultrasound) and endocrine profile (enzyme-
linked immunosorbent assay and colorimetry), were taken before and after arm 
immobilisation in a mixed sex population. Supplementation of EAA (n = 9 vs. 
placebo n = 7) during three weeks of immobilisation, -3 (n = 8) or vitamin D (n = 
8) during two weeks of immobilisation (placebo n = 8) and EAA for two weeks pre-
immobilisation (n = 5 vs. placebo n = 5). 
Main findings: Immobilisation resulted in decreases in muscle thickness, arm girth, 
lean mass, isometric and isokinetic elbow torque, and an increase in sub-
cutaneous adipose thickness. Muscle fatigability, resting arterial blood flow, EMG 
co-contraction and endocrine profile were unchanged. At the current dosage -3 
xviii 
 
supplementation only attenuated the increase in sub-cutaneous adipose thickness. 
Despite some trends, neither -3 nor vitamin D supplementation attenuated any 
other parameters. EAA supplementation during immobilisation impacted positively 
on the immobilisation-induced changes in the structural and functional 
characteristic of the remaining muscle. EAA supplementation before 
immobilisation did not attenuate the immobilisation-induced changes in muscle 
structure and function. 
Conclusion: Although EAA supplementation only showed some benefit to muscle 
size and function with immobilisation, it was confirmed that the sling immobilisation 
model used in the thesis, is a suitable model for observing the effects of relatively 
short-term immobilisation. The findings of the thesis are relevant to both sporting 
(e.g. off-season detraining modulation) as well as clinical (e.g. injury/illness 
induced short-term immobilisation/bed rest) populations. This relatively short-term 
sling immobilisation provides a model to be used to assess other supplements and 
treatments in future studies. The modest effect of supplementation suggests 
further research into either: a) more at risk populations (e.g. injury or ageing); b) 
larger doses of these supplements. 
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Chapter 1: Thesis introduction and literature review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter appears in publication as: Bostock, E. L., Morse, C. I., Winwood, K., 
McEwan, I., and Onambélé-Pearson, G. L. (2013) ‘Hypo-activity induced skeletal 
muscle atrophy and potential nutritional interventions: A review.’ World Journal of 
Translational Medicine, 2(3), pp. 36-48. 
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Thesis introduction 
Skeletal muscle is one of the most adaptable tissues in the body, and as such, it is 
capable of altering its structure in response to different levels of physical activity. 
Prolonged reductions in muscle activity and mechanical loading result in many 
physiological adaptations in skeletal muscle size and function (Kawakami et al., 
2001; LeBlanc et al., 1992; Veldhuizen et al., 1993; White et al., 1984). Muscle 
atrophy (decrease in muscle mass) is seen during reduced activity (e.g. sedentary 
behaviour, de-training) (Andersen and Aagaard, 2000; Hakkinen et al., 2000; 
Hortobagyi et al., 1993; Narici et al., 1989) or disuse models (e.g. immobilisation, 
bed-rest) (Akima et al., 2000; Grosset and Onambele-Pearson, 2008; Kawakami 
et al., 2001; Veldhuizen et al., 1993). It is evident that the degree of muscle 
atrophy is not constant across muscle groups or hypo-activity models (Convertino, 
Doerr, Mathes, et al., 1989; LeBlanc et al., 1992; Veldhuizen et al., 1993; Yue et 
al., 1997). 
Simply reducing normal levels of activity can be classed as the first stage of 
disuse. Decrements in muscle mass and strength have been documented in 
trained humans undergoing de-training (Andersen and Aagaard, 2000; Colliander 
and Tesch, 1992; Hakkinen et al., 2000; Hakkinen and Komi, 1983; Hortobagyi et 
al., 1993; Houston et al., 1983; Narici et al., 1989). Bed-rest conditions result in the 
removal of normal weight-bearing forces acting on the bones of the lower limbs in 
the vertical position and a decrease in number and/or magnitude of muscle 
contractions, particularly in the postural musculature. During bed-rest, muscular 
contraction is still possible although it is limited and the muscular force required for 
producing movement is very much diminished, once ground reaction forces are 
removed. A more rigid immobilisation can be achieved by casting a limb, resulting 
in more rapid decrements in muscle mass than does bed-rest alone. The final 
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method of hypo-activity commonly reported in the literature, is that of unilateral 
lower limb suspension (ULLS), a method of reducing habitual activity whilst 
causing lesser degree of inconvenience to the participants.  
The aim of this chapter is to assess the varying impact of different hypo-
activity models on the skeletal muscle system. This is broken down into the effects 
of hypo-activity on muscle morphology, muscle strength and muscle fatigability. In 
order to provide some homogeneity in the results based on the variable duration of 
the hypo-activity, values are presented per week and where relevant the duration 
of the hypo-activity is provided in parenthesis. Exercise is not always a practical 
prescription, even when it would be recommendable, to individual’s under-going 
immobilisation or bed-rest after trauma or illness, due to the presence of 
contraindications for exercise such as pain, immobilisation in a cast etc. In some 
cases of hypo-activity, isometric and static contractions are still possible but not in 
all cases, for example with muscle tears. Thus, other interventions are required to 
attenuate losses in muscle mass and function. Therefore, this chapter will also 
discuss potential nutritional interventions for preventing the loss of muscle 
mass/function seen with hypo-activity, where increased physical activity is not 
combined with the nutritional treatment. Studies were found using search terms 
‘bed-rest and atrophy’ and ‘immobilisation and atrophy’ in PubMed. However, this 
returned over 1400 hits. To focus the search criteria and make it relevant to the 
population to be examined in subsequent chapters, only data on healthy humans 
were selected through the inclusion of the ‘human’ and ‘clinical trial’ filters in the 
PubMed search. This resulted in 98 studies, suitable for inclusion in the present 
chapter. Some hand searching and an additional search with the term ‘disuse’ was 
completed to insure no relevant texts were ignored. 
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Literature review 
1.1.  Muscle morphology 
1.1.1. Muscle anatomical cross sectional area 
Anatomical cross sectional area (ACSA) is the cross-sectional area of the muscle 
at right angles to its longitudinal axis. Muscle ACSA is a major determinant of 
maximal voluntary contraction (MVC) torque (Bamman et al., 2000; Narici et al., 
1992) and hypo-activity models have been shown to result in the decrease in this 
parameter (Figure 1.1.). Periods of detraining (24 weeks) have resulted in a 
decrease in ACSA of the quadriceps (Hakkinen et al., 2000). Likewise, Narici et al. 
(1989) reported decreases in leg ACSA (~0.7 %·wk-1) in response to 40 days de-
training. 
Stricter hypo-activity models result in greater decreases in muscle ACSA. 
Following 30 days bed-rest Convertino et al. (1989) reported decreases in ACSA 
of the calf (~1.1 %·wk-1) and thigh (~1.9 %·wk-1). Similarly, a 2.4 %·wk-1 decrease 
in plantar flexors ACSA was found following 5 weeks horizontal bed-rest (LeBlanc 
et al., 1988). Again, a 1.8 %·wk-1 decrease in knee extensors was observed 
following 8 weeks horizontal bed-rest (Mulder et al., 2006). Muscle group-specific 
adaptations have been demonstrated in skeletal muscle ACSA of the leg and 
lumbar musculature after 17 weeks of bed-rest (LeBlanc et al., 1992). The plantar-
flexors were more susceptible to atrophy (~1.8 %·wk-1) than the dorsiflexors (~0.9 
to 1.2 %·wk-1) (LeBlanc et al., 1992). The intrinsic lumbar muscles atrophied ~0.5 
%·wk-1 but there was no significant change in psoas muscle mass (LeBlanc et al., 
1992). Rittweger et al. (2005) reported a decrease in calf muscle ACSA (~2.0 
%·wk-1), which was greater than the reported decrease in the forearm ACSA (0.5 
%·wk-1) in response to 90 days bed-rest. 
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Figure 1.1. Relative change in muscle anatomical cross sectional area (ACSA), 
physiological cross sectional area (PCSA) and volume in response to hypo-activity 
models. Values are taken from the references used in the text for de-training 
(ACSA – 40 days and 24 weeks) (Hakkinen et al., 2000; Narici et al., 1989), bed-
rest (ACSA – 30 days to 17 weeks) (Convertino, Doerr, Mathes, et al., 1989; 
LeBlanc et al., 1988; LeBlanc et al., 1992; Rittweger et al., 2005; Mulder et al., 
2006) (PCSA – 20 days) (Akima et al., 2000; Kawakami et al., 2001; Kawakami et 
al., 2000; Kawashima et al., 2004) (Volume – 7 days and 32 days) (Convertino, 
Doerr, Mathes, et al., 1989; Ferrando et al., 1995; Krainski et al., 2014; Trappe et 
al., 2007), immobilisation (ACSA – 9 days to 4 weeks) (Christensen et al., 2008; 
Miles et al., 1994; Oates et al., 2010; Thom et al., 2001; Veldhuizen et al., 1993; 
White et al., 1984; Yasuda et al., 2005; Yue et al., 1997)  (Volume – 2 weeks and 
4 weeks) (Grosset and Onambele-Pearson, 2008; Urso, Clarkson, et al., 2006; 
Yue et al., 1997) and unilateral lower limb suspension (ULLS) (ACSA – 23 days 
and 4 weeks) (Clark et al., 2006; Clark et al., 2007; de Boer, Maganaris, et al., 
2007; Seynnes et al., 2008). Where there are missing bars, this shows gaps in the 
literature (i.e. values are not available for a parameter during a specific hypo-
activity model). Values are presented as means; error bars denote SD. 
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Immobilisation of the leg through plaster cast has shown to decrease calf 
ACSA (~3 to 5 %·wk-1) (Christensen et al., 2008; White et al., 1984) and 
quadriceps ACSA (~5 %·wk-1) (Hespel et al., 2001) after just 2 weeks. Changes in 
quadriceps ACSA (~8.3 %·wk-1) have also been documented with as little as 10 
days leg cast immobilisation (Thom et al., 2001). Similarly, Veldhuizen et al. 
(1993) reported decreases in quadriceps ACSA (~5.3 %·wk-1) with 4 weeks leg 
casting. Immobilisation of the knee using a brace has also resulted in decreases in 
muscle ACSA (Oates et al., 2010; Yasuda et al., 2005; Dirks et al., 2014). 
Fourteen days of knee-brace immobilisation has resulted in ACSA decreases of 
the thigh (~3.1 %·wk-1), quadriceps (~2.9 to 3.8 %·wk-1), gastrocnemius (~4.7 
%·wk-1) and soleus (~3.3 %·wk-1) muscles (Oates et al., 2010; Yasuda et al., 
2005). Yasuda et al. (2005) found no sex-based differences in the quadriceps 
ACSA response to knee-brace mediated immobilisation. There is considerably 
less data on immobilisation-induced atrophy of the upper limb muscles. Casting of 
the arm for as little as 9 days has shown to decrease ACSA of the forearm (~3.2 
%·wk-1) (Miles et al., 1994). Yue et al. (1997) investigated the effect of 4 weeks 
elbow joint immobilisation with a fibre glass cast and reported a decrease in elbow 
flexor ACSA (~2.8 %·wk-1). 
Tesch et al. (1991) developed a model to study the effects of an unloaded 
limb in humans that allows for freely moveable joints but minimises load bearing. 
In this ULLS method, a sling suspends one lower leg and the contralateral shoe 
has an elevated sole to allow for a relaxed position of the unloaded limb. ULLS 
also results in decreases in muscle ACSA, though to a lesser degree than seen 
with immobilisation. ULLS of 23 days has been reported to decrease knee 
extensor (~3 %·wk-1) (de Boer, Maganaris, et al., 2007) and plantar flexor (~2.7 
%·wk-1) (Seynnes et al., 2008) ACSA. Correspondingly, decreases in plantar flexor 
(~2.0 to 2.3 %·wk-1 and 1.6 %·wk-1) and knee extensor (~2.0 %·wk-1 and 1.9 %·wk-
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1) ACSA have been reported in response to 4 weeks and 30 days of ULLS, 
respectively (Clark et al., 2006; Clark et al., 2007; Cook et al., 2014). It would 
therefore, seem that in terms of ACSA at least, the most impactful model of hypo-
activity is immobilisation. 
1.1.2. Muscle physiological cross sectional area 
Physiological cross-sectional area (PCSA) is the area of the muscle at right angles 
to the longitudinal axis of the fibres. Muscle PCSA has been associated with the 
maximal force generating capacity of a muscle (Powell et al., 1984) and has been 
shown to decrease with bed-rest (Akima et al., 2000; Kawakami et al., 2001; 
Kawakami et al., 2000). Twenty days bed-rest has been shown to decrease PCSA 
of the thigh (between ~2.7 to 3.6 %·wk-1) and adductor muscle group (~2.3 %·wk-1) 
(Kawakami et al., 2001; Kawakami et al., 2000; Kawashima et al., 2004). Akima et 
al. (2000) demonstrated muscle group-specific adaptations, demonstrating a 
decrease in PCSA of knee extensor (~2.5 %·wk-1), knee flexor (~4.0 %·wk-1) and 
plantar flexor (~4.5 %·wk-1) muscles in response to 20 days of 6 degrees head-
down-tilt bed-rest. It is generally accepted that muscle losses are greater in the 
knee extensors than the knee flexors after unloading in humans (Bloomfield, 
1997). Akima et al. (2000) demonstrated the opposite to this, which could be due 
to the methodology used to determine PCSA. In addition, since a muscle placed in 
a shortened position experiences a greater degree of atrophy than one placed in a 
lengthened position (Williams and Goldspink, 1973), the pattern/magnitude of 
disuse would, therefore, be expected to be modulated by both the mode of hypo-
activity and the joint angle adopted in the immobilisation. Bed-rest, however, had 
no effect on the PCSA of the tibialis anterior (Akima et al., 2000). The tibialis 
anterior experiences lower activation during habitual physical activities than other 
muscles such as the plantar flexor, and as such may explain the lack of decrease 
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in tibialis anterior muscle PCSA with bed-rest. Comparisons of bed-rest to other 
hypo-activity models in terms of PCSA changes is not yet possible, as research is 
lacking with this parameter being measured. 
1.1.3. Muscle volume 
Muscle volume is a major determinant of joint torque (Fukunaga et al., 2001) and 
has been shown to decrease in response to bed-rest and immobilisation models 
(Convertino, Doerr, Mathes, et al., 1989; Ferrando et al., 1995; Grosset and 
Onambele-Pearson, 2008; Urso, Clarkson, et al., 2006; Yue et al., 1997). Muscle 
volume of the thigh decreases (~3 %·wk-1) with as little as 7 days bed-rest 
(Ferrando et al., 1995). Following 30 days bed-rest Convertino et al. (1989) 
reported decreases in calculated leg volumes of the calf (~2.3 %·wk-1) and thigh 
(~1.1 %·wk-1). Similarly, significant decreases in quadriceps (-1.8 %·wk-1 and -2.45 
%·wk-1) and calf (-3.8 %·wk-1) muscle volume have been reported with 5 and 8 
weeks of head-down-tilt bed-rest, respectively (Krainski et al., 2014; Trappe et al., 
2007). Yue et al. (1997) investigated the effect of 4 weeks elbow joint 
immobilisation with a fibre glass cast and reported a decrease in elbow flexor 
volume (~2.9 %·wk-1). A case study of a fracture patient who fractured the fifth 
metatarsal of the right foot displayed substantial and rapid losses in muscle 
volumes, both proximally and distally to the immobilisation site after 4 weeks of 
subsequent immobilisation (Grosset and Onambele-Pearson, 2008). The degree 
of muscle volume decrease varied between the different muscle sites of the triceps 
surae (~5.5 %·wk-1), quadriceps (~6.0 %·wk-1) and hamstrings (~1.6 %·wk-1) 
(Grosset and Onambele-Pearson, 2008). This is in agreement with the general 
acceptance that muscle volume is  lost to a  greater extent in the knee extensors 
compared to the knee flexors (Bloomfield, 1997). Urso et al. (2006) demonstrated 
different responses to 2 weeks adductor pollicis immobilisation between younger 
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and older males. Adductor pollicis volume decreased ~2.1 %·wk-1 (not significant) 
in young males and significantly decreased by ~4.8 %·wk-1 in older males (Urso, 
Clarkson, et al., 2006). 
1.1.4. Upper vs. lower limb 
Immobilisation through casting appears to have a greater effect on the lower limb 
musculature than the upper body. This is not surprising since the habitual loading 
of the lower extremities, because of body weight in normal ambulation and even in 
the absence of intended physical exertion, is far more substantial than that in the 
upper extremities. Understandably, this thereby affects the required threshold of 
decrease in muscle activity necessary to negatively impact on muscle metabolism. 
(Table 1.1). Forearm muscle ACSA decreased 4.1 % with 9 days arm casting 
(Miles et al., 1994), whereas, a similar period of immobilisation of the lower limb 
with 10 days casting resulted in an 11.8 % decrease in quadriceps ACSA (Thom et 
al., 2001). Similarly, with longer periods of immobilisation the effect seems to be 
greater in the lower limbs. In response to 4 weeks elbow joint casting, Yue et al. 
(1997) reported an 11.2 % decrease in elbow flexor ACSA, whereas, Veldhuizen 
et al. (1993) reported a 21 % decrease in quadriceps ACSA in response to 4 
weeks leg casting. 
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1.1.5. Intermuscular adipose tissue 
Using signal intensity analysis of lower limb magnetic resonance images (MRI), 
Manini et al. (2007) discriminated between the relative changes in adipose and 
skeletal muscle tissue resulting from a 4-week period of ULLS. In addition to the 
characteristic reduction in muscle ACSA, there was a concomitant 15 % increase 
in intermuscular adipose content after 4 weeks of lower limb suspension (Manini et 
al., 2007). Thus, these findings suggest that hypo-activity induced alterations in 
skeletal muscle morphology goes beyond muscle atrophy alone. 
1.1.6. Summary: muscle morphology 
Together, these findings show that the extent of muscle atrophy differs depending 
on the hypo-activity model. Certain factors may modulate the differential 
responses to hypo-activity models (e.g. age, nutritional status). Indeed, both 
Kortebein et al. (2007) and Yue et al. (2006) suggested that older individuals 
experience greater losses in muscle mass when compared to younger individuals. 
A change in nutritional status, whether it is due to physiological changes directly 
caused by hypo-activity or to altered behaviour that is caused by hypo-activity and 
leads to changes in diet, could affect the physiological systems in question. The 
above also suggest that the degree of muscle atrophy differs between muscle 
groups, with the leg and postural muscles being most susceptible to atrophy. This 
is likely to be due to the comparatively substantial decrease in habitual weight-
bearing forces applied to the lower limb during hypo-activity. Hypo-activity not only 
decreases muscle content, but also impacts on the intrinsic composition of the 
said skeletal muscle through increased adiposity (Manini et al., 2007) and altered 
muscle architecture (de Boer et al., 2008). Fibre type differences have been 
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reported in response to hypo-activity, with a transition from slow to fast fibre types 
(Trappe et al., 2004). 
The decrease in muscle mass seen with hypo-activity may be the result of 
an imbalance between protein synthesis and protein breakdown (Ferrando et al., 
1996; Gibson et al., 1987; Urso, Scrimgeour, et al., 2006). In response to 14 days 
simulated microgravity, Ferrando et al. (1996) reported a loss of lean muscle 
mass, accompanied with a 14 % decrease in protein synthesis and no change in 
protein breakdown. Similarly, Gibson et al. (1987) reported a marked fall in muscle 
protein synthesis in response to 7 weeks leg immobilisation. A shorter period of 
immobilisation (21 days) provided little evidence of increases in messenger 
ribonucleic acid (mRNA) for catabolic enzymes or increases in enzyme activity 
during this period (de Boer, Selby, et al., 2007). However, there is some evidence 
to suggest that increases in catabolic potential do occur, and that this event 
happens very quickly (48 hours) after immobilisation (Urso, Scrimgeour, et al., 
2006). Nevertheless, collectively the evidence suggests that protein breakdown is 
unlikely to be a key modulator in the process of muscle atrophy occurring during 
immobilisation in humans (Rennie, 2009; Rennie et al., 2010). 
The molecular signalling responses to de-training are only just beginning to be 
investigated, and to date, only changes in metabolic proteins have been reported 
in human skeletal muscle (Burgomaster et al., 2007; Simsolo et al., 1993). With 
bed-rest, Ogawa et al. (2006) reported increased mRNA expression of the E3 
ligases, Cbl-b and Atrogin-1 in response to 20 days bed-rest. This was 
accompanied by a threefold increase in ubiquitinated proteins (Ogawa et al., 
2006). Investigation into the effects of limb immobilisation on cell signalling in 
humans is limited. Modest changes in mRNA for many genes in the first 2 days 
after immobilisation have been reported but these changes do not affect protein 
levels of most transcripts (Urso, Scrimgeour, et al., 2006). However, the Akt 
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protein synthesis pathway and extracellular matrix components seem to be 
affected within 48 hours of immobilisation (Urso, Scrimgeour, et al., 2006). Chen et 
al. (2007) and Jones et al. (2004) reported increases in the E3 ligases, Atrogin-1 
and muscle ring finger 1 (MuRF-1) in response to 11 to 14 days immobilisation in 
humans. These changes were not seen with 48 hours of immobilisation (Urso, 
Scrimgeour, et al., 2006) and are, therefore, thought to only occur after long 
duration (days rather than hours) immobilisation. Increased metallothionein 
expression in human skeletal muscle fibres has been associated with exposure to 
physiological stress, which results in elevated levels of reactive oxygen species 
(ROS) (Penkowa et al., 2005). Urso et al. (2006) reported a more than two-fold 
increase in metallothioneins in human skeletal muscle with 48 hours of 
immobilisation. However, neither Chen et al. (2007) nor Jones et al. (2004) 
identified changes with longer periods of immobilisation. This may suggest that 
metallothioneins are increased in the first few days of hypo-activity to prevent 
ROS-mediated DNA or cellular damage. De Boer et al. (2007) investigated the 
effects of ULLS on gene expression and cell signalling. They reported increased 
expression of mRNA for MuRF-1 by approximately threefold after 10 days without 
changes in MAFbx or tripeptidyl peptidase II mRNA, but all decreased between 10 
and 21 days (de Boer, Selby, et al., 2007). These authors concluded that both 
myofibrillar and tendon protein synthetic rates show progressive decreases during 
21 days of disuse; in muscle this is accompanied by decreased phosphorylation of 
focal adhesion kinase (FAK), with no marked increases in genes for proteolytic 
enzymes (de Boer, Selby, et al., 2007). Overall, whilst it is clear that cell signalling 
responses differ between hypo-activity models; further research is needed to 
provide a definitive description of the timing, magnitude and nature of these 
molecular adaptations. 
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1.2.  Muscle strength 
The associated decline in strength through hypo-activity can be best described 
based on the mode of assessment. Both isometric and dynamic strength have 
been reported to decline with hypo-activity, the relative magnitude of which 
appears to largely reflect the patterns of atrophy described above. 
1.2.1. Isometric strength 
Hypo-activity models alter muscular isometric torque. After 40 days de-training, 
Narici et al. (1989) reported a decrease in knee extension isometric MVC (~2.1 
%·wk-1). Similarly, maximal isometric quadriceps strength has been reported to 
decrease with 90 days de-training (~1.3 %·wk-1) (Andersen and Aagaard, 2000). 
More dramatic losses in isometric torque are seen with stricter hypo-activity 
models. Bed-rest models have been shown to decrease maximal voluntary force 
of plantar flexion (~2.4 to 7.5 %·wk-1) (Kamiya et al., 2004; Blottner et al., 2014; 
Krainski et al., 2014) and knee extensor torque (~2.1 to 5.0 %·wk-1) (Berg et al., 
1997; Krainski et al., 2014; Mulder et al., 2006). Correspondingly, Kawakami et al. 
(2001) showed a decrease in muscle force for knee extension (~3.8 %·wk-1) with 
20 days bed-rest. 
Studies using 2 weeks of cast immobilisation have reported decreases in 
triceps surae isometric MVC torque (~8.5 and 12 %·wk-1) (Gondin et al., 2004; 
White et al., 1984). A discrepancy between the magnitudes of change in the two 
studies may be due to the degree of immobilisation. Gondin et al. (2004) simply 
immobilised the ankle joint, whilst, White et al. (1984) utilised a full leg cast. In the 
full leg cast a larger muscle mass is immobilised as compared to that of the ankle 
joint immobilisation, therefore, resulting in greater relative decreases in MVC 
torque. A significant decrease in quadriceps isometric MVC strength has been 
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reported with as little as 5 days knee immobilisation (Dirks et al., 2014). Knee-
brace mediated immobilisation has resulted in a decrease in knee extensor and 
plantar flexion isometric strength (~11.2 and 12.7 %·wk-1, respectively) (Oates et 
al., 2010). Knee-cast mediated immobilisation resulted in a slightly larger decrease 
in isometric leg strength (~15.7 %·wk-1) (Hortobagyi et al., 2000). Christensen et 
al. (2008) utilised a knee-to-toe plaster cast and reported a decrease in isometric 
calf muscle strength (~4.5 %·wk-1). Studies using casting to immobilise the elbow 
joint have found decreases in isometric MVC of the elbow flexors (~5.3 to 8.8 
%·wk-1) (Semmler et al., 2000; Vaughan, 1989; Yue et al., 1997), and a decrease 
in the maximum load that could be lifted (Yue et al., 1997). A more dramatic 
decrease in isometric MVC torque has been reported in the flexors and extensors 
of the wrist (~22.8 to 25.3 %·wk-1) in response to immobilisation (Lundbye-Jensen 
and Nielsen, 2008; Miles et al., 1994). 
With ULLS, isometric torque appears to be affected to a lesser degree than 
with immobilisation models. An explanation for the above observation may be that 
ULLS removes weight bearing but allows for freely moveable joints (hence a 
degree of muscular activity) whereas immobilisation is a more rigid model that 
does not allow joint movement (hence a greater restriction of muscular activity). 
Studies have reported plantar flexor (~5 to 7 %·wk-1) (Clark et al., 2006; Seynnes 
et al., 2008; Cook et al., 2014) and knee extensor (3.7 %·wk-1) (Cook et al., 2014) 
isometric MVC torque to decrease with ULLS. With ULLS, increased fluctuations in 
plantar flexion (~3 %·wk-1) and knee extension (~5.5 %·wk-1) isometric force have 
been demonstrated (Clark et al., 2007).  
1.2.2. Isokinetic strength 
In addition to the established decline in isometric strength (torque and force), 
hypo-activity models also result in reductions in dynamic torque outputs. After 14 
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days de-training isokinetic eccentric and concentric knee extension force has been 
shown to decrease by ~6 and 1.2 %·wk-1, respectively (Hortobagyi et al., 1993). 
With as little as 14 days bed-rest decrements in knee extensor 1 repetition 
maximum (~4.5 %·wk-1) are seen along with a fall in MVC (~7.5 %·wk-1) (Bamman 
et al., 1998). After 6 weeks bed-rest, maximal voluntary concentric knee extensor 
torque was shown to decrease uniformly across angular velocities (~4.1 to 5.0 
%·wk-1) (Berg et al., 1997). Muscle-specific adaptations are evident with bed-rest, 
as shown by Dudley et al. (1989) who reported a decrease in concentric and 
eccentric isokinetic knee extensor peak torque (~4.4 %·wk-1), with no alterations in 
knee flexors in response to 30 days 6 degrees head-down-tilt bed-rest. Again, 
muscle-specific adaptations were demonstrated by Le Blanc et al. who reported a 
decrease in plantar flexor concentric isokinetic strength (~2.6 %·wk-1) and no 
change in the isokinetic strength of the dorsiflexors with 5 weeks bed-rest 
(LeBlanc et al., 1988). As with the knee extensors vs. knee flexors difference in 
sensitivity to hypo-activity alluded to above, the plantar flexor muscles experience 
a greater level of recruitment during gait than the tibialis anterior. Thus, habitual 
muscle recruitment prior to hypo-activity would appear to be a large determinant of 
the relative magnitude of hypo-activity-induced changes. 
Results from lower limb immobilisation models indicate that short-term 
immobilisation is associated not only with atrophy, but also with a diminished 
capacity of the muscle to perform both concentric and eccentric strength 
(Hortobagyi et al., 2000; Miles et al., 1994). Lower limb casting results in a 
dramatic decrease in isokinetic quadriceps strength (~12.5 to 29.1 %·wk-1) (Thom 
et al., 2001; Hespel et al., 2001) and isokinetic knee extensor torque (~15.5 %·wk-
1) (Kubota et al., 2011). There is evidence that the effect of leg cast immobilisation 
on isokinetic strength of the knee extensors and flexors is greater in the knee 
extensors, demonstrated by a fall in peak torque of ~13.3 %·wk-1 for the knee 
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extensors and ~3.3 %·wk-1 for knee flexors (Veldhuizen et al., 1993). Cast 
immobilisation of the arm also results in decreased concentric (~6.9 to 16.9 %·wk-
1) and eccentric (~9.7 to 14.4 %·wk-1) strength for flexion, extension, pronation and 
supination of the wrist (Miles et al., 1994). 
Less dramatic decreases in isokinetic strength are seen with ULLS 
compared to immobilisation. De Boer et al. (2007) found a decrease in isokinetic 
knee extensor torque in response to 23 days ULLS (~6.4 %·wk-1). Similarly, after 4 
weeks ULLS mean average peak isokinetic torque is decreased (~4.3 %·wk-1) 
(Berg, Dudley, et al., 1993). With as little as 14 days ULLS, a decrease in peak 
isokinetic torque (~5 to 8.6 %·wk-1) and total work performed (~7.5 to 10.0 %·wk-1) 
by knee extensors and flexors was reported (Deschenes et al., 2002). 
1.2.3. Strength vs. size changes 
There is evidence to suggest that decreases seen in strength in response to hypo-
activity models are greater than the changes seen in muscle size. With de-training 
the loss in leg muscle ACSA (~0.7 %·wk-1) was not as great as the decrease seen 
in knee extension MVC (~2.1 %·wk-1) (Narici et al., 1989). Similarly, in bed-rest 
Kawakami et al. (2001) suggested that the decrease in knee extension mean 
muscle force (~3.8 %·wk-1) seen after 20 days head-down-tilt bed-rest was related 
more to changes in neural activation than those in PCSA (~2.7 %·wk-1). 
Correspondingly, Berg et al. (1997) suggested that  the decline seen in strength 
(~4.1 to 5.0 %·wk-1) could not be entirely accounted for by decreased ACSA (~2.3 
%·wk-1), and that the strength loss could also be due to factors resulting in 
decreased neural input to muscle and/or reduced specific tension of muscle, as 
evidenced by a decreased torque to EMG ratio. Discrepancies between decreases 
in muscle size and muscle strength have also been reported in upper and lower 
limb immobilisation studies. White et al. (1984) reported a ~5 %·wk-1 decrease in 
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muscle ACSA whilst triceps surae MVC decreased ~12 %·wk-1. Additionally, the 
upper limb decreases in forearm ACSA (~3.2 %·wk-1) were much smaller than 
those reported in forearm flexor and extensor strength (~22.8 to 25.3 %·wk-1) 
(Miles et al., 1994). Again, in ULLS models muscle torque (~5 to 7 %·wk-1) 
appears to decrease to a greater degree than muscle ACSA (~2.3 to 2.7 %·wk-1) 
(Clark et al., 2006; Seynnes et al., 2008). 
1.2.4. Summary: muscle strength 
Bed-rest appears to have varying degrees of impact on the upper and lower body. 
After 14 days of 6 degrees head-down-tilt bed-rest maximum voluntary force for 
plantar flexion was decreased (~7.5 %·wk-1) whilst no effect was observed on 
maximal voluntary force of handgrip (Kamiya et al., 2004). Similar results were 
demonstrated by LeBlanc et al. (1992) who showed after 17 weeks of continuous 
bed-rest that isokinetic muscle strength decreased significantly in the thigh and 
calf with no loss in the arms. These results further support the idea that the lower 
limbs are primarily affected by bed-rest, more so than the upper limb. However, 
Gogia et al. (1988) did observe a decrease in elbow flexor torque (~3.8 %·wk-1) 
and a non-significant decrease in elbow extension torque (~1.4 %·wk-1) after 5 
weeks of bed-rest. Thus, suggesting that strength in the upper limb is affected by 
bed-rest but only in specific muscles, during specific tasks. 
Together, these findings show that in addition to the reduction in muscle 
mass, hypo-activity also results in a dramatic loss of strength (Figure 1.2). Models 
in which the joint is immobilised appear to have a greater impact on strength than 
unloading models. These changes in muscular strength vary between hypo-activity 
models. The degree of loss in muscular strength surpasses the loss of muscle 
mass. Therefore, other alterations in the neuromuscular system, other than the 
reduction in contractile proteins must contribute to the excessive loss of strength. 
19 
 
Voluntary force production is associated with neurological (e.g. EMG activity) and 
skeletal muscle (fibre type, connective tissue, oxygen supply to skeletal muscle) 
properties, thus suggesting these two factors as mechanisms accounting for the 
loss of strength with hypo-activity models. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Relative change in isometric and isokinetic strength in response to 
hypo-activity models. (A) Values taken from references in the text for upper limb 
(UL) changes in strength in response to de-training, bed-rest (isokinetic) (Gogia et 
al., 1988; Kamiya et al., 2004; LeBlanc et al., 1992), immobilisation (isometric) 
(Lundbye-Jensen and Nielsen, 2008; Miles et al., 1994; Semmler et al., 2000; 
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Vaughan, 1989; Yue et al., 1997)  (isokinetic) (Miles et al., 1994)  and ULLS. (B) 
Values taken from references in the text for lower limb (LL) changes in strength in 
response to de-training (isometric) (Andersen and Aagaard, 2000; Narici et al., 
1989) (isokinetic) (Hortobagyi et al., 1993), bed-rest (isometric) (Berg et al., 1997; 
Kamiya et al., 2004; Kawakami et al., 2001; Blottner et al., 2006; Krainski et al., 
2014; Mulder et al., 2006) (isokinetic) (Bamman et al., 1998; Berg et al., 1997; 
Dudley et al., 1989; LeBlanc et al., 1988), immobilisation (isometric) (Christensen 
et al., 2008; Gondin et al., 2004; Hortobagyi et al., 2000; Oates et al., 2010; White 
et al., 1984; Dirks et al., 2014; Hespel et al., 2001; Kubota et al., 2011) (isokinetic) 
(Thom et al., 2001; Veldhuizen et al., 1993) and ULLS (isometric) (Clark et al., 
2006; Clark et al., 2007; Seynnes et al., 2008; Cook et al., 2014) (isokinetic) (Berg, 
Dudley, et al., 1993; de Boer, Maganaris, et al., 2007; Deschenes et al., 2002).  
Where there are missing bars, this shows gaps in the literature (i.e. values are not 
available for that parameter during a specific hypo-activity models). Values are 
presented as means; error bars denote SD. 
 
1.3. Muscle fatigability 
Studies have also examined the impact of hypo-activity models on the fatigability 
of skeletal muscle. Kamiya et al. (2000) showed no change in time to fatigue after 
14 days bed-rest. After a longer period of bed-rest (8 weeks), Mulder et al. (2007) 
demonstrated an increase in fatigability (7.2-10.2 %/min decrease in maximum 
voluntary isometric torque per minute exercise; or ~0.9-1.3 %·wk-1 fatigability 
increment). The contrast between the two studies would tend to suggest a delay in 
the impact of hypo-activity on muscle fatigability. 
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The effect of immobilising a limb has various different effects on skeletal 
muscle fatigability. Two weeks of full leg cast immobilisation resulted in no effect 
on muscle fatigability (White et al., 1984). In contrast, Veldhuizen et al. (1993) 
found a decrease in isokinetic quadriceps endurance work from 9.1 kJ to 5.6 kJ 
after 4 weeks leg cast immobilisation. These results suggest that short periods of 
lower limb immobilisation (≤2 weeks) have little effect on muscle fatigability whilst 
longer periods of immobilisation (≥4 weeks) increases muscle fatigability. Studies 
investigating the effects of immobilisation on skeletal muscle fatigability in the 
upper limbs have found different effects to those in the lower limbs. Similar to 
lower limbs shorter periods of immobilisation in the upper limbs appear to have 
minimal effects on muscle fatigability (Miles et al., 1994). Unlike the lower limb, 
longer periods of immobilisation of the upper limb show a trend towards increased 
resistance to fatigability. Following 3 weeks of hand-forearm immobilisation time to 
task failure increased by 21 % (~7 %·wk-1) (Clark et al., 2008). Semmler et al. 
(2000) investigated the effects of fiberglass cast immobilisation of the elbow joint, 
and reported 7 out of the 12 immobilised participants exhibited an unusual pattern 
of muscle activity during a fatiguing contraction after immobilisation. In those 
individuals with this unusual pattern of muscle activity there was an associated 
increase in the ability to maintain a contraction over an extended period of time in 
the elbow flexor muscles (Semmler et al., 2000). The physiological basis for the 
sometimes-observed immobilisation-induced decreased fatigability is not clear but 
it is likely to be related to neural factors (Semmler et al., 2000). In contrast to this, 
Miles et al. (2005) found an increase in fatigability in response to 3 weeks arm 
suspension in untrained but not trained individuals. Previous research showed that 
ULLS led to increased fatigability after 4 weeks of unloading (Berg, Dudley, et al., 
1993). Results from Deschenes et al. (2002) found a contrasting decrease in 
fatigability after just 2 weeks of unloading.  
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Collectively these results suggest that muscle fatigability varies between 
different hypo-activity models (Figure 1.3). Shorter periods of hypo-activity (≤2 
weeks) generally appear to have little impact on fatigability. Muscle fatigability 
appears to increase in weight-bearing muscles but immobilisation in the upper 
limbs suggests an increase in resistance to fatigue. Differences between studies 
could be due to the duration of unloading or in the method used to test fatigue 
resistance. The mechanisms that cause fatigue are specific to the task being 
performed (Enoka and Duchateau, 2008; Hunter et al., 2004). Therefore, variability 
between fatigue resistance responses to hypo-activity models may be due to task 
specificity. Studies investigating a comparison of different fatigue tasks before and 
after hypo-activity are sparse. Yue et al. (1997) demonstrated a task-dependent 
effect on muscle fatigue with substantially increased endurance time (reduced 
fatigability) at a low force (20 % MVC) and no statistical effect at a moderate force 
(65 % MVC) in the elbow flexors. The selective improvement of fatigue resistance 
for the low-force contraction was accompanied by the absence of a change in the 
time course of the twitch, suggesting that the immobilisation-induced adaptation 
included an improved efficacy of some excitation-contraction processes and 
underscored the major role of these mechanisms in determining the endurance 
time for low-force, long-duration contractions. It appears that the hypo-activity 
induced adaptations in muscle fatigability vary with the specifics of the task being 
performed. More research is needed to investigate these task-specific responses 
to different models of hypo-activity. 
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Figure 1.3. Relative change in muscle fatigability in response to hypo-activity 
models (mean ± SD). Positive percentage change depicts an increase in 
fatigability whilst negative percentage change shows a decrease in fatigability. 
Values are separated into the effect of each hypo-activity model on the upper limb 
(UL) versus the lower limb (LL). The values are taken from the references used in 
the text for bed-rest (LL) (Kamiya et al., 2000; Mulder et al., 2007), immobilisation 
(UL) (Clark et al., 2008; Miles et al., 1994) (LL) (Veldhuizen et al., 1993; White et 
al., 1984) and ULLS (LL) (Berg, Dudley, et al., 1993; Deschenes et al., 2002). 
Where there are missing bars, this shows gaps in the literature (i.e. values are not 
available for a parameter during a specific hypo-activity model). 
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Numerous adaptations in fatigue mechanisms have been hypothesised to 
explain the observed preservation and decrease in fatigability in response to hypo-
activity. As stated previously, hypo-activity results in muscle atrophy and a 
decrease in muscle strength, has been reported to be accompanied by myofiber 
transitions from slow to fast (Fitts et al., 2000) and a shift in fuel metabolism away 
from lipid fuels toward glycolysis (Stein and Wade, 2005). Typically, these 
changes are associated with increased fatigability. Cardiovascular adaptations 
with hypo-activity (Convertino, 1997) reduces oxygen delivery and oxygen 
utilization which may impair prolonged exercise capacity. Additionally, exercise 
tolerance may be influenced by impaired muscle activation after hypo-activity 
(Gondin et al., 2004; Kawakami et al., 2001). In light of this, the reports of 
decreased fatigability with hypo-activity are puzzling, and the underlying 
mechanisms remain unclear. It is possible that an atrophy-induced decrease in 
absolute force production will result in decreased intramuscular pressure. This in 
turn, will increase blood flow to the muscle and increase supply to match the 
metabolic demand (Bodor, 2002; Semmler et al., 2000). Other potential 
mechanisms include adaptations in the neural activation strategy utilised 
(Semmler et al., 2000), adaptations in the basal inorganic phosphate concentration 
(Shaffer et al., 2000), and changes in excitation-contraction coupling (Yue et al., 
1997). 
1.4. Nutritional supplementation 
As mentioned above, there is strong evidence that protein synthesis is decreased 
in response to periods of bed-rest and immobilisation (de Boer, Selby, et al., 2007; 
Ferrando et al., 1996; Gibson et al., 1987). That resistance exercise provides an 
anabolic stimulus during hypo-activity is undisputed (Akima et al., 2000; Bamman 
et al., 1998; Ferrando et al., 1997). When supplemented with nutritional 
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interventions, the benefits of exercise during bed-rest appear additive (Brooks et 
al., 2008), thereby suggesting synergistic pathways for counteracting atrophy. It 
may not always be practical to prescribe exercise to counteract the atrophy 
brought about by inactivity. In these cases, such as trauma, pharmaceuticals may 
be used and have been tried with varying degrees of success (Jones et al., 2009). 
However, effective long-term medication is not a palatable option (e.g. costs, side 
effects, repeated injections). Where exercise is not a practical prescription, 
supplementing the diet with potential/recognised hypertrophic nutrients may be an 
effective and easily adhered to intervention programme for preventing the loss of 
muscle mass/function seen with hypo-activity. In this latter therapeutic group, 
potential candidates include proteins (essential amino acids (EAA) and Leucine in 
particular), creatine, omega-3 (-3) fatty acids, vitamin D and antioxidants, to 
name but a few (Kim et al., 2010; Sakuma and Yamaguchi, 2012). 
1.4.1. Protein 
Stuart et al. (1990) sought to determine whether the catabolic effects of bed-rest in 
humans was due to a decrease in protein synthesis, and if so, to assess whether 
increasing the amount of dietary protein might be beneficial. The calculated non-
oxidative Leucine disappearance was used as a measure of whole-body-protein 
synthesis, which was shown to decrease when dietary protein was low. Bed-rest 
resulted in a 24 % decrease in nonoxidative Leucine disappearance in participants 
assigned to a lower-protein diet (0.6 g protein·kg body wt-1·d-1), whereas Leucine 
kinetics were unchanged by the same bed-rest protocol in participants who 
received a higher-protein diet (1.0 g protein·kg body wt-1·d-1) (Stuart et al., 1990). 
In other words, whereas protein synthesis is suggested here to decrease with bed-
rest, dietary supplementation of protein appears to protect against this deleterious 
response. Even short periods of muscle disuse have been shown an early 
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catabolic molecular signalling response accompanying a substantial loss of 
skeletal muscle mass and strength (Wall et al., 2014). More recently, Wall et al. 
(2013) reported that knee immobilisation impaired the muscle protein synthetic 
response to dietary protein intake in vivo in healthy young men. 
1.4.2. Essential amino acids 
The ingestion of a mixed meal can switch human muscle protein balance from 
negative to positive (Rennie et al., 1982). This stimulation of muscle protein 
synthesis with a mixed meal appears to be mainly attributable to the increased 
availability of amino acids; therefore, amino acids alone appear to be able to 
stimulate muscle protein synthesis (Bennet et al., 1989; Fryburg et al., 1995; Smith 
et al., 1992). Studies have demonstrated directly that whey proteins and their 
constituent amino acids efficiently promote protein synthesis (Bos et al., 1999; 
Fouillet et al., 2002). The ingestion of only EAAs is sufficient for the acute 
stimulation of muscle protein synthesis (Børsheim et al., 2002). Bolus oral 
ingestion of EAAs produces a several-fold increase in plasma amino acid levels 
(Paddon-Jones, Sheffield-Moore, Zhang, et al., 2004) and has been shown to 
stimulate net protein synthesis to a greater extent than a mixed meal or a solution 
containing nonessential amino acids (Tipton et al., 1999). Studies have shown that 
providing a nutritional supplement enriched with EAAs could improve lean body 
mass, strength and physical function even without exercise (Katsanos et al., 
2006). 
Previous studies have shown improved nitrogen balance during both 6 and 
14 days of bed-rest when provided with a daily supplementation of 11 g of branch-
chain amino acids (BCAA), compared with the same dose of nonessential amino 
acids (Stein et al., 2003; Stein et al., 1999). It appears that a greater dose of EAAs 
(49.5 g·d-1) during 28 days bed-rest prevented any noticeable changes in muscle 
27 
 
mass (Paddon-Jones, Sheffield-Moore, Urban, et al., 2004). Paddon-Jones et al. 
(2004) however, reported that during this 28-day period, that although no changes 
in muscle mass were observed they did find a decline in muscle strength. 
Nonetheless, the decrease in muscle strength with EAAs (11 %) was still 
noticeably less than the decrease in strength seen in the control group (23 %) 
(Paddon-Jones, Sheffield-Moore, Urban, et al., 2004). These results collectively 
demonstrate a positive effect of EAAs supplementation during periods of bed-rest 
ranging from 6 to 28 days on both muscle mass and function (Paddon-Jones, 
Sheffield-Moore, Urban, et al., 2004; Stein et al., 2003; Stein et al., 1999). 
1.4.3. Creatine 
Creatine supplementation is another potential supplement that may attenuate 
hypo-activity induced decreases in muscle size and strength. Johnston et al. 
(2009) reported that short-term (29 days) creatine supplementation (20 g·d-1) 
attenuates the loss in muscle mass and strength during upper arm immobilisation. 
It is well known that muscle total creatine content can be rapidly raised by a high-
dose oral creatine intake (Harris et al., 1992) and that long-term creatine intake 
can enhance the effects of weight training on muscle size and strength (Terjung et 
al., 2000; Vandenberghe et al., 1997). Creatine supplementation during 10 weeks 
of resistance training has been shown to accelerate the rate of muscle hypertrophy 
in young adults who previously had their knee flexors immobilised for 2 weeks 
(Hespel et al., 2001). Furthermore, 14 days creatine supplementation during hind-
limb immobilisation lessened the rate of loss in the plantarflexors in a rodent model 
(Aoki et al., 2004). Additionally, Op’t Eijinde et al. (2001) showed that creatine 
supplementation prevented the loss of glucose transporter type 4 (GLUT4) during 
muscle disuse and increased muscle GLUT4 content above normal levels during 
subsequent rehabilitation. Collectively these studies suggest that creatine 
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supplementation during resistance training and rest may be effective at reversing 
or maintaining lower-body muscle mass during and after an immobilised state. 
1.4.4. Antioxidants 
Intricate antioxidant defence systems in the body work to continually manage 
oxidative stress. To counteract  ROS, enzymatic and nonenzymatic antioxidants 
work together (Mates et al., 1999). Enzymes work to improve or maintain an 
antioxidant balance and to avert oxidative damage by scavenging or preventing 
transformation of ROS to intracellular molecules and inhibiting their conversion to 
more deleterious forms. Endogenous nonenzymatic antioxidants such as vitamins 
C and E, carotenoids and flavonoids play important roles by contributing to the 
antioxidant system as cofactors for antioxidant enzymes. Results from Zwart et al. 
(2009) provide evidence that increased oxidative stress occurs during bed-rest. 
These data are also supported by results of several other studies that show 
evidence for elevated oxidative stress and increased ROS (Pawlak, Kedziora, 
Zolynski, Kedziora-Kornatowska, Blaszczyk andWitkowski, 1998; Pawlak, 
Kedziora, Zolynski, Kedziora-Kornatowska, Blaszczyk, Witkowski, et al., 1998; 
Zezerov et al., 1989). It would be interesting to see whether antioxidant 
supplementation during hypo-activity models will have beneficial effects on these 
outcome measures and furthermore, see whether this would then result in the 
attenuation of muscle loss in these models. 
1.4.5. Vitamin D 
Ceglia (2009) proposed vitamin D supplementation as an effective nutritional 
intervention to attenuate age related sarcopenia. Vitamin D is required to absorb 
calcium and phosphorus in the body and serves several important functions. It 
plays a crucial role in maintaining bone, muscle function, modulation of cell 
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growth, neuromuscular and immune function. Vitamin D has been shown to have 
direct effects on muscle (Ceglia and Harris, 2012); however, the exact 
mechanisms remain unknown. The identification of the vitamin D receptor (VDR) 
on muscle cells (Zanello et al., 1997; Bischoff et al., 2001) provides support for a 
direct effect of vitamin D on muscle tissue. The functions of vitamin D are 
characterised as genomic, mediated through the VDR transcriptional effects inside 
the cell nucleus, and non-genomic, when the VDR induces rapid signalling, 
situated on the cell membrane and/or cytoplasm. Once vitamin D has been 
transported to and bound to its nuclear receptor it results in changes in the gene 
transcription of mRNA and subsequent de novo protein synthesis (Freedman, 
1999). Research has demonstrated that vitamin D impacts on both the trans-
membranous flows of calcium and phosphate in skeletal muscle, and the synthesis 
rate of contractile properties (Stewart and Rittweger, 2006). 
Vitamin D supplementation (800 IU per day) for periods of 8 to 12 weeks 
has been reported to reduce postural sway and improve the risk of falling in elderly 
individuals (Bischoff et al., 2003; Pfeifer et al., 2000). Longer periods (12 months) 
of vitamin D supplementation (800 IU per day) in the elderly has been shown to 
increase strength, decrease body sway and increase physical performance 
(Pfeifer et al., 2009). However, in a healthy elderly population with no vitamin D 
deficiency, vitamin D supplementation does not appear to improve muscle strength 
or function (Grady et al., 1991; Johnson et al., 1980). It remains to be seen, 
whether vitamin D supplementation in healthy persons with no vitamin D 
deficiency, any enhancement in muscle structural or contractile properties can be 
attained in the presence of hypo-activity. 
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1.4.6. Omega-3 (EPA) 
Recent studies supplemented healthy young and elderly individuals with -3 fatty 
fish-oils for 8 weeks and found a significant increase in the muscle protein 
synthetic response to amino acid administration (Smith et al., 2011a; Smith et al., 
2011b). Though the mechanism responsible remains to be elucidated, it does not 
seem to be related to the proposed anti-inflammatory properties of omega-3 fatty 
acids. Instead, the authors suggested that omega-3 fatty acid supplementation 
may amplify the stimulatory effects of amino acids on the mTOR/p70S6K 
signalling pathway. They concluded in the elderly model that -3 fatty acids might 
be useful for the prevention and treatment of sarcopenia (Smith et al., 2011a). 
Dietary fish oil has also been shown to alleviate soleus muscle atrophy during 
immobilisation in association with Akt signalling in rats (You et al., 2010). It would 
therefore, seem reasonable to suggest that more investigation is needed in to the 
potential of -3 fatty acids as a nutritional supplement for attenuating muscle 
atrophy with hypo-activity. In parallel, it is believed that -3 fatty acids may impact 
on lean body mass though decreasing the effectiveness of catabolic cytokines, 
reduced protein degradation and improving insulin sensitivity (Siddiqui et al., 
2004). There is evidence to suggest that eicosapentaenoic acid (EPA) an -3 fatty 
acid may reduce the pro-inflammatory cytokines associated with inflammation 
(Magee et al., 2008). Magee et al. (2008) demonstrated in vitro that EPA inhibits 
the effects of tumour necrosis factor alpha (TNF-α) by reducing its apoptotic 
effects and enabling myogenesis. Previous research has suggested the potential 
of EPA to increase isometric and isokinetic torque (Houghton and Onambele, 
2012). It is unclear whether this supplement would have a beneficial effect during 
disuse models, where it is generally accepted that there is muscle atrophy 
(Grosset and Onambele-Pearson, 2008), which is associated with decreased 
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protein synthesis (de Boer, Selby, et al., 2007), but scant evidence for increased 
protein breakdown (Ferrando et al., 1996). 
1.5. Conclusion 
Hypo-activity models result in profound changes in skeletal muscle morphology 
and strength. Muscle mass and strength losses vary between different hypo-
activity models, with immobilisation causing the most profound decreases, greater 
than bed-rest and limb suspension. Decrements in muscle size and strength are 
seen in response to hypo-activity models with the greatest decrements seen in 
antigravity muscles. The decreases in strength seen with hypo-activity models 
surpass the losses in muscle mass and as such, the nervous system and 
contractile properties adapt to adjust for this excessive loss of strength. Nutritional 
supplementation may stand as a viable intervention to combat muscle atrophy with 
hypo-activity when exercise is not a practical prescription. There are several 
potential nutritional supplements that could be used to combat muscle atrophy but 
extensive research is needed to determine the most affective. 
1.6. Aims and objectives 
Consequently, the overall aim of the current thesis was to determine the role that 
nutritional supplementation may play in attenuating hypo-activity-induced atrophy. 
More specifically, the objectives were: 
1. To analyse changes in in vivo muscle as well as endocrine parameters and 
blood flow kinetics in response to immobilisation 
2. To determine the impact of several different nutritional supplements on the 
magnitude of change in these physiological parameters 
3. To identify whether pre-immobilisation supplementation has any impact on 
the effectiveness of reducing immobilisation-induced atrophy 
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1.7. Overview of thesis 
Chapter 1: This chapter has already discussed the varying impact of different 
hypo-activity models on: 
- muscle morphology 
- muscle strength 
- muscle fatigability 
The chapter also discussed potential nutritional interventions for preventing the 
loss of muscle mass/function seen with hypo-activity. 
 
 
 
 
 
Chapter 2: Effects of essential amino acid supplementation on muscular 
adaptations to 3 weeks of combined unilateral glenohumeral & radiohumeral joints 
immobilisation 
Participants 
Females n = 11, males n = 5, aged 21 ± 3.1 years 
Intervention 
Non-dominant arm immobilised in a sling for 9 waking hours a day over 3 
continuous weeks 
Essential amino acid vs. placebo supplementation during immobilisation 
Measures 
- Muscle and sub-cutaneous adipose thickness (b-mode ultrasonography) 
- Upper and lower arm girth (anthropometry) 
- Isometric torque (dynamometry) 
- Muscle activation (electromyography) 
- Serum interleukin-6 (ELISA) 
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Chapter 3: Omega-3 fatty acids and vitamin D in immobilisation: Modulation of 
appendicular mass content, composition and structure 
Participants 
Females n = 15, males n = 9, 23.0 ± 5.8 years 
Intervention 
Non-dominant arm immobilised in a sling for 9 waking hours a day, over 2 
continuous weeks 
Placebo vs. omega-3 fatty acids vs. vitamin D supplementation during 
immobilisation 
Measures 
- Muscle and sub-cutaneous adipose thickness (B-mode ultrasonography) 
- Body composition (DXA) 
- Arm girth (anthropometry) 
 
 
 
Chapter 4: Omega-3 fatty acids and vitamin D in immobilisation: Modulation of 
muscle functional, vascular and electromyographic profiles 
Participants 
Females n = 15, males n = 9, 23.0 ± 5.8 years 
Participants were the same sample as in Chapter 3 
Intervention 
Non-dominant arm immobilised in a sling for 9 waking hours a day, over 2 
continuous weeks 
Placebo vs. omega-3 vs. vitamin D supplementation during immobilisation 
Measures 
- Isometric and isokinetic torque (dynamometry) 
- Muscle co-contraction (electromyography) 
- Muscle fatigability indices (dynamometry and electromyography) 
- Arterial resting blood flow (Doppler ultrasound) 
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Chapter 5: Systemic endocrine profile following a small muscle, short duration, 
limb immobilisation 
Participants 
Females n = 12, males n = 9, 22.7 ± 6.7 years 
Participants were the same sample as in Chapter 3, with the exception of three 
participants for whom blood samples were not obtained 
Intervention 
Non-dominant arm immobilised in a sling for 9 waking hours a day, over 2 
continuous weeks 
Placebo vs. omega-3 vs. vitamin D supplementation during immobilisation 
Measures 
- Circulating creatine kinase (CK) 
- Circulating interleukin 6 (IL-6) 
- Circulating interleukin 10 (IL-10) 
- Circulating tumour necrosis factor alpha (TNF-α)  
- Circulating insulin like growth-factor (IGF-1) concentrations 
 
 
Chapter 6: Impact of pre-immobilisation protein supplementation on the time 
course of immobilisation-induced atrophy and asthenia 
Participants 
Females n = 6, males n = 4, 22.1 ± 4.3 years 
Intervention 
Non-dominant arm immobilised in a sling for 9 waking hours a day, over 2 
continuous weeks 
Essential amino acid vs. placebo supplementation before immobilisation 
Measures 
- Muscle and sub-cutaneous adipose thickness (B-mode ultrasonography) 
- Body composition (DXA) 
- Arm girth (anthropometry) 
- Isometric and isokinetic torque (dynamometry) 
- Muscle co-contraction (electromyography) 
- Muscle fatigability indices (dynamometry and electromyography) 
- Arterial resting blood flow (Doppler ultrasound) 
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Chapter 7: Summary, conclusions and recommendations 
- Contains the general discussion and conclusion of the thesis 
- In combining the findings of the preceding chapters, this chapter also considers 
the implications of these for future research in addition to outlining possible 
future directions 
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Chapter 2: Effects of essential amino acid 
supplementation on muscular adaptations to 3 weeks of 
combined unilateral glenohumeral & radiohumeral joints 
immobilisation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter appears in publication as: Bostock, E. L., Pheasey, C. M., Morse, C. 
I., Winwood, K., and Onambélé-Pearson, G. L. (2013) ‘Effects of essential amino 
acid supplementation on muscular adaptations to 3 weeks of combined unilateral 
glenohumeral & radiohumeral joints immobilisation.’ Journal of Athletic 
Enhancement 2(3). DOI: 10.4172/2324-9080.1000116 
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2.1. Introduction 
As discussed in Chapter 1, skeletal muscle has adaptive potential, meaning it is 
capable of altering its structure in response to environmental changes. In other 
words, the human muscular system shows great plasticity in response to different 
levels of physical activity. Prolonged reductions in muscle activity and mechanical 
loading, such as those experienced during limb suspension (de Boer, Maganaris, 
et al., 2007), bed-rest (LeBlanc et al., 1992), and immobilisation (Veldhuizen et al., 
1993), result in numerous physiological adaptations in skeletal muscle structure 
and function. It has consistently been demonstrated that long periods of hypo-
activity result in skeletal muscle atrophy (Abe et al., 1997; Akima et al., 2001) and 
a decrease in maximal voluntary strength (Clark et al., 2008; Hortobagyi et al., 
2000; Miles et al., 1994; Semmler et al., 2000; Veldhuizen et al., 1993; Yue et al., 
1997). However, discrepancies exist between the reductions in muscle strength 
and in muscle size seen with hypo-activity models (Clark et al., 2006; Kawakami et 
al., 2001; Thom et al., 2001; Veldhuizen et al., 1993). These observations would 
tend to suggest that part of the observed reduction in maximal voluntary 
contraction (MVC) may be due to reduced drive from the central nervous system 
to the muscle. 
Reductions in muscle mass with hypo-activity may be the result of a 
decrease in protein synthesis, an increase in protein breakdown or a combination 
of the two (Bamman et al., 1998). On the topic of potential for increased protein 
breakdown, it is noted that periods of immobilisation have been associated with 
increased fatty tissue deposition (Manini et al., 2007). Adipose tissue produces 
and secretes inflammatory cytokines, for example interleukin-6 (IL-6) (Mohamed-
Ali et al., 1998) and the expression and plasma levels of such cytokines increase 
with increased adiposity (Ahima and Flier, 2000; Pedersen et al., 2003). The 
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elevation of “pro-inflammatory” cytokines such as IL-6 is generally viewed to be 
potentially deleterious with regard to skeletal muscle. For example, it has been 
observed that IL-6 either directly or indirectly mediates catabolic effects on skeletal 
muscle (Goodman, 1994). It should be noted that whilst some IL-6 signalling is 
also important to initiate the cascade to signal protein synthesis (Saini et al., 
2009), findings from Haddad et al. (2005) suggest that down-regulation of growth 
factor-mediated intracellular signalling may be a mechanism contributing to the 
development of muscle atrophy induced by significantly elevated IL-6. On the topic 
of potential for increased protein breakdown, it is noted that Ferrando et al. (1996) 
reported a loss of lean muscle mass, accompanied with a 14 % decrease in 
protein synthesis and no change in protein breakdown in response to 14 days 
simulated microgravity. Gibson et al. (1987) noted a marked fall in muscle protein 
synthesis in response to 7 weeks leg immobilisation. More recently, a shorter 
period of immobilisation (21 days) provided very little evidence of any increases in 
messenger ribonucleic acid (mRNA) for catabolic enzymes or increases in enzyme 
activity during this period (de Boer, Selby, et al., 2007). In contrast to this there is 
some suggestion in the literature that such increases in catabolic potential do 
occur, and for this event to happen very quickly (48 hours) after immobilisation 
(Urso, Scrimgeour, et al., 2006). Nonetheless, the weight of the evidence would 
suggest that it is unlikely that protein breakdown is a key modulator in the process 
of muscle atrophy occurring during immobilisation in humans (Rennie, 2009; 
Rennie et al., 2010).  
There is clear evidence that physical activity (and resistance exercise in 
particular) provides an anabolic stimulus during hypo-activity (Akima et al., 2000; 
Bamman et al., 1998; Ferrando et al., 1997). Moderate-resistance exercise (5 sets 
x 8 reps to volitional fatigue) every other day during 14 days bed-rest prevented a 
decline in muscle protein synthesis, whereas bed-rest alone elicited a 46 % 
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decrease in muscle protein synthesis (Ferrando et al., 1997). Isometric leg press 
training (3 sets x 30 reps) during 20 days of bed-rest resulted in no changes in 
physiological cross sectional area (PCSA), whereas in the bed-rest control group 
PCSA decreased by 7.8 % (Akima et al., 2000). A number of nutritional 
interventions exist that have proven anabolic effects. For instance, when 
supplemented with either whole proteins (Burke et al., 2001) or simply essential 
amino acids (EAA) (Brooks et al., 2008), the benefits of exercise appears additive. 
It may not, however, always be practical to prescribe exercise to counteract the 
atrophy brought about by hypo-activity. This would tend to be linked to the 
presence of counter-indications for exercise such as pain or immobilisation in a 
cast. In these cases, supplementing the diet with potential/recognised hypertrophic 
nutrients may be an intervention of choice for preventing the loss of muscle 
mass/function seen with hypo-activity. Promising results have been observed in 
research utilising an increased protein intake (from 0.6 to 1.0 g·kg-1·day-1) to 
ameliorate the catabolic responses to 1 week of bed-rest (Stuart et al., 1990). 
Unlike protein supplementation, EAA supplementation does not affect 
satiety, and further, does not alter the metabolic effects of subsequent meals 
(Paddon-Jones et al., 2005). This thus, means that EAAs are likely to be the 
preferred nutritional supplement. Bolus oral ingestion of EAAs produces a rapid, 
several-fold increase in plasma amino acid levels (Paddon-Jones, Sheffield-
Moore, Zhang, et al., 2004) and has been shown to  stimulate net protein 
synthesis to a greater extent than a mixed meal or a solution containing 
nonessential amino acids (Tipton et al., 1999). A study has in fact suggested that 
providing a nutritional supplement enriched with EAAs could improve lean body 
mass, strength and physical function, even without exercise (Katsanos et al., 
2006).  
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It is evident from previous research that immobilisation decreases lean 
body mass, and that EAA supplementation improves lean body mass in several 
models from increased physical activity (Kraemer et al., 2009) to bed-rest 
(Paddon-Jones, Sheffield-Moore, Zhang, et al., 2004).  Whilst these findings are 
interesting, they cannot be extended to all models of hypo-activity. Indeed, 
previous studies show that each model of hypo-activity impacts on muscle 
structure and function differently (Clark, 2009), hence, decreasing one’s ability to 
extrapolate the effects of one treatment between models of hypo-activity. 
Research is lacking in immobilisation studies in humans in which EAA 
supplementation is given as an intervention.  
The aim of the present study was, therefore, to determine the role that EAA 
supplementation may play in attenuating atrophy induced through a model that 
would emulate relatively short-term decreased local mobility/activity in humans. 
The differential effect of immobilisation on in vivo muscle (size, strength), sub-
cutaneous adipose tissue (thickness), neural (electromyography (EMG) activity) 
and cytokine (circulating interleukin-6) factors, in the presence or absence of EAA 
supplementation, was systematically monitored. It was hypothesised that EAA 
supplementation during combined shoulder and arm immobilisation would 
attenuate the deleterious changes in muscle, fat and cytokine in vivo 
characteristics associated with hypo-activity models. 
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2.2. Methods 
2.2.1. Participants 
Eighteen healthy volunteers were recruited from the local university campus; via 
word of mouth and posters. All participants gave written informed consent to take 
part in the study. Prior to commencement of the study, the local Ethics Committee 
of Manchester Metropolitan University approved all procedures and experimental 
protocols. Exclusion criteria included any conditions requiring the use of 
medications likely to affect muscle function or musculoskeletal health, and any 
current or history of kidney/liver disease. Before taking part in the study, 
participants completed a questionnaire (Appendix 4) to ascertain health and 
habitual physical exercise levels. The questionnaire confirmed that all participants 
were recreationally active and free from recent upper limb injury. Participants were 
randomly assigned to one of two groups, though two subsequently withdrew 
during the course of the study for personal reasons. Hence, the present report 
describes data from the remaining sixteen participants: EAA group [EAA: n = 9 (3 
male, 6 female), 20 ± 1.5 years, 63.8 ± 8.1 kg, 169.6 ± 8.7 cm] and placebo group 
[PLA: n = 7 (2 male, 5 female), 23 ± 3.9 years, 66.9 ± 9.5 kg, 167.0 ± 7.2 cm]. 
2.2.2. Study design 
The study used a randomised, double-blind, placebo-controlled design. Following 
familiarisation with testing procedures at least one week prior to testing, 
participants attended the laboratory between 8h00 and 10h00 after an overnight 
fast, as to standardise the time of day across sessions and participants. The non-
dominant arm of the participants was placed in a sling immediately after baseline 
testing and the correct procedure for sling wear was explained to the participant. 
Essentially, the aim was to minimise any movement medio-laterally at the elbow 
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and shoulder (see Figure 2.1), whilst requiring participants to not contract the 
upper musculature (including the hands) during the hours of immobilisation. 
Participants were required to wear this sling for approximately nine waking hours 
per day, over a 3-week period. A 3-week period was chosen as it is in-line with 
previous upper limb studies as described in Chapter 1. Removal of the sling was 
only permitted when necessary (e.g. taking a bath/showering, driving, going to bed 
at night) but the 9 hours did not have to be continuous. Measures of muscle and 
subcutaneous adipose thickness, upper and lower arm girth, serum cytokine, 
isometric torque and electromyographic activation were taken immediately before 
immobilisation (Pre; i.e. on day 1 of immobilisation) and immediately on removal of 
the sling (Post; i.e. within 2 days of remobilisation). Details of all the procedures 
are below. 
During the 3 weeks immobilisation phase participants in the EAA group 
ingested 2 x 30 mL per day of a commercially available EAA drink (BodyFortress, 
Holland & Barrett, UK), whereas participants in the PLA group ingested a placebo 
drink. Each 30 mL dose of the Liquid Amino nutritional supplement is described by 
the manufacturer as containing 22 g of protein (~30% EAA) i.e.: 1121 mg L-
Alanine; 1223 mg L-Arginine; 655 mg L-Aspartic Acid; 1456 mg L-Glutamic Acid; 
3394 mg Glycine; 1311 mg L-Histidine; 218 mg L-Hydroxylysine; 1791 mg L-
Hydroxyproline; 175 mg L-Isoleucine; 378mg L-Leucine; 480 mg L-Lysine; 131 mg 
L-Methionine; 233 mg L-Phenylalanine; 1995mg L-Proline; 495 mg L-Serine; 277 
mg L-Threonine; 87 mg L-Tyrosine; and 320 mg L-Valine. The placebo mixture 
consisted of a homemade blend of water, wild cherry flavouring, honey, salt and a 
red food colourant, designed to emulate the appearance and to a degree the taste 
of the EAA supplement. At day 1 of immobilisation, participants were given clear 
instructions regarding the dosage of the formula.  Participants ingested the twice-
daily dose of EAA or placebo at 8h00 and 18h00, these timings allowed for 
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consistency within and between participants. During the 3 weeks immobilisation 
period, participants were instructed to maintain their normal diet and refrain from 
unaccustomed strenuous activity. To monitor this, participants completed a daily 
food and activity diary and wore a pedometer to record the number of steps taken 
each day. Participants were asked to report their dietary intake as accurately as 
possible and were provided with strict instructions. Dietary analysis does rely on 
the compliance of participants and this cannot be guaranteed, however, previous 
studies have reported good reliability with self-reported dietary intake (Brunner et 
al., 2001; Day et al., 2001). 
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Figure 2.1. (A) Front, side and back view demonstrating sling wear. The sling was 
initially demonstrated by the experimenter and on subsequent applications, sling 
application was self-administered by each participant. (B) Anatomical diagram of 
the immobilised muscles and bones. (C) Anatomical diagram of the radiohumeral 
joint. 
Origin 
Origin Biceps 
Triceps 
Humerus 
Insertion 
Insertion 
Radius 
Ulna 
Humerus 
Radius 
Ulna Lateral epicondyle 
A 
B 
C 
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2.2.3. Muscle and sub-cutaneous adipose thickness measures 
To avoid fluid shifts that might induce interstitial and/or intracellular changes all 
images were recorded after approximately 20 minutes of seated rest (Berg, 
Tedner, et al., 1993). B-mode ultrasonography (AU5, Esaote, Genoa, Italy), using 
a 7.5-MHz linear phased-array probe (image depth: 37.1 – 92.8 mm), was applied 
in the sagittal plane to obtain images of the muscles and sub-cutaneous adipose 
tissue of the upper arm. Images were recorded using an analogue capture card 
(Pinnicale DV500, Adobe, Maidenhead, UK) and stored for later analysis. Care 
was taken to apply minimal pressure onto the tissue area of interest during 
scanning, in order to avoid any image distortion. This method has been used many 
times previously by others, with great reliability (Miyatani et al., 2004; Miyatani et 
al., 2002; Onambele et al., 2006). 
Images were obtained with the participant in an upright-seated position, 
their arms hanging by the sides in the anatomical position. In the upper arm, the 
proximal and distal insertions of the biceps and triceps brachii were identified, 
marked on the skin and the mid-point was identified. Upper arm ultrasonography 
images were collected in the sagittal plane, mid-limb length, and at the level of the 
mid-acromiale-radial. Muscle thickness was measured as the distance from the 
top of the superficial muscle aponeurosis to the bone in the biceps and triceps 
brachii (see Figure 2.2). Sub-cutaneous adipose thickness was measured as the 
distance from the bottom of the epidermis to the top of the superficial muscle 
aponeurosis in the biceps and the triceps brachii (see Figure 2.2). These distances 
were measured at three standardised points on each ultrasound frame to obtain 
average muscle and sub-cutaneous adipose thicknesses using ImageJ analysis 
software (ImageJ 1.37, Maryland, USA). 
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Figure 2.2. Ultrasound images of the biceps Pre- (A) and Post-immobilisation (B) 
and the triceps brachii Pre- (C) and Post-immobilisation (D). The red arrows 
indicate sub-cutaneous adipose thickness measurement sites. The white arrows 
indicate muscle thickness measurement sites. 
2.2.4. Arm girths 
Participants were asked to assume a relaxed standing position with arms hanging 
by the sides, palms facing the sides of the hips. Upper arm girth (relaxed) was 
measured using a measuring tape at the level of the mid-acromiale-radial: with the 
arm abducted slightly to allow the tape to be passed around. Forearm girth was 
measured at a fixed point 1/4 of the way (from the proximal end) along the length 
of the radiale-stylion: with the arm slightly flexed at the shoulder and the elbow 
extended. 
73.3 mm 
49.3 mm 
A B 
C D 
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2.2.5. Isometric dynamometry 
Maximal isometric torque was measured using a Cybex dynamometer (Cybex, 
New York, USA). Participants were positioned as per the manufacturers’ 
recommendations. Briefly, they were fastened to the dynamometer in a supine 
position with the trunk and lower limbs firmly strapped to minimise any extraneous 
movement. The axis of rotation of the dynamometer was aligned with the 
anatomical axis of rotation of the elbow joint (lateral epicondyle) and the upper arm 
secured using padded strapping, mid acromiale-radial. The participant’s functional 
range of motion was measured and safety stops were set both electronically and 
manually, to prevent hyper- extension/flexion. A gravity correction was made for 
limb weight on torque measurements. All measurements were preceded by a 
warm-up period consisting of 2 mins of isokinetic contractions increasing in 
intensity, followed, after 2 mins rest, by one isometric contraction at a 90° elbow 
joint angle. Following a further 2 mins rest, two repetitions of isometric 
contractions, 60 sec apart, were performed at a 90° elbow joint angle and the 
highest torque was recorded as the participant’s MVC.  During all MVC attempts, 
participants were instructed to rapidly exert maximal torque against the Cybex 
lever arm over a 3-4 s period, first in the direction of flexion and, 5 sec after return 
to baseline, in the direction of elbow extension. Participants were encouraged to 
exert maximal torque through a combination of verbal and visual feedback. Torque 
and angle were displayed on the screen of a computer (Macintosh G4; Apple 
Computer, Cupertino, CA), which was interfaced with an A/D system 
(Acknowledge, Biopac Systems, Santa Barbara, CA) with a sample frequency of 
200 Hz. Peak torque was averaged over a 500 ms period (i.e. 250 ms either side 
of the instantaneous peak). The highest of the repeated efforts was used as the 
participant’s measure of MVC. 
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2.2.6. Electromyographic measurement 
EMG was used to asses muscle activation patterns. The skin was prepared by 
shaving, abrading and cleaning with an alcohol-wipe to minimise resistance below 
5k. Self-adhesive Ag-Cl (Medicotest, Rugmarken, Denmark) surface electrodes 
were then placed in pairs on the midsagittal plane of the biceps and the triceps 
brachii muscles, with reference electrodes placed on the lateral and medial 
epicondyle of the humerus. Cross talk was minimised by a) the cables being 
insulated, b) having very small electrodes c) leaving a 2 cm gap between 
electrodes (Winter et al., 1994). These data were acquired using the same system 
that acquired the torque data (as described above). Raw EMG data were recorded 
at 2000 Hz, with a band pass filter set at 10-500 Hz, with a notch set at 50 Hz. 
2.2.7. Interleukin-6 (IL-6) 
After a 10-12-hour overnight fasting period, before any of the other laboratory 
measures, blood samples were taken from the antecubital vein of the forearm by a 
hospital-trained phlebotomist, using a 21ml gauge needle (S-Monovette, Sarstedt, 
Germany). Subsequently, 5-10 mL of venous blood was permitted to clot on ice for 
up to 1 hour. Samples were then centrifuged (Hermle Z 380, Huddersfield) at 5°C 
and at 7500 rpm for 15 minutes to separate the serum from the blood cells. 
Aliquots (~1000 μl each) of the resulting sera were stored at -20oC for later analysis. 
IL-6 (R&D systems, Abingdon, UK) in the sera samples was quantified using 
standard quantikine high sensitivity (i.e. up to 10 pg/mL of IL-6) enzyme-linked 
immunosorbent assay (ELISA). Optical density was read at 490 nm with a lambda 
correction at 650 nm. Intra-assay (coefficient of variation (CV) = 7.4 %) and inter-
assay (CV = 7.8 %) precisions, were all within acceptable boundaries. The minimum 
detectable dose ranged from 0.016 to 0.110 pg/mL (average = 0.039 pg/mL). 
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2.2.8. Statistics 
Data were analysed using IBM SPSS v19 (IBM Inc, USA). The Shapiro-wilk test 
revealed some of the data to be non-parametric (triceps sub-cutaneous adipose 
thickness, triceps muscle thickness change, biceps torque, biceps torque change, 
EMG and serum IL-6) and in those cases, the data sets were log transformed. 
Once transformed the data was checked for normality. Parametric Pre to Post 
difference data were analysed using paired sample t-tests. If non-parametric, the 
differences between Pre to Post were analysed using the Wilcoxon signed-rank 
test. Between group differences in relative change data were analysed either using 
unpaired t-tests (if parametric), or Mann-Whitney U test (if non-parametric). All 
data are presented as mean ± standard deviation (SD). Statistical significance was 
set with alpha at ≤0.05. 
2.3. Results 
2.3.1. Measurements reliability 
The assessment of the intra- and inter-day repeatability of measurements was 
conducted in a sub-sample of five participants. Those randomly chosen 
participants were asked to attend a separate repeatability testing date for between 
day measures, no less than seven days prior to their Pre-immobilisation testing 
session. A seven-day period was chosen as to not let the testing session impact 
on the results of the sub-sequent session. The repeatability of unilateral isometric 
strength, EMG, muscle and sub-cutaneous adipose thickness, as well as 
anthropometry were measured at the same time-of day to avoid any difference 
owing to diurnal effects (Pearson and Onambele, 2005). Within-day CV of 4.9 %, 
4.9 %, 3.6 %, 8.9 %, 0.6 % and 4.4 %, and between-day CVs of 8.6 %, 8.6 %, 4.0 
%, 7.4 %, 1.7 % and 6.4 % were yielded for unilateral elbow flexion torque at 90°, 
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unilateral elbow extension torque at 90°, mid-upper arm biceps muscle thickness, 
mid-upper arm triceps muscle thickness, mid-upper arm biceps fat thickness and 
mid-upper arm triceps fat thickness, respectively. 
2.3.2. Daily physical functioning and nutritional intake 
No significant change was observed in habitual physical activity (p>0.374) or in 
calorific intake (p>0.420) during the course of immobilisation. This effect was true 
for both the EAA and the PLA groups. Dietary analysis revealed no significant 
difference in habitual protein intake over the three-week period between the EAA 
and PLA groups (see figure 2.3). 
2.3.3. Muscle and sub-cutaneous adipose thicknesses 
Muscle and sub-cutaneous adipose thickness values are displayed in Table 2.1. 
Comparisons of percentage change in biceps and triceps muscle thicknesses 
revealed no significant differences between the EAA and PLA groups (biceps 
p=0.096; triceps p=0.172). Comparison of percentage change in biceps sub-
cutaneous adipose thickness revealed a significant difference between the EAA 
and PLA groups (Student’s t-test; p=0.03). Comparison of percentage change in 
triceps sub-cutaneous adipose thickness revealed no significant difference 
between the EAA and PLA groups (Student’s t-test; p=0.100). 
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Figure 2.3. Daily protein intake (g·kg bw-1 ± SD) for: A) the EAA group (white bars) 
and PLA group (grey bars); B) EAA group plus protein intake provided by the EAA 
supplement (white bars) and the PLA group (grey bars). † Significant difference in 
protein intake between supplement groups. 
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Table 2.1. Differences in muscle and sub-cutaneous adipose thickness 
measurements Pre- and Post-immobilisation (mm ± SD) of the biceps and the 
triceps brachii. Values are reported for the EAA and PLA groups. Percentage 
changes from Pre- to Post-immobilisation are also reported (% change ± SD). * 
Significantly different change from Pre- to Post-immobilisation (p<0.05). † 
Significant difference in % change between EAA and PLA groups. 
 
 
 
 
 
 
 
 EAA PLA 
Biceps muscle 
thickness 
Pre 24.7 ± 2.5 25.2 ± 4.2 
Post 23.4 ± 3.3 25.2 ± 4.6 
% Change -5.1 ± 11.4 % -0.4 ± 3.8 % 
Biceps sub-
cutaneous 
adipose  thickness 
Pre 5.0 ± 3.0 4.9 ± 3.7 
Post 4.9 ± 3.0 5.0 ± 2.7 
% Change -3.3 ± 11.8 % † 19.6 ± 30.5 % † 
Triceps muscle 
thickness 
Pre 32.0 ± 7.9 30.4 ± 7.5 
Post 27.8 ± 7.0* 28.4 ± 6.5 
% Change -11.7 ± 15.0 % -5.5 ± 11.4 % 
Triceps sub-
cutaneous 
adipose  thickness 
Pre 10.3 ± 6.0 13.0 ± 7.9 
Post 10.1 ± 5.4 13.0 ± 8.2 
% Change -0.8 ± 9.3 % 0.0 ± 11.4 % 
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2.4.4. Arm girth 
Pair-wise (Students t-test) comparisons revealed that upper and lower arm girths 
decreased significantly Post-immobilisation in the PLA group (30.6 ± 3.6 cm to 
30.1 ± 3.6 cm (p<0.01) and 25.9 ± 1.9 cm to 25.4 ± 1.8 cm (p<0.01), respectively) 
but not the EAA group (29.3 ± 3.3 cm to 29.2 ± 3.2 (p>0.05) and 25.0 ± 1.8 to 24.9 
± 1.8 (p>0.05), respectively). Percentage change in arm girth was significantly 
greater in the PLA group than the EAA group in both the upper and lower arm 
(Student’s t-test; p=0.010, p=0.045, respectively) (Figure 2.4).  
  
 
 
 
 
 
 
 
 
Figure 2.4. Percentage changes (% ± SD) in upper and lower arm girth for the 
EAA (white bars) and the PLA (grey bars) groups. † Significant difference in % 
change between EAA and PLA groups. 
2.3.5 Isometric dynamometry 
Elbow flexion torque values are shown in Table 2.2. Pair-wise (Students t-test) 
comparisons revealed elbow flexion torque decrease from Pre- to Post-
immobilisation only in the EAA group (p=0.04). Elbow extension torque values are 
shown in Table 2.2. Despite the apparent trend for a decrease in elbow flexion and 
† † 
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extension torque values, to be greater in the PLA group than EAA group, this 
effect was not significant (p>0.05). 
Normalising elbow flexion torque by biceps muscle thickness, this ratio 
decreased by 6 % in the EAA group (0.81 Nm/mm (Pre) to 0.76 Nm/mm (Post)) 
and 20 % in the PLA group (0.80 Nm/mm (Pre) to 0.64 Nm/mm (Post)) (p>0.05). 
Normalising elbow extension torque by triceps muscle thickness, this ratio 
increased by 15 % in the EAA group (0.60 Nm/mm (Pre) to 0.69 Nm/mm (Post)) 
and decreased by 23 % in the PLA group (0.65 Nm/mm (Pre) to 0.50 Nm/mm 
(Post)) (p>0.05). 
2.3.6. Agonist and antagonist EMG activity 
EMG data were non-parametric. Values for agonist EMG activity and antagonist 
co-contraction ratios are shown in Table 2.2. Statistical analysis revealed no within 
or between group differences in agonist EMG activity or antagonist co-contraction 
ratios in either flexion or extension isometric contractions. 
2.3.7. Circulating IL-6 levels 
Changes in IL-6 are shown in Figure 2.5. A pair-wise (Students t-test) comparison 
revealed no significant effect of supplement group on the degree of percentage 
change in IL-6 values from Pre- to Post-immobilisation (p>0.05). 
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Table 2.2. Differences in elbow flexion and extension torque (Nm ± SD), agonist 
activation (mV ± SD) and co-activation ratio (% ± SD) Pre- and Post-
immobilisation. Values are reported for the EAA and PLA groups. Percentage 
change in mean torque and agonist EMG activity from Pre- to Post-immobilisation 
are also reported. * Significantly different change from Pre- to Post-immobilisation 
(p<0.05). 
  EAA PLA 
Elbow flexion 
Torque 
Pre 20.0 ± 7.0 20.2 ± 5.3 
Post 
17.7 ± 7.0*  
(p=0.04) 
16.2 ± 2.7 
(p=0.21) 
% Change -11.5 % -19.8 % 
Elbow flexion 
agonist EMG activity 
Pre 173 ± 176 170 ± 71 
Post 236 ± 73 207 ± 153 
% Change 36 % 21 % 
Elbow flexion  
antagonist co-activation ratio 
Pre 69.1 ± 23.0 % 66.5 ± 34.7 % 
Post 54.3 ± 13.8 % 53.1 ± 13.1 % 
Elbow extension  
torque 
Pre 19.3 ± 5.2 19.8 ± 4.6 
Post 
19.1 ± 7.7  
(p=0.82) 
14.3 ± 6.6 
(p=0.20) 
% Change -1.0 % -27.8 % 
Elbow extension  
agonist EMG activity 
Pre 281 ± 112 252 ± 172 
Post 156 ± 14 289 ± 118 
% Change -44.5 % 14.7 % 
Elbow extension 
antagonist co-activation ratio 
Pre 60.1 ± 20.7 % 81.4 ± 23.9 % 
Post 59.4 ± 18.6 % 64.5 ± 21.4 % 
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Figure 2.5. Plasma IL-6 levels for the EAA (white bars) and the PLA (grey bars) 
groups, Pre- and Post-immobilisation (pg/mL ± SD). 
2.3.8. Association studies 
Bivariate correlations between relative change values for all reported measures 
are displayed in Table 2.3.  The change in bicep sub-cutaneous adipose thickness 
correlated with the change in triceps brachii muscle thickness (r=0.57, p=0.01). 
The relative change in upper arm girth correlated with percentage changes in 
lower arm girth (r=0.70, p=0.001), elbow extension torque (r=0.52, p=0.03), and IL-
6 levels (r=0.56, p=0.02). Percentage changes in extension torque and IL-6 levels 
were also strongly correlated (r=0.80, p<0.001). 
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2.4. Discussion 
The purpose of this study was to determine the effect of 3 weeks of 9-waking-
hours-per-day arm immobilisation on in vivo muscle characteristics (size, strength 
and EMG activity), sub-cutaneous adipose content and IL-6 profile and to 
determine any impact of EAA supplementation on the magnitude of change in 
these physiological parameters. The hypothesis was that EAA supplementation 
during arm immobilisation would attenuate the deleterious changes associated 
with hypo-activity models. Evidence was found to partly support this hypothesis, in 
that arm girth decreased more so with the placebo supplement than the EAA 
supplement and with a notable trend towards a greater decrease in elbow flexion 
and extension torque, as well as significantly further increased sub-cutaneous fatty 
tissue with the placebo supplement. The changes in muscle thickness (only 
significant in the triceps brachii), do not explain the differential arm girth responses 
between groups. 
Upper and lower arm girths were shown to significantly decrease Post-
immobilisation in the PLA group only. Girth was used as a gross marker of skeletal 
muscle atrophy, as previously used by Matsumura et al. (2008). Decreases in 
upper arm girth (0.9 % = 0.04 %/day) suggest a decrease in muscle CSA in the 
upper arm in the PLA group and this supports previous findings of a decrease in 
elbow flexor muscles CSA (11.2 % = 0.4 %/day) and volume (11.6 % = 0.4 %/day) 
with arm immobilisation (Yue et al., 1997). The decrease in lower arm girth (1.1 % 
= 0.05 %/day) suggests a decrease in forearm muscle CSA in the PLA group. This 
is in line with findings from Miles et al. (1994) who reported a 4.1 % (0.5 %/day) 
decrease in forearm muscle CSA with 9 days arm casting. Other studies suggest 
that forearm immobilisation does not induce a decrease in muscle CSA as 
evaluated both by magnetic resonance imaging (MRI) and circumference 
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measurement during relatively short duration (3 weeks) immobilisation (Kitahara et 
al., 2003; Matsumura et al., 2008). The changes in arm girth, as well as the 
decrease in upper arm triceps brachii muscle thickness, in the current study 
suggest that changes in muscle CSA are lower than those reported in previous 
studies (Miles et al., 1994; Yue et al., 1997). This apparent discrepancy with the 
rest of the literature, whereby in the current study relatively small degrees of 
atrophy during limb immobilisation were observed, where others have observed 
(though not always) a substantial atrophic response could be due to the following: 
a) the method of measuring the change in muscle CSA: in the present study arm 
girth and sagittal plane ultrasound scans were used as markers of muscle size, 
whereas previous studies have used MRI as a direct measure; b) the method of 
immobilisation and resultant immobilisation compliance: the immobilisation in the 
present study was for 9 waking hours a day with a self-administered sling, 
compared to continuous immobilisation in other studies which used casts for the 
full immobilisation period. Nonetheless, differences in changes in arm girth from 
Pre- to Post-immobilisation between the EAA and PLA groups suggest that EAA 
supplementation may attenuate changes in muscle size. This supports promising 
results observed in 1 week of bed-rest that showed increased protein intake (from 
0.6 to 1.0 g·kg-1·day-1) to modulate the catabolic response (Stuart et al., 1990).  
The significant difference in limb CSA is not reflected entirely in the current 
ultrasound data, since the current study found no change in biceps muscle 
thickness but a decrease in triceps brachii muscle thickness Post-immobilisation. 
The fact that there is a decrease in skeletal muscle tissue with immobilisation, 
even though relatively moderate in its duration/restriction of movement, was in fact 
not surprising (Miles et al., 1994). However, it had been expected that the muscle 
held in the shortened position (i.e. the biceps), to be impacted on more, than the 
muscle held in the lengthened position (i.e. the triceps brachii).  Muscle stretch is a 
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modulator of sarcomeres being added in series and as such acts as a signal for 
protein synthesis. Previous research suggests that when the muscle is 
immobilised in the lengthened position sarcomeres are added in series, and when 
the muscle is immobilised in the shortened position sarcomeres are lost (Tabary et 
al., 1972; Williams and Goldspink, 1973). The current findings are in contrast with 
those of Yue et al. (1997) who investigated the effect of 4 weeks elbow joint 
immobilisation with a fibre glass cast and reported decreases in elbow flexor CSA 
(11.2 % = 0.4 %/day) and volume (11.6 % = 0.4 %/day). One probable cause of 
the discrepancy between the current study and that of Yue et al. (1997), could be 
the method of quantifying muscle size. Whereas those authors utilised CSA using 
MRI scans of the whole muscle, the present study used a single plane scan of the 
biceps at mid-limb length (which does not correspond to mid muscle length). 
These differences are key, in relation to 1) the fact that the biceps is a fusiform 
muscle and thus any positional change along its length would result in a difference 
in size. Since it is recognised that the greatest degree of muscle hypertrophy for a 
muscle is at the belly (Narici, 1999), it is not surprising that in the present study the 
degree of change reported is reduced relative to that of those previous authors. 2) 
the reliability of the single sagittal scans (e.g. CV = 2.2 % in the current study) 
versus that of CSA (error for repeated measures = <1 %) (Yue et al., 1997), could 
also be a factor on the ability to capture the real size alteration events in the 
muscle. It should be noted nonetheless, that a large number of studies have 
previously found decreases in thigh (0.8 – 1.2 %/day) (Thom et al., 2001; 
Veldhuizen et al., 1993) and calf (0.3 – 0.6 %/day) (Haggmark and Eriksson, 1979; 
White et al., 1984) muscle CSA with lower limb immobilisation using a variety of 
techniques including computed tomography (Haggmark and Eriksson, 1979; 
Veldhuizen et al., 1993), ultrasonography (Thom et al., 2001) and limb 
circumference measures (White et al., 1984).  Observations are that the degree of 
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muscle atrophy is greater in the lower limbs than in the upper limbs. This may be 
explained by the weight-bearing nature and greater musculature in the lower 
limbs. It may be the case, that the threshold of muscle synthesis is such that it 
takes little decrease in loading of lower limbs to demonstrate a change in protein 
metabolism in favour of decreased protein synthesis (Tesch et al., 2008). 
Contrary to expectation, no main effect was shown for supplement group on 
muscle thickness of the biceps or of triceps brachii. This does not support a study 
that showed a decrease in the catabolic response to 1 week of bed-rest with 
increased protein intake (Stuart et al., 1990). Stuart et al. (1990) investigated the 
effects of 7 days bed-rest on two groups consuming iso-caloric diets containing 
either 0.6 or 1.0 g·kg -1·day-1 of protein and found that the decrease in protein 
synthesis seen with low dietary protein, was prevented by higher dietary protein. 
However, they did not measure muscle size and the changes found in protein 
synthesis may not have resulted in phenotypical changes in muscle size. 
Comparisons between the study of Stuart et al. (1990) and the current study are, 
therefore, difficult, particularly as their treatment manipulated whole protein 
content of iso-caloric diets, whereas the current study supplemented the habitual 
diet with EAAs. The amount of supplement provided in the present study may not 
have been sufficient to induce an attenuation of muscle thickness decrease. An 
alternative explanation for the small effectiveness of EAA supplementation in this 
study can be through the “muscle full” hypothesis (Millward and Pacy, 1995), in 
which there is an upper limit of amino acid delivery before muscle cells can no 
longer use them as a substrate for muscle protein synthesis, instead diverting 
them toward oxidation (Bohe et al., 2001).  The mean percentage change in 
biceps sub-cutaneous adipose thickness was significantly different in the PLA 
group than in the EAA group, whereby PLA demonstrated an increase in sub-
cutaneous adipose thickness from Pre- to Post-immobilisation, and the EAA group 
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exhibited a slight decrease in sub-cutaneous adipose thickness. This is in 
agreement with previous studies (Manini et al., 2007). EAA supplementation, 
therefore, appeared to attenuate the increase in biceps sub-cutaneous adipose 
thickness. A previous study showed that providing a nutritional supplement 
enriched with EAAs could improve lean body mass even without exercise 
(Katsanos et al., 2006). In this case, the results may suggest that the EAA 
supplement is working towards maintaining lean mass by reducing the increase in 
fat mass. Indeed levels of circulating insulin help modulate the long-term level of 
fat stored in the body in any particular environment (Porte et al., 1998; Woods et 
al., 1998). EAA ingestion has been shown to significantly increase insulin levels 
(Paddon-Jones, Sheffield-Moore, Zhang, et al., 2004) and, therefore, this may 
provide an explanation as to why the EAA supplement attenuated the increase in 
subcutaneous adipose thickness in the current study. 
As mentioned in the introduction, previous research suggests that 
immobilisation results in a greater decrease in muscle strength than muscle size. 
Miles et al. (1994) investigated the effects of 9 days cast immobilisation 
suspended from the neck by a sling on the muscles acting on the wrist. They 
reported a decrease in muscle CSA (4.1 %) and reductions in isometric (29.3 to 
32.5 %), concentric (8.9 % to 21.7 %) and eccentric strength (12.5 to 18.5 %) 
(Miles et al., 1994). A study using casting to immobilise the elbow joint for four 
weeks found decrements in MVC and a decrease in the maximum load that could 
be lifted (Yue et al., 1997). Again here, the reduction in MVC force (35 %) was 
greater than the observed decrease in muscle size (11 %) (Yue et al., 1997). 
Similarly, in the present study a greater percentage loss in muscle torque (elbow 
flexion: -11.5 to -19.8 %; elbow extension: -1.0 to -27.8 %) than in muscle 
thickness (biceps: -0.4 to -5.1 %; triceps brachii: -5.5 to -11.7 %) was generally 
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found. This therefore, further supports the idea of neural factors being involved in 
the mal-adaptations to immobilisation. 
Elbow flexion torque significantly decreased in the EAA supplement group. 
Gross ratios of ‘isometric strength to muscle thickness’ revealed greater 
decrements in the PLA group compared to EAA group. For the biceps muscle this 
ratio decreased by 6 % in the EAA group and 20 % in the PLA group. For elbow 
extension torque by triceps muscle thickness, the ratio in fact increased by 15 % in 
the EAA group whereas it decreased by 23 % in the PLA group. This is interesting, 
as it appears that despite a decrease in triceps muscle thickness in the EAA 
group, the intrinsic quality of the remaining muscle was in fact improved. This may 
be due to the triceps brachii being immobilised in a lengthened position, allowing 
sarcomeres to be added in series (Tabary et al., 1972; Williams and Goldspink, 
1973) with additional availability of EAAs. These further data explorations tend to 
support the idea that EAA supplementation may help to attenuate immobilisation-
induced decreases in muscle strength. 
Data collected for agonist and antagonist EMG activity highlighted no 
differences in agonist or antagonist co-activation from Pre- to Post-immobilisation. 
Previous research on EMG responses to immobilisation point to large decreases 
in EMG amplitude measurements during flexion in both the agonist and antagonist 
muscle (Vaughan, 1989; Yue et al., 1997).  Vaughan et al. (1989) examined the 
EMG characteristics during extension and found significant decreases occurred in 
agonist peak EMG amplitude and antagonist peak  EMG amplitude. Care should 
be taken when drawing conclusions from the EMG findings of the above as well as 
the present study. Indeed, a) the dimensional changes in the muscle could mean 
that a different population of motor units is likely being recorded from (Clark and 
Fielding, 2012); b) the reliability of EMG assessment in the present study (CV = 
~11 % within day, and ~20 % between days) as in previously published studies 
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(de Araujo et al., 2009; Fukuda et al., 2010) is not very high, and this is a general 
limitation of studies utilising longitudinal EMG monitoring. 
There was no significant changes in IL-6 from Pre- to Post-immobilisation in 
either EAA or PLA group. Research in humans demonstrates an increase in 
cytokine release in response to periods of bed-rest (Biolo et al., 2008; Bosutti et 
al., 2008; Hojbjerre et al., 2011). The muscle investigated in the current study is 
small (upper arm contains ~5.1 % of body mass) and as such any endocrine 
effects would be limited when compared to bed-rest in which more of the 
musculature is sedentary (Biolo et al., 2008; Bosutti et al., 2008; Hojbjerre et al., 
2011). As mentioned in the introduction, there is a link between increased fatty 
tissue deposition (Manini et al., 2007), and increased expression and plasma 
levels of cytokines, such as IL-6 (Ahima and Flier, 2000; Pedersen et al., 2003). In 
the present study, it would appear that any observed changes in subcutaneous 
adipose tissue was not great enough to impact on circulating IL-6 levels.   
Correlation analyses revealed that those participants who experienced a 
greater change in triceps brachii muscle thickness also had a greater change in 
triceps brachii sub-cutaneous adipose thickness. This suggests that any 
adaptations in the triceps brachii with immobilisation occur in both the muscle and 
the sub-cutaneous adipose content. Unsurprisingly, greater changes in upper arm 
girth were associated with greater changes in lower arm girth, denoting that both 
the directly immobilised, as well as anatomically proximate musculature, exhibit 
deleterious responses to increased local hypo-activity. Changes in upper arm girth 
were associated with elbow extension torque. The changes to the musculature, 
therefore, appear to be not only quantitative but also qualitative. Similarly, the fact 
that relative changes in IL-6 levels was associated with changes in upper arm girth 
and elbow extension torque, suggests that increased circulating IL-6 may only be 
a small reflection of greater changes at a cellular level. 
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2.5. Conclusion 
A trend for a positive effect of EAA supplementation on upper and lower arm girth 
Post-immobilisation was observed. The multi-ingredient nature of the supplement 
makes it difficult to identify which specific amino acid or combination thereof, may 
have been responsible for the observed changes. Based on the literature, the 
likelihood is that leucine was the main effector (for a recent review, read Breen 
and Phillips (2012). It is suggested that the current results warrant future research 
in arm immobilisation of similar duration. In particular, it is proposed that the model 
used in this current study could have relevance to a sporting population in which 
short-term immobilisation may be prescribed (e.g. treatment for minor injury). The 
use of single sex populations, as well as multiple sites being monitored along the 
length of the muscle are proposed. Single sex populations are suggested, to rule 
out any potential differences in the response to immobilisation between males and 
females. In this manner, the overall impact of EAA supplementation (e.g. on elbow 
flexors/ extensors) may be further clarified. 
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Chapter 3: Omega-3 fatty acids and vitamin D in 
immobilisation: modulation of appendicular mass 
content, composition and structure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter appears in publication as: Bostock, E.L., Morse, C.I., Winwood, K., 
McEwan, I. & Onambélé, G.L., (2016). Omega-3 fatty acids and vitamin D in 
immobilisation: Part A- Modulation of appendicular mass content, composition and 
structure. The journal of nutrition, health & aging, pp 1-8. 
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3.1. Introduction 
As discussed in Chapters 1 and 2 skeletal muscle undergoes structural 
adaptations in response to changes in functional demand. Prolonged periods of 
reduced muscle activity and mechanical loading, e.g. immobilisation, limb-
suspension or bed-rest, result in changes in skeletal muscle structure and 
function, bone mineral density (BMD) and intermuscular adipose content 
(Bloomfield, 1997; de Boer, Maganaris, et al., 2007; LeBlanc et al., 1992; Manini et 
al., 2007; Rittweger et al., 2005; Veldhuizen et al., 1993). Musculoskeletal trauma 
and sports injuries are often treated with orthopaedic surgery/ limb immobilisation, 
which inevitably leads to periods of hypo-activity and disuse. The prognosis of 
orthopaedic surgery patients is poor especially in the older population with a ~6 to 
17 % mortality rate within three years of hip and knee joint replacement (National 
Joint Registry, 2012).  Exercise could be beneficial in these circumstances, but is 
not always practical. In addition, there is a notable need to identify non-
pharmacological interventions since polypharmacy in itself is conducive to skeletal 
tissue loss (Moylan and Binder, 2007). Nutritional supplementation may serve as a 
valid intervention for attenuating the effects of disuse (summarised in Chapter 1). 
Chapter 2 investigated the potential of EAA and now the current Chapter 
introduces two further supplements. 
Eicosapentaenoic acid (EPA) is an n-3 polyunsaturated fatty acid with anti-
inflammatory properties, which is synthesised from ingested alpha-linolenic acid or 
consumed in fish, or in fish oil, such as sardines and cod liver oil. Despite there 
being no established Dietary Reference Intake for -3 fatty acids, adequate intake 
(AI) is set at 1.6 and 1.1 g/day for men and women, respectively (A Report of the 
Panel on Macronutrients et al., 2005). There is evidence to suggest that EPA may 
reduce the pro-inflammatory cytokines associated with muscle damage-induced 
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inflammation (Magee et al., 2008). Magee et al. (2008) demonstrated in vitro that 
EPA inhibits the effects of tumour necrosis factor alpha (TNF-α) by reducing its 
apoptotic effects and enabling myogenesis. It is unclear whether this supplement 
would have a beneficial effect during immobilisation, where it is generally accepted 
that there is muscle atrophy (Grosset and Onambele-Pearson, 2008), which is 
associated with decreased protein synthesis (de Boer, Selby, et al., 2007) but 
scant evidence for increased protein breakdown (Ferrando et al., 1996).  
Another non-pharmacological agent that may potentially be used against 
the asthenia and atrophy induced through immobilisation is vitamin D. Vitamin D is 
required to absorb calcium and phosphorus and plays a crucial role in maintaining 
bone, muscle function, modulation of cell growth, neuromuscular and immune 
functions, and reduction of inflammation. The main source of vitamin D is sunlight, 
with smaller amounts found in certain foods. The Recommended Dietary 
Allowance for vitamin D is 600 IU/day (Ross et al., 2011). Vitamin D 
supplementation is another way of making sure the recommended allowance is 
achieved. Vitamin D has been shown to have direct effects on muscle (Ceglia and 
Harris, 2012); however, the exact mechanisms remain unknown. To date, 
research has indicated an association between genetic variation in the vitamin D 
receptor (VDR) gene and muscle strength, fat mass and body mass in 
premenopausal women (Grundberg et al., 2004). Moreover, vitamin D has been 
reported to impact on both the trans-membranous flows of calcium and phosphate 
in skeletal muscle, and the synthesis rate of contractile properties (Stewart and 
Rittweger, 2006). Vitamin D supplementation reduced falls by 49 % and improved 
musculoskeletal function in frail elderly women with vitamin D deficiency (Bischoff 
et al., 2003). It remains to be seen whether vitamin D supplementation in healthy 
persons with no known vitamin D deficiency, would lead to any enhancement in 
muscle structural and contractile properties in the presence of immobilisation. 
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In the present study, an arm immobilisation model was chosen as it is 
relatively less restrictive on daily life and causes fewer burdens on participants. 
The aim was to determine the role that the two potential protein-sparing 
modulators (EPA or vitamin D supplementation) may play in attenuating atrophy 
induced through a model that would emulate relatively short-term decreased local 
mobility/activity in humans. The differential effect of immobilisation on in vivo 
muscle (thickness), limb composition (lean mass, bone parameters and fat mass), 
and anthropometry (arm girth) was systematically monitored. Participants received 
either omega 3 (-3, a fish oil of a complex of EPA and docosahexaenoic acid 
(DHA)), vitamin D or placebo (Lecithin), hereafter simply referred to as EPA, 
vitamin D or placebo supplementation. It was hypothesised that muscle thickness, 
lean mass and arm girth will decrease with limb immobilisation. It was also 
hypothesised that EPA will be the most effective supplement at minimising these 
changes, since it is understood to act on the protein synthesis pathways. 
3.2. Methods 
3.2.1. Participants 
Twenty-four healthy volunteers were recruited from the local university campus. All 
participants provided written informed consent before taking part in this study, 
which was approved by the local Ethics Committee of Manchester Metropolitan 
University. Exclusion criteria were any conditions requiring the use of medication 
likely to affect muscle function or musculoskeletal health (e.g. statins and oral 
steroids), and any current or history of kidney/liver disease, as those suffering with 
such conditions are more susceptible to the side effects of nutritional 
supplementation. A questionnaire (Appendix 4) to ascertain health and habitual 
physical exercise levels prior to the study confirmed all participants were 
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recreationally active and free from recent (last 6 months) upper limb injury or 
nutritional supplementation. Participants were randomly assigned to one of three 
groups by an independent person, using block randomisation: placebo [PLA: n = 
8]; EPA [EPA: n = 8]; or vitamin D [Vit-D: n = 8]. For anthropometric 
measurements in the three populations, please see the results section (Table 3.1). 
3.2.2. Study design 
The study used a randomised, double-blind, placebo-controlled design. All 
participants attended a familiarisation session at least one week prior to the first 
testing session. All testing sessions were completed after an overnight fast. After 
baseline testing, the non-dominant arm was immobilised in a sling, with the correct 
sling wearing procedure demonstrated to each participant (Figure 2.1, Chapter 2). 
The non-dominant arm was chosen to minimise the burden on participants. 
Participants were required to wear the sling for nine waking hours a day for two 
continuous weeks, removal of the sling was permitted only when necessary (e.g. 
taking a bath/shower, driving, sleeping etc.), minimising any movement medio-
laterally at the elbow and shoulder, whilst requiring participants to not contract the 
upper musculature (including the hands) during the hours of immobilisation. 
Measures of upper arm muscle and sub-cutaneous fat thickness, body 
composition (lean mass, bone parameters and fat mass), and upper and lower 
arm girth were taken immediately before immobilisation (Pre), on removal of the 
sling (Post), and two weeks after re-mobilisation (Post2).  
 The PLA group consumed two 1200 mg capsules of Soya Lecithin (Holland & 
Barrett, UK) a day, each daily dose typically providing 1464 mg of Phosphatides. 
The EPA group consumed three softgel of High EPA Formula (MorEPA, Minami 
Nutrition, Belgium), with the daily dose providing 1770 mg EPA and 390 mg DHA. 
The Vit-D group consumed one softgel of Vitamin D3 (Now Foods, Bloomingdale, 
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U.S.A.), each dose providing 1,000 IU of Vitamin D3. The participants consumed 
the nutritional supplements during the two weeks of limb immobilisation. 
Participants were asked to maintain their habitual diet and not to perform any 
unaccustomed strenuous exercise during the 2 weeks of immobilisation and 
remobilisation. To monitor this, during the immobilisation period participants 
completed a 3-day food diary, a daily activity log (including sling-wear hours) and 
wore a pedometer (Omron Walking style III step counter, Omron Healthcare Co., 
Ltd, Kyoto, Japan) to record the number of steps taken each day. The food diaries 
were analysed for macronutrient and micronutrient average intake using Microdiet 
Plus 1.2 (Microdiet, Downlee Systems Ltd, UK). All participants recorded their 
daily sling wear hours and were questioned during their final testing session, to 
confirm their compliance with the protocol. 
3.2.3. Muscle and sub-cutaneous adipose thickness measures 
All images were recorded after approximately 20 minutes seated rest to avoid fluid 
shifts that might induce interstitial and/or intracellular changes (Berg, Tedner, et 
al., 1993). Images of the muscle and sub-cutaneous adipose tissue of the upper 
arm were obtained using B-mode ultrasonography (AU5, Esaote, Genoa, Italy). A 
7.5-MHz linear phased-array probe (image depth: 37.1-92.8mm) was applied in 
the sagittal plane with minimal pressure to the tissue area of interest to avoid 
image distortion. This method has previously been shown to be highly reliable for 
determining muscle and adipose thickness (Miyatani et al., 2004; Miyatani et al., 
2002; Onambele et al., 2006). Images were recorded using Adobe Premiere 6.0 
(Adobe Systems, USA) and stored for later analysis. 
 Images were obtained with the participant in an upright, seated position with 
their arm abducted square to the body (elbow at 0˚) and resting on the ultrasound 
machine. In the upper arm, the proximal and distal insertions of the biceps and 
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triceps brachii were identified by sonography and marked on the skin. The 
midpoint (L50) and a third of the distance (L33) from the distal end of the biceps 
and triceps brachii were identified and marked onto the skin (Figure 3.1). Upper 
arm ultrasonography images were collected in the sagittal plane, at both sites on 
both the biceps and triceps brachii. Muscle thickness was measured as the 
distance from the top of the superficial muscle aponeurosis to the bone at both 
sites along the biceps and triceps brachii. Ultrasound assessment of muscle tissue 
content has previously been validated (Giles et al., 2014; Dupont et al., 2001; 
Temes et al., 2014; Abe et al., 2014). Sub-cutaneous adipose thickness was 
measured as the distance from the bottom of the epidermis to the top of the 
superficial muscle aponeurosis in the biceps and triceps at both sites. Each of 
these distances were measured at three standardised points along the width of the 
probe (Figure 2.2, Chapter 2) to obtain average muscle and sub-cutaneous 
adipose thicknesses using ImageJ analysis software (ImageJ 1.37, Maryland, 
USA). 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Insertion (i), origin (o), L50 and L33 markings on the biceps (A) and 
triceps (B). 
B 
i o L50 L33 
A 
i o L50 L33 
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3.2.4. Body composition analysis 
Body composition was determined using dual-energy x-ray absorptiometry (DXA) 
scanner (Hologic Discovery; Vertec Scientific, Reading, Berkshire, UK). Whole 
body scans were performed (Figure 3.2) lasting approximately seven minutes with 
a dose-area product (DAP) of 21 cGy*cm2. The appendicular mass was isolated 
from the trunk and head using DXA regional computer-generated default lines, 
with manual adjustment, on the anterior view planogram. Measures of BMD, bone 
mineral content (BMC), lean mass, fat mass and fat percentage are reported for 
the immobilised arm only. 
 
 
 
 
 
 
 
Figure 3.2. DXA scan set-up. 
3.2.5. Arm girths 
Participants assumed a relaxed standing position with arms hanging by the sides 
and palms facing the hips. A measuring tape was used to measure upper arm girth 
at the mid-acromial-radial and lower arm girth at a fixed point a third of the way 
(from the proximal end) along the length of the radiale-stylion. Measurements were 
repeated three times at each point and average girths were calculated. 
3.2.6. Measurement reliability 
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All protocols were assessed for intra as well as inter-day reliability. This utilised 
five participants and entailed carrying out measurements on two repeat visits. The 
two visits were conducted at the same time of day, approximately a week apart. 
Each ultrasound scan and arm girth measurement were taken three times on each 
day and analysed as per the method section. Within-day coefficient of variation 
(CV) of 0.1 %, 0.1 %, 0.4 %, 0.2 %, 0.3 % and 0.3 %, and between-day CVs of 0.4 
%, 0.2 %, 0.6 %, 0.2 %, 0.2 % and 0.4 % were yielded for upper arm girth, lower 
arm girth, biceps muscle thickness, triceps muscle thickness, biceps 
subcutaneous adipose thickness and triceps subcutaneous adipose thickness, 
respectively. DXA reliability is reported with a CV of 1.0 %. 
 An investigation to assess the impact of small limb rotations on DXA-
recorded bone parameters, used a bovine tibia bone, placed on a hinged Perspex 
device on the DXA bed (Figure 3.3). The hinged device allowed for controlled and 
quantifiable rotations of the bone model, through custom designed, laser cut 
Perspex triangles holding the device at specific angles (Figure 3.3) ranging from 0° 
to 50° (5° increments). A DXA forearm scan protocol (forearm length set at 42cm, 
scan length set at 15.3 cm) was performed twice at every angle. Each scan was 
analysed for bone area, BMC, BMD, T-scores and Z-scores. Intraclass correlation 
coefficient (ICC) was used to assess the consistency between repeated scans at 
each angle. ICC values of 0.95, 0.92, 0.98, 0.97 and 0.97 were yielded for bone 
area, BMC, BMD, T-scores and Z-scores, respectively. Bone area and BMC 
decreased with increasing angle rotation. BMD, T-scores and Z-scores increased 
with increasing angle rotation of the bovine tibia bone. The effect of bone rotation 
angle was assessed by linear regression. The regression coefficients R = 0.975 
(p<0.05), 0.945 (p<0.05), 0.946 (p<0.05), 0.945 (p<0.05) and 0.943 (p<0.05) were 
yielded for bone area, BMC, BMD, T-scores and Z-scores, respectively. 
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Figure 3.3. Set-up of the DXA for the assessment of limb rotation on DXA bone 
parameter outputs. 
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3.2.7. Statistical analyses 
Data were analysed using IBM SPSS v21 (IBM Inc, USA). The Shapiro-Wilk test 
revealed some of the data to be non-parametric (upper arm muscle and adipose 
thickness, upper and lower arm girths). The effect of immobilisation was examined 
by assessing the changes seen in the PLA group by either repeated measures 
ANOVA (parametric data) or a Friedman test (non-parametric data). Parametric 
change relative to baseline values (Pre-to-Post: (Post-Pre)/Pre; and Pre-to-Post2: 
(Post2-Pre)/Pre) were analysed using a repeated measures ANOVA, with post-
hoc Bonferonni corrected 2-tailed t-tests to determine group difference. Non-
parametric between group effects on change data were analysed using the 
Kruskal Wallis test, with post-hoc Mann-Whitney U tests. All data are presented as 
mean ± standard deviation (SD). Statistical significance was set with alpha at ≤ 
0.05. 
3.3. Results 
3.3.1. Homogeneity of sample 
There were no significant differences in baseline characteristics between the 
groups (Table 3.1). The groups similarly did not differ in baseline muscle size  (e.g. 
bicep muscle thickness (L50) - PLA: 28.7 ± 7.1 mm; EPA: 31.1 ± 5.4 mm; Vit-D: 
32.1 ± 6.5 mm), arm girth (PLA: 28.8 ± 3.0 cm; EPA: 28.1 ± 4.0 cm; Vit-D: 29.4 ± 
3.2 cm), nor body composition (e.g. lean mass – PLA: 1874.5 ± 595.8 g; EPA: 
2361.0 ± 1116.8 g; Vit-D: 2531.1 ± 832.6 g). 
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Table 3.1. Baseline characteristics of all participants. 
 
 
3.3.2. Daily physical activity and nutritional intake 
No significant differences were observed in calorific intake (PLA: 1797 ± 934 
kcal/day; EPA: 1647 ± 551 kcal/day; Vit-D: 1960 ± 756 kcal/day (p>0.05)) or in 
habitual physical activity (PLA: 6825 ± 1660 steps/day; EPA: 7529 ± 3310 
steps/day; Vit-D: 6145 ± 2081 steps/day (p>0.05)) between the groups during the 
course of the immobilisation. This effect was true for the EPA, Vit-D and PLA 
groups. Further diet composition analyses revealed no group differences in protein 
(PLA: 1.1 ± 0.3 g·kg-1·bw/day; EPA: 1.0 ± 0.3 g·kg-1·bw/day; Vit-D: 1.0 ± 0.6 g·kg-
1·bw/day), carbohydrate (PLA: 3.1 ± 1.5 g·kg-1·bw/day; EPA: 3.1 ± 1.1 g·kg-
1·bw/day; Vit-D: 3.0 ± 1.0 g·kg-1·bw/day), fat (PLA: 1.0 ± 0.5 g·kg-1·bw/day; EPA: 
1.0 ± 0.5 g·kg-1·bw/day; Vit-D: 1.0 ± 0.3 g·kg-1·bw/day), vitamin D (PLA: 1.7 ± 0.7 
μg/day; EPA: 1.6 ± 0.9 μg/day; Vit-D: 2.0 ± 1.6 μg/day) or -3 (PLA: 0.37 ± 0.30 
g/day; EPA: 0.36 ± 0.19 g/day; Vit-D: 0.36 ± 0.20 g/day) intake over the 
immobilisation period between the three groups. 
Results of the questionnaire revealed that participants walked to and from 
work, university and/or shopping a minimum of 30 minutes per day. Examination of 
 PLA EPA Vit-D 
Age (years) 26 ± 6.7 19 ± 1.6 23 ± 5.9 
Males n = 2 n = 4 n = 3 
Females n = 6 n = 4 n = 5 
Height (cm) 168.7 ± 11.1 169.5 ± 12.0 172.2 ± 8.0 
Mass (kg) 69.1 ± 14.2 69.6 ± 23.1 75.2 ± 14.5 
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the activity diaries completed by the participants themselves during the 
immobilisation period, confirmed that the majority of participants spent at least half 
an hour outside each day. 
3.3.3. Muscle and sub-cutaneous adipose thickness measures 
Muscle thickness decreased from Pre to Post at both sites (L50 and L33) on the 
biceps and triceps brachii (p<0.05) in the PLA group. The percentage decrease in 
muscle thickness was significantly greater in the triceps brachii (L50 & L33) than 
the biceps brachii (L33) (p<0.05) The percentage change in muscle thickness at 
both sites on the biceps and triceps brachii did not significantly differ between the 
groups (Figure 3.4), though both EPA and Vit-D groups showed a non-significant 
trend towards differing from the PLA group (bicep L50 p=0.078; bicep L33 
p=0.063; triceps L50 p=0.072; triceps L33 p=0.074). Sub-cutaneous adipose 
thickness increased significantly Post immobilisation at L50 of the biceps brachii 
(p<0.05), with no significant change at L33 of the biceps brachii or either site on 
the triceps brachii. The percentage change in adipose thickness was not 
significantly different between groups at both sites on the triceps brachii (Figure 
3.4). Percentage change in adipose thickness was significantly greater in the PLA 
than the EPA group (L50 p=0.028; L33 p=0.015) and in the Vit-D than the EPA 
group (L50 p=0.038; L33 p=0.028) at L50 and L33 along the biceps brachii (Figure 
3.4). 
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Figure 3.4. Percentage change (% ± SD) in muscle thickness (A) and sub-
cutaneous adipose thickness (B) from Pre-to-Post for PLA (white bars), EPA (grey 
bars) and Vit-D (black bars) at the midpoint (L50) and a third of the distance (L33) 
along the length of the biceps and triceps brachii. * Significant difference between 
Pre and Post immobilisation in the PLA group. † Significant difference in % change 
between groups. ‡ Significant difference in % change values between ultrasound 
sites. 
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3.3.4. Body composition 
There was a significant decrease in lean mass Post immobilisation (p<0.03) but no 
significant effect of supplement group on the percentage change in lean mass 
(p=0.09) (Figure 3.5). Percentage changes in BMC, BMD, fat mass and fat 
percentage are displayed in Table 3.2. No significant change was observed in 
BMD, fat mass or fat percentage. There was a significant decrease in BMC from 
Pre to Post immobilisation in the PLA group (p<0.05). There was no significant 
difference in percentage change in BMC, BMD, fat mass or fat percentage 
between the groups Post or Post2 (p>0.05). 
 
 
 
 
 
 
 
 
Figure 3.5. Percentage change (% ± SD) in lean mass from Pre-to-Post and Pre-
to-Post2 for PLA (white bars), EPA (grey bars) and Vit-D (black bars). * Significant 
difference between Pre and Post immobilisation in the PLA group. 
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3.3.5. Arm girths 
Upper and lower arm girths significantly decreased from Pre to Post immobilisation 
(p<0.05) in the PLA group. There was no significant difference in the percentage 
change in upper or lower arm girth between groups (Figure 3.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Percentage change (% ± SD) in upper (A) and lower (B) arm girth from 
Pre-to-Post and Pre-to-Post2 for PLA (white bars), EPA (grey bars) and Vit-D 
(black bars). * Significant difference between Pre and Post immobilisation in the 
PLA group. 
* 
* 
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3.3.6. Non-immobilised limb data 
All parameters were also recorded on the non-immobilised, control limb. A phase 
specific degree of change was calculated to obtain one value for control limb 
corrected relative change for each variable (phase control-corrected change = 
immobilised limb percentage change – non-immobilised limb percentage change). 
The ‘phase control-corrected change’ values were analysed using the same 
statistical analysis process as those used for the immobilised limb only results. 
The outcome revealed that normalisation for the non-immobilised limb made no 
difference on any of the outcome parameters (p>0.05) apart from sub-cutaneous 
adipose thickness at the L33 site on the biceps (p<0.05). There was a significant 
decrease in muscle thickness, arm girth, lean mass and BMC and a significant 
increase in sub-cutaneous adipose thickness at both sites on the biceps brachii. 
As in the immobilised limb only data, the only significant effect of supplement 
group was on the percentage change in adipose thickness. This change was 
significantly greater in the PLA than the EPA group (p<0.05) and in the Vit-D than 
the EPA group (p<0.05) at L50 and L33 along the biceps brachii. Due to the lack of 
impact of normalisation for the non-immobilised limb, it was decided that only the 
immobilised limb data would be presented. 
3.4. Discussion 
The purpose of this study was to determine the role that two potential protein-
sparing modulators (EPA or vitamin D supplementation) may play in attenuating 
the deleterious physiological changes induced through 2 weeks of 9-waking-hours-
per-day combined arm and shoulder immobilisation. It was hypothesised that 
muscle thickness, lean mass and arm girth would decrease with limb 
immobilisation. Evidence was found to support this, with significant decreases in 
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muscle thickness (PLA: -3.2 to -7.8 % dependent on anatomical site), arm girth 
(PLA: -0.8 to -1.3 % dependent on anatomical site) and lean mass (PLA: -3.6 % 
for the immobilised limb). In addition, there was a significant increase in sub-
cutaneous adipose thickness (PLA: 10.3 %) and a significant decrease in BMC 
(PLA: -2.3 %). It was also hypothesised that EPA would be the most effective 
supplement at minimising the effects of immobilisation. In fact, the data show that 
neither EPA nor vitamin D had any significant effect on the responses to non-
injurious immobilisation, other than on the associated accumulation of sub-
cutaneous fatty tissue. Nonetheless, a few trends (p<0.1) towards attenuations in 
deleterious physiological events were observed, in the EPA and Vit-D treated 
groups. The observed trends for the attenuation of some parameters are 
discussed. 
A significant change in upper limb muscle thickness is evidenced in the 
ultrasound data, with a significant decrease in biceps and triceps brachii muscle 
thickness with immobilisation. The ultrasound data demonstrate a greater 
decrease in triceps brachii muscle (L50 and L33) thickness than the biceps brachii 
(L33) in the PLA group. It was expected, in fact, that the muscle held in the 
shortened position (i.e. the biceps) to be impacted on more than the muscle held 
in the lengthened position (i.e. the triceps); previous research suggests that 
sarcomeres are added in series when the muscle is immobilised in the lengthened 
position, and sarcomeres are lost when the muscle is immobilised in the shortened 
position (Williams and Goldspink, 1973).  In the present study, the elbow was 
immobilised at a 90° angle and, as such, would not have exerted maximal 
lengthening or shortening on the triceps and biceps brachii. The EPA and Vit-D 
supplementation groups demonstrated non-significant trends towards smaller 
decreases in muscle thickness in response to immobilisation, suggesting that EPA 
and vitamin D may have some role to play in attenuating muscle atrophy 
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associated with hypo-activity. A recent study in an animal model demonstrated 
distinct effects of EPA and DHA on protein metabolism (protein synthesis and 
breakdown) with EPA showing a greater ability to result in skeletal muscle protein 
accretion. Further work in humans is required to further investigate this and the 
effects EPA may have in human disuse models. Indeed, it is likely that the dose, 
duration and/or whole body measurement of muscle mass that was adopted in 
these animal studies diminished the comparability of animal models from the 
immobilisation model used in this current study.  
 Upper and lower arm girths were shown to decrease significantly Post 
immobilisation in the PLA group. Arm girth was used as a gross marker of skeletal 
muscle atrophy, as previously used by Matsumura et al (2008). A decrease in 
upper arm girth (in the PLA group) suggests a decrease in muscle CSA in the 
upper arm and this supports the ultrasound data along with previous findings of a 
decrease in elbow flexor muscle CSA and volume with arm immobilisation (Yue et 
al., 1997). The decrease in lower arm girth suggests a decrease in forearm muscle 
CSA, and this is in line with findings from Miles et al. (1994) who reported a 
decrease in forearm muscle CSA with 9 days arm casting. The significant 
decrease in limb CSA is reflected in the DXA data, with a significant decrease in 
lean mass with immobilisation. The decrease in upper arm girth appeared to be 
attenuated by EPA and vitamin D supplementation, with EPA having the greater 
effect. Similarly, in the lower arm, supplementation showed a trend towards 
attenuating the losses in arm girth, this time with vitamin D having a slightly 
greater effect. The EPA group appear to show a smaller decrease in lean mass 
than both other groups. 
The ultrasound data revealed no significant change in sub-cutaneous 
adipose thickness in the triceps brachii over the immobilisation period. Biceps sub-
cutaneous adipose thickness, however, did significantly increase at the midpoint 
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site in the PLA group. Manini et al. (2007) reported a significant increase in 
intermuscular adipose tissue and no significant change in subcutaneous adipose 
tissue in response to 4-weeks unilateral lower limb suspension (ULLS). The 
difference between the response of sub-cutaneous adipose tissue to disuse in the 
current study in comparison to Manini et al. (2007) may be due to the different 
techniques used to assess the parameter (i.e. ultrasound vs. magnetic resonance 
imaging (MRI)) and/or the differing modes of immobilisation (i.e. arm 
immobilisation vs. ULLS). It is possible that the more stringent immobilisation in 
their study (throughout daily mobile activities, for four weeks), as well as the 
adiposity site (intermuscular), may account for the fact that they observed 
significant increases in adiposity. The present study partially agrees with their 
findings as the current data showed a significant increase at one region, 
subcutaneously, along the upper arm (i.e. 50 % of upper limb length). The EPA 
group demonstrated a significantly smaller increase in biceps sub-cutaneous 
adipose thickness following immobilisation than both the PLA and Vit-D groups. 
This effect may, indeed, be meaningful given that diet was monitored and the 
dietary records demonstrated neither time nor between group differences in total 
calories, macronutrients or vitamin D intakes, throughout the study. EPA 
supplementation shows potential for attenuating increases in sub-cutaneous 
adipose thickness in response to disuse. The Vit-D group also demonstrated a 
trend towards an attenuation in the increase of sub-cutaneous adipose thickness 
in comparison to the PLA group. 
DXA analysis revealed no significant changes in fat mass or fat percentage 
with limb immobilisation. The difference in the response of adiposity to disuse in 
the current study in comparison to Manini et al. (2007), who reported a significant 
increase in intermuscular adipose tissue, may be due to the different techniques 
used to assess the parameter (i.e. DXA vs. MRI) or the different mode and/or 
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duration of disuse (i.e. 2 weeks arm immobilisation vs. 4 weeks ULLS). 
Interestingly, the increases reported in the present study in sub-cutaneous adipose 
thickness were not matched by the DXA analysis of fat mass or percentage. 
Possible explanations for this include: a) the DXA takes the average of the whole 
limb rather than regional data and hence would have ‘missed’ the regional 
changes observed with the ultrasound; b) it is possible that the tissue density 
changes with immobilisation mean that the DXA may have miss-qualified muscle 
and fat after immobilisation (Roubenoff et al., 1993). 
There was no significant change in BMD (-0.8 %/week), but a significant 
decrease in BMC (-1.2 %/week) following immobilisation. Decreases in bone are 
often reported in more severe and longer periods of disuse. For example, 
Rittweger et al. (2005) reported significant decreases in BMC of the tibia (-0.1 to -
0.5 %/week) and radius (-0.03 to -0.05 %/week) in response to 90 days bed-rest. 
Marchetti et al. (1996) found significant decreases in BMD (-1.0 to 2.3 %/week) in 
response to 6 weeks arm immobilisation, however, the participants had also 
undergone surgery, which could contribute to greater decreases in BMD. Values 
for BMC and BMD changes with immobilisation showed a trend towards 
attenuation of changes with EPA and vitamin D supplementation. Previous 
research indicates that BMD is affected by changes in body weight and 
composition (Van Loan et al., 1998), therefore, the observed changes in muscle 
and sub-cutaneous adipose thickness may have influenced the BMD values. The 
value of BMD can also be limited by the inherent limitations of using a two-
dimensional x-ray projection to estimate bone area and geometrical changes.  The 
use of peripheral quantitative computed tomography (pQCT) may have been more 
advantageous to examine these specific changes. 
The formula of each supplement was chosen so that the dose provided 
would be able to be bought over the counter and be taken without prescription. 
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The chosen dose of EPA and DHA of the -3 supplement in the current chapter is 
in line with previous levels used in the literature (Bloomer et al., 2009; Lenn et al., 
2002; Phillips et al., 2003). The vitamin D dose of 1000 IU is equal to 25 μg. Public 
Health England suggest that adults at risk of vitamin D deficiency should take a 
daily supplement containing 10 μg of vitamin D (Public Health England, 2014). The 
selected dose is much higher than this and as such should be sufficient in the 
healthy population used in the current chapter. The lack of the effectiveness of 
vitamin D and EPA in the current study may be due to the dosage of the 
supplements used and therefore this needs to be altered, potentially increased, in 
future studies. 
The NHS consensus on vitamin D states that if people achieve a sufficient 
supply of vitamin D in the summer, most should keep levels greater than the 
deficiency threshold of 25nmol/l in winter even without supplements (NHS 
Livewell, 2010). In the current study, participants reported that they typically spent 
at least 30 minutes outdoors every day of the week and as such would reach the 
necessary sunlight exposure for adequate vitamin D level.  We therefore suggest 
that the current population are unlikely to be vitamin D deficient. The ‘healthy, 
presumably non-deficient’ status of the participants may have been another 
reason for the lack of effectiveness of the supplementation in the current study. 
Blinding of -3 supplementation is sometimes an issue in studies, due to 
the fact that it often repeats on participants. On completion of the study, 
participants were asked whether they were able to identify what supplement they 
believed they were taking. None of the participants correctly guessed the 
supplement they were taking and in fact, two participants receiving the placebo 
supplement believed they were taking an -3 supplement. 
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3.5. Conclusion 
In accordance with previous research, the results of this study demonstrate a 
decrease in muscle thickness, arm girth and lean mass with upper limb 
immobilisation. A significant decrease in BMC was also observed, with no effects 
of immobilisation on fat mass or BMD. Interestingly nonetheless, it was observed 
that in the case of sub-cutaneous adiposity on the biceps brachii, there is a 
protective effect of EPA supplementation against limb immobilisation. It is 
proposed that the model used in the current study could have relevance to a 
sporting population in which short-term immobilisation may be prescribed (e.g. 
treatment for minor injury) or in clinical populations (e.g. injury/surgery induced 
short-term immobilisation/bed-rest). 
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Chapter 4: Omega-3 fatty acids and vitamin D in 
immobilisation: modulation of muscle functional, 
vascular and electromyographic profiles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter appears in publication as: Bostock, E.L., Morse, C.I., Winwood, K., 
McEwan, I. & Onambélé, G.L., (2015). Omega-3 fatty acids and vitamin D in 
immobilisation: Part B- Modulation of muscle functional, vascular and 
electromyographic profiles. The journal of nutrition, health & aging, pp 1-8. 
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4.1. Introduction 
Chapter’s 1 to 3 show that skeletal muscle adapts to environmental changes and 
differing levels of physical activity. It has consistently been demonstrated, that 
disuse models, including immobilisation, bed-rest and limb-suspension result in 
skeletal muscle atrophy (Berg et al., 1997; Clark et al., 2006; Miles et al., 1994), a 
decrease in maximal voluntary strength (Berg et al., 1997; Clark et al., 2006; Miles 
et al., 1994), and changes in electromyographic characteristics (Vaughan, 1989). 
Numerous studies have also documented the effects of immobilisation models on 
muscle fatigability, with equivocal findings of both decreased, increased and no 
change in resistance to fatigue (Miles et al., 1994; Miles et al., 2005; Yue et al., 
1997). With progressing fatigue, there is a shift in electromyography (EMG) to 
lower frequencies, and median power frequency can be used as an index of this 
frequency shift. A decrease in the median power frequency serves as an index of 
fatigue (Knaflitz et al., 1990; Soderberg and Knutson, 2000). Fast Fourier 
transform (FFT) of EMG produces a discrete-time, discrete-frequency 
representation and can be used to determine median power frequency. There are 
also several reports of the impact of disuse on the cardiovascular system with 
reports of decreased reactive hyperaemic blood flow (Gayeski and Honig, 1983; 
Henriksson and Reitman, 1977; Shoemaker et al., 1998). Early research 
demonstrated that static muscular contractions were accompanied by a marked 
impairment in blood flow to exercising muscles (Barcroft and Millen, 1939). Since 
then impaired blood flow has been used as an explanation for muscle fatigue 
during isometric contractions. Local changes in vascular dimensions and blood 
flow characteristics have been shown in response to resistance training, with de-
training resulting in a worsening in these parameters (beyond pre-training values) 
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(Stebbings et al., 2013). Therefore, decreased loading with disuse, may negatively 
impact on vascular structure and function. 
The ever-increasing population of frail elderly puts a strain on healthcare 
services, with increased disability and functional impairment, cognitive decline and 
the accumulating burden of disease due to the obesity epidemic. Indeed, 
prolonged sedentarism/hypo-activity as may be encountered in enforced bed rest, 
immobilisation owing to orthopaedic clinic events, or simply even, decreased 
habitual physical activity, all show a high incidence in older persons (D'Antona et 
al., 2003; Sayer et al., 2008; Morley et al., 2001; Marcell, 2003; Dock, 1944). A 
common and serious problem for older adults is falls, with polypharmacy and 
some medications contributing to falls in many patients (Moylan and Binder, 2007). 
This factor however, is remediable and non-pharmacological interventions are 
needed to prevent the age-associated loss in muscle size and function. As 
discussed in the previous chapters, exercise could be beneficial in these 
circumstances but is not always a practical prescription; and as such, nutritional 
interventions could be key. 
As described in Chapter 3 (i.e. the previous study), an arm immobilisation 
model was chosen as it is relatively less restraining on daily life and causes less 
burden on participants. The potential of omega 3 (-3) and vitamin D as nutritional 
supplements, to attenuate disuse atrophy are discussed and investigated in 
Chapter’s 1 and 3. In Chapter 3, whilst there was no significant effect of 
supplement group on muscle size decreases with immobilisation, a non-significant 
trend for lesser atrophy in the treatment groups was seen. Based on the greater 
decline in muscle strength (due to the combined effects of neural and muscle 
components) with disuse, it is possible that functional measures are more 
sensitive to immobilisation than structural changes. It is possible therefore, that 
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EPA and vitamin D may preserve muscle function to a greater extent than a 
placebo over the period of immobilisation. 
The aim, therefore, was to determine the role that vitamin D or EPA 
supplementation may play in attenuating the changes associated with limb 
immobilisation. The differential effect of immobilisation on isometric and isokinetic 
elbow torque, agonist co-contraction, muscle fatigability and resting arterial blood 
flow (vessel diameter, heart rate, resistance index and flow by diameter), was 
systematically monitored with participants receiving either -3 (a fish oil of a 
complex of EPA and docosahexaenoic acid (DHA)), vitamin D or placebo 
(Lecithin), hereafter simply referred to as EPA, vitamin D or placebo 
supplementation. It was hypothesised that muscle function will decrease, muscle 
co-contraction characteristics will change, and indices of healthy vascular function 
will deteriorate, with limb immobilisation. It was also hypothesised that EPA would 
be the most successful supplement at minimising these changes, as it acts on the 
protein synthesis pathways. 
4.2. Methods 
4.2.1. Participants & study design 
Participant inclusion criteria and study design were as described in study Chapter 
3. Briefly, twenty-four healthy volunteers participated in the study, following 
appropriate ethical approval, and then randomly assigned to one of three groups 
(placebo (PLA): n = 8 (6 females, 2 males); EPA: n = 8 (4 females, 4 males); 
vitamin D (Vit-D): n = 8 (5 females, 3 males)).  The study used a randomised, 
double-blind, placebo-controlled design with the placebo group consuming 1464 
mg Soya Lecithin (Holland & Barrett, UK) daily, the Vit-D group consuming 1,000 
IU of Vitamin D3 (Now Foods Bloomingdale, U.S.A.) daily, and the EPA group 
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consuming 1770 mg EPA plus 390 mg DHA (MorEPA, Minami Nutrition, Belgium), 
daily during the immobilisation period.  
Participants attended a familiarisation session at least one week prior to the 
first testing session. After baseline testing, the non-dominant arm was immobilised 
in a sling for a minimum of nine waking hours a day, for two continuous weeks. 
The correct sling wearing procedure was demonstrated to each participant (Figure 
2.1. of Chapter 2), the removal of the sling was only permitted when necessary 
(e.g. driving, taking a bath/shower etc.). The sling minimised any movement 
medio-laterally at the elbow and shoulder and participants were required to not 
contract the upper musculature (including the hands) during immobilisation hours. 
Measures of isometric and isokinetic elbow torque, EMG co-contraction, muscle 
fatigability and arterial dimensions and blood flow, were taken immediately before 
the immobilisation period (Pre), immediately after the immobilisation period (Post), 
and two weeks after remobilisation (Post2). During the immobilisation period, 
participants completed a 3-day food diary, a daily activity log and wore a 
pedometer to record the number of steps taken each day. The techniques and 
equipment used are described in Chapter 3. Nutritional information and steps 
taken each day are reported in the results section of Chapter 3. 
4.2.2. Dynamometry 
Isometric and isokinetic elbow torque were assessed using a Cybex dynamometer 
(Cybex, New York, USA). Participants were positioned as per the manufacturer’s 
recommendations. Briefly, they were positioned in a supine position with the axis 
of rotation of the dynamometer aligned with the anatomical axis of rotation of the 
elbow joint (lateral epicondyle) (Figure 4.1). 
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Figure 4.1. Participant positioning and Cybex dynamometer set-up. 
 
4.2.3. Isometric dynamometry 
Following a warm up at 60°/sec at the participant’s self-perceived ~75 % of 
maximum effort, two repetitions of isometric contractions were performed at six 
different elbow joint angles (60°, 70°, 80°, 90°, 100° and 110°), 60 seconds apart. 
The highest torque was recorded as the participant’s maximal voluntary 
contraction (MVC) for each angle. Participants were instructed to rapidly exert 
maximal torque against the dynamometer lever arm over a 3-4 second period. 
First in flexion and, five seconds after return to baseline, in extension. Torque and 
angle were displayed on the screen of a computer (Macintosh G4; Apple 
Computer, Cupertino, CA), which was interfaced with an A/D system 
(Acknowledge, Biopac Systems, Santa Barbara, CA), with a sample frequency of 
200 Hz. Participants were encouraged to exert maximal torque with the use of 
visual and verbal feedback. Peak torque was averaged over a 500 ms period (i.e. 
250 ms either side of the instantaneous peak). The highest of the repeated efforts 
was used as the participant’s measure of MVC at each angle for elbow flexion and 
extension. 
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4.2.4. Isokinetic dynamometry 
Isokinetic contractions were completed with three continuous elbow extensions 
and flexions at six different speeds (30, 60, 90, 120, 180 and 240°/sec) separated 
by 90 seconds, in a randomised order. The highest of the three consecutive efforts 
was recorded as peak torque (25 ms either side of the instantaneous peak) for 
elbow extension and flexion at each speed. 
4.2.5. Electromyographic measurements 
Muscle activation patterns were assessed using EMG during the isometric and 
isokinetic contractions The skin was prepared by shaving, abrading and cleaning 
with an alcohol-wipe to minimise resistance below 5 kΩ (Hermens et al., 2000). 
Self-adhesive electrodes were placed in pairs either side of the marker of a third of 
the distance along the biceps and triceps brachii, with reference electrodes placed 
on the lateral and medial epicondyle of the humerus. Raw EMG data were 
recorded at 2000 Hz, with a band pass filter set at 10-500 Hz, and a notch set at 
50 Hz (Biopac Systems). Biceps co-contraction was calculated (biceps EMG 
during extension / biceps EMG during flexion) for both isometric and isokinetic 
contractions. Triceps co-contraction was also calculated (triceps EMG during 
flexion / triceps EMG during extension) again for both isometric and isokinetic 
contractions. Biceps and triceps EMG values were taken during the same windows 
as in isometric and isokinetic torque. 
4.2.6. Fatiguing contractions 
The dynamometer lever arm was locked at a 90° angle (where 0° is full elbow 
extension) and participants were required to exert a maximal isometric contraction 
in the direction of elbow flexion for 30 seconds. After 90 seconds of recovery, the 
participant then repeated the maximal isometric contraction for 30 seconds, this 
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time in the direction of elbow extension. The mean, slope and standard deviation 
of the torque trace were recorded for the length of the 30-second contractions. 
FFT was computed for the agonist muscle during the first five and last five 
seconds of each fatiguing contraction. Median frequency values were determined 
for these time points and a change in median frequency was then computed as a 
measure of the fatigability of the muscle. 
4.2.7. Arterial resting blood flow 
After more than 20 minutes seated rest (following muscle ultrasound scans), 
allowing for the regulation of vascular tone, measurements in the sagittal plane of 
resting brachial artery diameter, heart rate (HR), resistance index (RI) and flow by 
diameter (FbD) were obtained from the ultrasound software (Figure 4.2). The 
measurements were obtained using an echo Doppler ultrasound machine (AU5, 
Esaote, Genoa, Italy) with a 5.0- 13.0 MHz broadband linear array transducer (with 
settings of Doppler gain 37-41, angle of insonnation 60 degrees). The ultrasound 
probe was applied to the arm in line with the marker of the midpoint of the biceps 
brachii (as previously marked earlier for obtaining muscle ultrasound images 
(Figure 3.1, Chapter 3). An average of nine data points were acquired for all 
measurements, with the mean value reported. 
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Figure 4.2. Ultrasound set-up and screen grab of arterial resting blood flow. 
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4.2.8. Measurement reliability 
All protocols were assessed for intra as well as inter-day reliability. This utilised 
five participants and entailed carrying out measurements on two repeat visits. The 
two visits were conducted at the same time of the day, approximately a week 
apart. Isometric and isokinetic contractions were performed three times (at every 
angle and speed, in the direction of flexion and extension) by each participant on 
both visits.  Arterial resting blood flow ultrasound scans were also taken three 
times on each visit. All measurements were analysed as per the method section; 
and within- and between-day coefficient of variation (CV) values calculated. 
Within-day CVs of 1.8 %, 2.0 %, 1.5 %, 5.4 %, 2.4 % and 12.0 %, and between-
day CVs of 2.5 %, 2.3 %, 2.3 %, 8.1 %, 4.0 % and 9.1 % were yielded for isometric 
torque, isokinetic torque, brachial artery diameter, HR, RI and FbD, respectively. 
4.2.9. Statistics 
Data were analysed using IBM SPSS v21 (IBM Inc, USA). The Shapiro-Wilk test 
revealed some of the data to be non-parametric (EMG, fatigue, brachial artery 
diameter, HR and FbD values). The effect of immobilisation was examined by 
assessing the changes seen in the PLA group by either repeated measures 
ANOVA (parametric data) or a Friedman test (non-parametric data). Parametric 
percentage change values (Pre-to-Post: (Post-Pre)/Pre; and Pre-to-Post2: (Post2-
Pre)/Pre) were analysed using a repeated measures ANOVA, with post-hoc 
Bonferonni corrected 2-tailed t-tests to determine group difference. Non-
parametric between group effects were analysed using the Kruskal Wallis test, 
with post-hoc Mann-Whitney U tests. All data are presented as mean ± standard 
deviation (SD). Statistical significance was set with alpha at ≤ 0.05. 
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4.3. Results 
4.3.1. Baseline characteristics 
There were no significant differences in baseline characteristics (Table 3.1. of 
Chapter 3). Additionally, the groups did not differ in baseline isometric MVC elbow 
torque (e.g. isometric elbow torque at 90° for flexion - PLA: 37.6 ± 15.0 Nm; EPA: 
42.0 ± 15.7 Nm; Vit-D: 42.3 ± 13.7 Nm) EMG and fatigue values, or resting arterial 
blood vessel characteristics (vessel diameter - PLA: 3.3 ± 0.5 mm; EPA: 3.3 ± 0.6 
mm; Vit-D: 3.2 ± 0.3 mm, HR – PLA: 69.6 ± 11.6 bpm; EPA: 68.5 ± 12.1 bpm; Vit-
D: 69.1 ± 6.7 bpm, RI – PLA: 0.7 ± 0.3; EPA: 0.8 ± 0.1; Vit-D: 0.9 ± 0.1, FbD – 
PLA: 0.11 ± 0.05 m/s; EPA: 0.07 ± 0.02 m/s; Vit-D: 0.06 ± 0.03 m/s). 
4.3.2. Isometric dynamometry 
Isometric MVC torque decreased for both elbow flexion (60° p=0.030; 70° 
p=0.005; 80° p=0.012; 90° p=0.019; 100° p=0.030) and extension (60° p=0.002; 
70° p=0.017; 80° p=0.023; 90° p=0.005) at every angle except for flexion at 110° 
(p=0.586) and extension at 100° (p=0.904) and 110° (p=0.300). Average isometric 
torque decrease from Pre to Post immobilisation across angles for flexion were 
12.1 ± 1.8 %, 11.4 ± 3.5 % and 8.1 ± 3.4 %, and for extension were 15.4 ± 3.3 %, 
12.0 ± 3.1 % and 10.7 ± 2.4 %, for PLA, EPA and Vit-D, respectively. There was 
no effect of group on the percentage change in isometric torque for flexion or 
extension at any of the six angles (p>0.05) (Figure 4.3). 
4.3.3. Isokinetic dynamometry 
Isokinetic torque decreased significantly for both elbow flexion (30°/sec p=0.018; 
60°/sec p=0.014; 120°/sec p=0.023; 180°/sec p=0.043; 240°/sec p=0.030) and 
extension (30°/sec p=0.003; 60°/sec p=0.009; 90°/sec p=0.003; 120°/sec p=0.005; 
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180°/sec p=0.014; 240°/sec p=0.013) at every speed except for flexion at 90°/sec 
(p=0.078). Average isokinetic torque decrease from Pre to Post immobilisation 
across speeds for flexion were 14.0 ± 4.5 %, 8.6 ± 1.3 % and 7.8 ± 5.5 %, and for 
extension were 10.3 ± 1.8 %, 8.1 ± 0.9 % and 7.1 ± 1.8 %, for PLA, EPA and Vit-
D, respectively. There was no effect of supplement group on the percentage 
change in isokinetic torque for flexion or extension at any of the six speeds 
(p>0.05) (Figure 4.4). 
4.3.4. Electromyographic measurements 
Analysis of biceps and triceps co-contraction RMS EMG values during the 
isometric contractions showed no significant changes from Pre to Post 
immobilisation (p>0.05) and no effect of supplement group from Pre-to-Post and 
Pre-to-Post2 (p>0.05) (Figure 4.5). Similarly, this was the case for the isokinetic 
contractions with no significant effect of immobilisation (p>0.05) nor of supplement 
group (p>0.05) on the EMG response to the immobilisation (Figure 4.6). 
4.3.5. Fatiguing contractions 
The mean, slope and standard deviation of the torque traces showed no significant 
changes with immobilisation phase for either flexion or extension fatiguing 
contractions, with no effect of supplement group on percentage changes (p>0.05). 
Analysis of the FFT of EMG traces of the biceps and triceps brachii revealed no 
significant effect of immobilisation or supplementation group on rate coding at 
either the beginning, or the end of a fatiguing maximal isometric contraction 
(p>0.05) (Table 4.1). 
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4.3.6. Arterial resting blood flow 
Brachial artery diameter, RI, FbD and HR did not change from Pre to Post 
immobilisation (p>0.05), nor Pre to Post2 (p>0.05). There was no significant 
difference in the percentage change in brachial artery diameter, RI, FbD or HR 
between the groups (p>0.05) (Table 4.2). 
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Figure 4.3. Pre (circles), Post (squares) and Post2 (triangles) values for isometric 
torque (Nm ± SD) for elbow flexion (A = PLA; B = EPA; C = Vit-D) and elbow 
extension (D = PLA; E = EPA; F = Vit-D) at the six different angles (60-110°). * 
Significant difference between Pre and Post immobilisation in the PLA group. 
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Figure 4.4. Pre (circles), Post (squares) and Post2 (triangles) values for isokinetic 
torque (Nm ± SD) for elbow flexion (A = PLA; B = EPA; C = Vit-D) and elbow 
extension (D = PLA; E = EPA; F = Vit-D) at the six different speeds (30-240°/sec). 
* Significant difference between Pre and Post immobilisation in the PLA group. 
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Figure 4.5. Pre (circles), Post (squares) and Post2 (triangles) values for co-
contraction (Nm ± SD) of the biceps (A = PLA; B = EPA; C = Vit-D) and triceps (D 
= PLA; E = EPA; F = Vit-D) during isometric elbow flexion and extension at the six 
different angles (60-110°). 
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Figure 4.6. Pre (circles), Post (squares) and Post2 (triangles) values for co-
contraction (Nm ± SD) of the biceps (A = PLA; B = EPA; C = Vit-D) and triceps (D 
= PLA; E = EPA; F = Vit-D) during isokinetic elbow flexion and extension at the six 
different speeds (30-240°/sec). 
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Table 4.1. Fatigue characteristics during a 30-second fatiguing contraction in 
flexion and extension in response to immobilisation and supplementation. 
 PLA EPA Vit-D 
Flexion 
mean torque (Nm) 
Pre 26.2 ± 12.7 27.1 ± 11.3 28.4 ± 10.8 
Post 24.5 ± 12.1 23.6 ± 10.0 26.8 ± 10.9 
Post2 25.8 ± 12.1 24.7 ± 8.9 26.8 ± 11.4 
Flexion 
standard deviation 
Pre 3.2 ± 1.4 3.4 ± 1.3 3.0 ± 1.3 
Post 2.7 ± 0.8 2.9 ± 1.4 3.5 ± 1.7 
Post2 3.3 ± 1.3 2.7 ± 1.3 3.5 ± 1.7 
Flexion 
Slope 
Pre -0.3 ± 0.2 -0.2 ± 0.1 -0.2 ± 0.1 
Post -0.3 ± 0.2 -0.2 ± 0.1 -0.3 ± 0.2 
Post2 -0.3 ± 0.2 -0.1 ± 0.1 -0.1 ± 0.1 
Flexion 
agonist FFT 
1st five seconds (Hz) 
Pre 113.6 ± 22.6 102.9 ± 8.5 102.3 ± 5.3 
Post 116.5 ±13.5 106.5 ± 7.8 103.9 ± 5.1 
Post2 112.1 ± 17.3 103.7 ± 8.0 102.1 ± 4.7 
Flexion 
agonist FFT 
last five seconds (Hz) 
Pre 115.2 ± 16.7 102.1 ± 8.0 104.2 ± 9.5 
Post 119.1 ± 15.8 105.5 ± 5.3 105.6 ± 8.5 
Post2 113.6 ± 12.7 101.8 ± 8.3 104.2 ± 9.2 
Extension 
mean torque (Nm) 
Pre 20.4 ± 14.4 23.8 ± 11.8 21.9 ± 12.1 
Post 19.2 ± 13.5 19.2 ± 8.7 17.7 ± 10.2 
Post2 21.3 ± 12.1 22.5 ± 10.7 22.3 ± 9.6 
Extension 
standard deviation 
Pre 2.9 ± 1.9 2.4 ± 1.6 2.2 ± 1.3 
Post 2.5 ± 1.5 2.5 ± 1.4 2.1 ± 0.9 
Post2 2.8 ± 2.1 2.2 ± 1.4 2.1 ± 1.1 
Extension 
Slope 
Pre -0.3 ± 0.6 0.1 ± 0.1 -0.2 ± 0.3 
Post -0.2 ± 0.2 -0.1 ± 0.2 -0.2 ± 0.2 
Post2 -0.3 ± 0.4 -0.1 ± 0.3 -0.1 ± 0.1 
Extension 
agonist FFT 
1st five seconds (Hz) 
Pre 131.8 ± 13.6 128.9 ± 13.3 131.5 ± 9.7 
Post 132.6 ± 16.5 130.3 ± 12.0 133.2 ± 13.2 
Post2 142.3 ± 15.8 130.1 ± 14.4 131.7 ± 9.9 
Extension 
agonist FFT 
last five seconds (Hz) 
Pre 124.7 ± 17.0 124.1 ± 16.0 127.7 ± 12.4 
Post 125.0 ± 19.3 125.7 ± 15.3 129.4 ± 13.7 
Post2 124.3 ± 18.6 125.1 ± 15.9 128.5 ± 12.4 
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4.3.7. Non-immobilised limb data 
All parameters were also recorded on the non-immobilised, control limb. A phase 
specific degree of change calculation was completed to obtain one value for 
control limb corrected relative change for each variable (phase control-corrected 
change = immobilised limb percentage change – non-immobilised limb percentage 
change). The ‘phase control-corrected change’ values were analysed using the 
same statistical analysis process as those used for the immobilised limb only 
results. This revealed that normalisation for the non-immobilised limb made no 
difference on any of the outcome parameters. Due to the lack of impact of 
normalisation for the non-immobilised limb, it was decided that only the 
immobilised limb data would be presented. 
4.4. Discussion 
The effects of two potential protein-sparing modulators (EPA of vitamin D 
supplementations) on the response to 2 weeks of 9-waking-hours-per-day 
combined arm and shoulder immobilisation are described. It was hypothesised 
that muscle function will decrease, muscle co-contraction characteristics will 
change, and indices of healthy vascular function will deteriorate, with limb 
immobilisation. Evidence was found to partially support the hypotheses, with 
significant immobilisation-induced decreases in isometric elbow flexion (PLA: 6.7 
to 18.4 %) and extension (PLA: 8.7 to 13.8 %) torque, as well as isokinetic elbow 
flexion (PLA: 9.3 to 13.7 %) and extension (PLA: 9.8 to 18.1 %) torque. It was also 
hypothesised that EPA would be the most effective supplement at minimising the 
response to immobilisation. The current data demonstrate that neither EPA nor 
vitamin D had any significant effect on the responses to non-injurious 
immobilisation. Nonetheless, a few trends towards (observation of p<0.1 when 
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analysing the effect of supplementation) the attenuation of elbow isometric and 
isokinetic torque immobilisation-induced decreases were observed, in the EPA 
and Vit-D treated groups. The observed trends for the attenuation of these 
parameters are discussed. It is also notable that this immobilisation model had no 
impact on the assessed co-contraction and muscle fatigability, or on the assessed 
blood flow kinetics. 
Isometric elbow extensor and flexor torque decreased following 
immobilisation. This supports previous findings of decreases in isometric MVC of 
the elbow flexors in response to 4 weeks of elbow cast immobilisation (Yue et al., 
1997). In addition to the established decline in isometric torque, disuse models 
also result in reductions in dynamic torque outputs. Cast immobilisation of the arm 
(9 days) also results in decreased concentric and eccentric strength for flexion and 
extension of the wrist (Miles et al., 1994). The current data also show a decrease 
in isokinetic strength for both elbow flexion and extension. However, muscle 
function in terms of isometric and/or isokinetic torque, did not show a significant 
effect of either EPA or vitamin D supplementation at the current doses, in spite of 
somewhat blunting the effect of immobilisation, as this protective effect was not 
statistically significant. 
Data collected for agonist and antagonist EMG activity highlighted no 
differences in biceps or triceps co-contraction following immobilisation. In contrast, 
some of the previous research shows a large decrease in EMG amplitude 
measurements during flexion in both the agonist and antagonist muscle (Vaughan, 
1989; Yue et al., 1997). When drawing conclusions from EMG findings care should 
be taken, as: 1) the changes in muscle dimensions could result in a different 
population of motor units being recorded from (Clark and Fielding, 2012); 2) EMG 
reliability in previously published studies is not very high, and this is a general 
limitation of studies utilising longitudinal EMG monitoring (de Araujo et al., 2009; 
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Fukuda et al., 2010). In addition, it is notable that EMG data in our, and previous 
work (Hermens et al., 2000), does not normalise the data for the clarity of the 
signal. Specifically, in Chapter 3 it was demonstrated that sub-cutaneous adiposity 
changed with immobilisation, hence the electromyographic signature would have 
differed (Solomonow et al., 1994). 
Numerous studies have documented the effects of immobilisation models 
on muscle fatigability, with equivocal findings of both decreased, increased and no 
change in resistance to fatigue (Miles et al., 1994; Miles et al., 2005; Yue et al., 
1997). In the current study, there were no significant changes in the mean, slope 
or standard deviation of the torque trace during the 30-second isometric 
contraction fatigue tasks that were implemented. Differences between studies 
could be due to the mode/duration of disuse or in the method used to test fatigue 
resistance since fibre recruitment level and pattern would vary with changes in 
contractile profile (Bogdanis, 2012). The mechanisms behind the varying effects of 
immobilisation on muscle fatigability are yet to be fully explained. The observation 
of no significant effect of immobilisation on the FFT of EMG traces at either the 
beginning or end of a maximal isometric contraction suggests no effect on motor 
unit rate coding and none on fibre type recruitment. 
Previous research suggests that decreases in physical activity leads to 
detrimental vascular adaptations (Delp et al., 2000; Louisy et al., 1997). Bed-rest 
studies measuring leg blood flow report inconsistent results, with some showing no 
changes in leg blood flow and others demonstrating a decrease in leg blood flow 
after periods of bed-rest (10-41 days) (Convertino, Doerr andStein, 1989; Louisy et 
al., 1997; Pawelczyk et al., 2001; Takenaka et al., 1994). None of these bed-rest 
studies report data on changes in arterial vessel diameter. Studies investigating 
vascular changes in response to upper limb immobilisation are lacking. No 
significant dimensional changes in vasculature with upper limb immobilisation are 
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reported in the current study. Similarly, there was no observation of any significant 
changes in resting HR in response to immobilisation. Similarly, the assessment of 
resting arterial blood flow (RI and FbD) revealed no significant changes in 
response to immobilisation; however, the results reported in the current study were 
resting and not reactive blood flow and as such it would be less likely for any effect 
to be observed (Shoemaker et al., 1998). The lack of change in muscle fatigability, 
however, goes hand in hand with the absence of vascularisation-related 
alterations. 
4.5. Conclusion 
In summary, upper limb immobilisation resulted in a decrease in elbow isometric 
and isokinetic torque, with no observed effect on co-contraction, muscle fatigability 
or resting blood flow. No significant effect of EPA or vitamin D supplementation on 
any of these parameters were observed. Despite greater relative decreases in 
torque than in tissue composition (Chapter 3), there is no significant effect of EPA 
or vitamin D supplementation on the decreases in torque. It would appear that 
muscle function might be a less reliable marker of the effectiveness of a 
supplement against the impact of immobilisation than tissue composition. 
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Chapter 5: Systemic endocrine profile following a small 
muscle, short duration, limb immobilisation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter appears in publication as: Gladys Onambele-Pearson, Emma 
Bostock, Christopher Morse, Keith Winwood, Islay McEwan, Claire Stewart, 2015. 
Chapter x: Sedentarism and The Endocrino-Metabolic System. In Sedentary 
Lifestyle, Health Risks and Physiological Implications. (Ed) Ahmad Alkhatib. Nova 
Science Publishers, New York [book in press] 
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5.1. Introduction 
Prolonged periods of disuse (e.g. limb immobilisation and head-down-tilt bed-rest) 
result in skeletal muscle atrophy (Abe et al., 1997; Akima et al., 2000) and 
declines in maximal voluntary strength (Clark et al., 2008; Hortobagyi et al., 2000; 
Miles et al., 1994; Semmler et al., 2000; Veldhuizen et al., 1993; Yue et al., 1997) 
(Refer to Chapter 1 for a review). Deconditioning of skeletal muscle is mainly 
characterised by a loss of muscle mass (Akima et al., 2001), decreased fibre 
cross-sectional area (Hortobagyi et al., 2000), reduced force (Miles et al., 1994), 
increased insulin resistance (Hirose et al., 2000) and transitions in fibre types 
(Trappe et al., 2004). The disuse-associated atrophy has been attributed to 
fundamental molecular mechanisms such as decreased protein synthesis, 
increased protein degradation, and suppression of bioenergetics pathways 
associated with mitochondrial function, and increased oxidative stress (Jankala et 
al., 1997; Kandarian and Jackman, 2006). Disuse-induced muscle atrophy is a 
highly ordered process that is controlled by interactions between intracellular 
signalling pathways.  
A growing body of literature (Reid and Li, 2001; Hopkins, 1996; Wilcox et 
al., 1996; Wilcox et al., 1992; Wilcox et al., 1994) indicates that cytokines are 
involved in the regulation of skeletal muscle function. Resting healthy human 
muscles express cytokines in a fibre type specific manner, suggesting that 
cytokines may play specific regulatory roles in normal physiology (Plomgaard et 
al., 2005). The fibre type changes seen within disuse models, could therefore, be 
demonstrated through changes in circulating cytokines. In this study, three 
cytokines associated with inflammation were selected, including interleukin 6 (IL-
6), interleukin 10 (IL-10) and tumour necrosis factor alpha (TNF-α). Along with the 
cytokines, creatine kinase (CK) and insulin-like growth factor 1 (IGF-1) were also 
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selected. CK was chosen as a marker of muscle damage. Raised levels of serum 
CK are closely associated with cell damage, muscle cell disruption, or disease, 
and these cellular disturbances can cause CK to leak from cells into blood serum 
(Totsuka et al., 2002). IGF-1 was selected, as it has been associated with muscle 
hypertrophy and atrophy (Barton et al., 2010; Barton-Davis et al., 1998; Schakman 
et al., 2005). 
Exercise prescription is not always practical during periods of hypo-activity 
and, as such, other interventions are needed to attenuate or prevent the disuse-
induced declines in muscle morphology and function (Chapters 3 and 4). 
Nutritional interventions are needed since polypharmacy in itself is conducive to 
skeletal tissue loss (Moylan and Binder, 2007). Two potential protein-sparing 
modulators omega 3 (-3, a fish oil of a complex of eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA)) and vitamin D, hereafter simply referred to as 
EPA or vitamin D supplementation, may be nutritional interventions with potential 
for attenuating disuse-induced atrophy. 
EPA is an n-3 polyunsaturated fatty acid with anti-inflammatory properties. 
There is in vitro evidence to suggest that EPA may reduce the pro-inflammatory 
cytokines associated with inflammation (Magee et al., 2008). It has been 
demonstrated in vitro that EPA inhibits the effects of TNF-α by reducing its 
apoptotic effects and enabling myogenesis (Magee et al., 2008). It is generally 
accepted that there is human muscle atrophy where limb immobilisation is 
enforced (Grosset and Onambele-Pearson, 2008) (Chapter 3), which is associated 
with decreased protein synthesis (de Boer, Selby, et al., 2007) and no change in 
protein breakdown in human models (Ferrando et al., 1996). Whether EPA 
supplementation would have a beneficial effect during immobilisation, therefore, 
remains to be seen. 
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Vitamin D plays a crucial role in maintaining bone, muscle function, 
modulation of cell growth, neuromuscular and immune functions, and reduction of 
inflammation. The vitamin D receptor (VDR) has been identified in a large number 
of human tissues (Reichel et al., 1989), indicating the potential for widespread 
effects. Vitamin D’s biologically active metabolite 1,25-dihydroxyvitamin D 
(1,25(OH)2D) binding with VDR influences the expression of genes involved in cell 
development, growth and differentiation (Bikle, 2010; Walters, 1992). Vitamin D 
mediates calcium and phosphorus metabolism and has been shown to have direct 
effects on muscle (Ceglia and Harris, 2012); although, the exact mechanisms 
remain unknown. Vitamin D has been reported to impact on the synthesis rate of 
contractile proteins (Stewart and Rittweger, 2006). Vitamin D supplementation 
reduced falls by 49 % and improved musculoskeletal function in frail elderly 
women with vitamin D deficiency (Bischoff et al., 2003). It remains to be seen, 
whether vitamin D supplementation in healthy persons with no known vitamin D 
deficiency, would lead to any preservation of muscle structural and contractile 
properties in the presence of immobilisation. 
Chapters 3 and 4 show significant atrophy (muscle thickness (ultrasound), 
lean mass (dual-energy x-ray absorptiometry) and arm girth) and declines in 
muscle strength in response to two weeks of arm immobilisation. This atrophy 
could be because of a change in endocrine factors. Whilst in the previous chapters 
supplementation did not significantly prevent or reduce skeletal muscle atrophy, 
but non-significant trends of attenuated atrophy they caused, could potentially be 
attributed to the early start of modulation of an endocrine cascade of changes. 
The cellular and molecular events controlling the atrophic process have still 
not fully been explored, and further investigations to allow novel interventions to 
combat disuse-induced atrophy need to be implemented. The aim of the present 
study was, therefore, dual: 1) monitor the response of circulating CK activity, 
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cytokines and IGF-1 levels to immobilisation; 2) investigate any protective 
influence of EPA or vitamin D supplementation, on the anticipated immobilisation-
induced deleterious changes in endocrine profile. 
5.2. Methods 
5.2.1. Participants 
Twenty-one healthy volunteers were recruited from the local university campus (a 
sub-sample of the study population from Chapters 3 and 4). Briefly, a 
questionnaire (Appendix 4) to ascertain health and habitual physical exercise 
levels prior to the study confirmed all participants were recreationally active and 
free from recent (last 6 months) upper limb injury. Exclusion criteria were any 
conditions requiring the use of medication likely to affect muscle function or 
musculoskeletal health (e.g. statins and oral steroids), and any current or history of 
kidney/liver disease, as those suffering with such conditions are more susceptible 
to side effects of nutritional supplementation. The screening process ruled out any 
participants with neuro-musculoskeletal disorders that could affect muscle 
function. Ethical approval was obtained through the Department of Exercise and 
Sport Science, Manchester Metropolitan University and all participants signed 
informed consent prior to taking part in the study. 
5.2.2. Intervention 
Full details are described in Chapters 3 and 4. Briefly, the study used a 
randomised, double blind, placebo-controlled design. Participants were randomly 
assigned to one of three groups: placebo [PLA: n = 7]; EPA [EPA: n = 7]; or 
vitamin D [Vit-D: n = 7] (Table 5.1). Participants attended the laboratory on three 
occasions for venous blood samples to be taken. Samples were immediately 
before immobilisation (Pre), on removal of the sling (Post), and two weeks after re-
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mobilisation (Post2). All testing sessions were completed after an overnight fast. 
After baseline testing, the non-dominant arm was immobilised in a sling, with the 
correct sling wearing procedure demonstrated to each participant (Figure 2.1, 
Chapter 2). Participants were required to wear the sling for nine waking hours a 
day for two continuous weeks, removal of the sling was permitted only when 
necessary (e.g. taking a bath/showering, driving, sleeping etc.), minimising any 
movement medio-laterally at the elbow and shoulder, whilst requiring participants 
to not contract the upper musculature (including the hands) during the hours of 
immobilisation. 
 Supplementation was taken during the immobilisation period. The PLA group 
consumed a daily dose of Soya Lecithin typically providing 1464 mg of 
Phosphatides (Holland & Barrett, UK) a day, each. The EPA group consumed a 
daily dose providing 1770 mg EPA and 390 mg DHA (MorEPA®, Minami Nutrition, 
Belgium). The Vit-D group consumed a daily dose providing 1,000 IU of Vitamin D3 
(Now Foods, Bloomingdale, U.S.A.). To monitor daily activity and nutritional intake 
participants completed a daily activity log (including steps taken and sling-wear 
hours) and a 3-day food diary (as described in detail in Chapters 3 and 4). 
 
Table 5.1. Baseline characteristics of all participants. 
 
 
 
 
 
 PLA EPA Vit-D 
Age (years) 25.6 ± 7.0 19.3 ± 1.7 23.3 ± 6.0 
Males n = 2 n = 4 n = 3 
Females n = 5 n = 3 n = 4 
Height (cm) 170.3 ± 11.0 170.1 ± 12.9 173.1 ± 8.2 
Mass (kg) 70.9 ± 14.2 69.9 ± 25.0 72.5 ± 13.4 
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5.2.3. Circulating CK, cytokines and IGF-1 
After a twelve hour, overnight fasting period a hospital-trained phlebotomist took a 
blood sample from the antecubital vein of the forearm, using a 21mL gauge needle 
(Terume, Neolus 100, Leuven, Belgium). The 5-10mL of venous blood was left to 
clot on crushed ice for up to 1 hour before being centrifuged (Thermo Scientific, 
IEC CL31 - CL31R Multispeed, Thermo Electron Corporation) at 4000 rpm at 0°C 
for 10 minutes to separate the serum from the blood cells. Using a 200-1000 μl 
pipette (Pipetman, Gilson®, Middleton, USA), the resulting serum sample was 
separated into three aliquots (~500 μl each) and stored in 1.5 mL microcentrifuge 
tubes (FlipTube®, Hampshire, UK) at -20°C until later analysis for CK, IL-6, IL-10, 
TNF-α and IGF-1. The sensitivity and intra-assay variability of the analysis kits are 
shown in Table 5.2. 
 CK levels were measured using a standard colorimetry procedure, measuring 
at optical density 340 nm (BioTek ELx800 96 well Microplate Reader) and 
immediately analysed (Gen5, version 2.0). Individual samples were run in 
duplicate using an EnzyChromTM CK Assay Kit (BioAssay Systems, Hayward, 
CA), reading enzyme activity after 20 minutes (25 minutes if necessary, with 
readings > 300 U/L at 20 minutes) and 40 minutes of exposure to the assay mix. 
An average of two to four readings were taken per sample, until the coefficient of 
variation (CV) of the repeated values was <10 %. 
 IL-6, IL-10, IGF-1 and TNF-α were individually analysed using the standard 
Quantikine enzyme-linked immunosorbent assay (ELISA) technique, measuring at 
optical density 450 nm (BioTek ELx800 96 well Microplate Reader) and 
immediately analysed (within 30 minutes) (Gen5, version 2.0). Individual samples 
were run in duplicate using ELISA kits for each cytokine (R&D Systems Inc. 
Minneapolis, USA). 
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Table 5.2. Manufacturer’s assessed sensitivity and intra-assay variability of the 
colorimetry and ELISA analysis kits. 
 
 
 
 
 
 
5.2.4. Statistical analysis 
Data were analysed using IBM SPSS v21 (IBM Inc, USA). The Shapiro-Wilk test 
revealed the data to be non-parametric. The effect of immobilisation was 
examined by assessing the changes seen in the PLA group by Friedman tests (3 
repeated measures within one group). Non-parametric comparisons of between 
group differences in endocrine changes relative to baseline values (Pre-to-Post: 
(Post-Pre)/Pre; and Pre-to-Post2: (Post2-Pre)/Pre) were analysed using the 
Kruskal Wallis tests, with post-hoc Mann-Whitney U tests. One-way analysis of 
variance (ANOVA) were used to determine any differences between groups in 
daily physical activity and nutritional intake during immobilisation. The change 
relative to baseline values, are displayed as boxplots in the figures, allowing for 
the distribution of the values to be seen. Statistical significance was set with alpha 
at ≤ 0.05. 
 A joint results and discussion section follows, allowing the comparison and 
discussion of each variable within the context of the literature. 
 Sensitivity Intra-assay variability  
(i.e. Coefficient of variation) 
CK 5 U/L ≤ 5.0 % 
IL-6 < 0.7 pg/mL 2.6 % 
IL-10 < 3.9 pg/mL 3.7 % 
TNF-α 0.5-5.5 pg/mL 4.7 % 
IGF-1 0.007-0.056 ng/mL 4.0 % 
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5.3. Results and Discussion 
5.3.1. Daily physical activity and nutritional intake 
No significant differences were observed in calorific intake (PLA: 1949 ± 895 
kcal/day; EPA: 1668 ± 592 kcal/day; Vit-D: 1924 ± 810 kcal/day (p>0.05)) or in 
habitual physical activity (PLA: 6970 ± 1737 steps/day; EPA: 7397 ± 3552 
steps/day; Vit-D: 6724 ± 1389 steps/day (p>0.05)) between the groups during the 
course of the two-week immobilisation. This effect was true for the EPA, Vit-D and 
PLA groups. Further diet composition analyses revealed no group differences in 
protein (PLA: 1.1 ± 0.3 g·kg-1·bw/day; EPA: 1.0 ± 0.3 g·kg-1·bw/day; Vit-D: 1.0 ± 
0.6 g·kg-1·bw/day), carbohydrate (PLA: 3.4 ± 1.4 g·kg-1·bw/day; EPA: 3.2 ± 1.2 
g·kg-1·bw/day; Vit-D: 3.0 ± 1.1 g·kg-1·bw/day), fat (PLA: 1.1 ± 0.5 g·kg-1·bw/day; 
EPA: 1.0 ± 0.5 g·kg-1·bw/day; Vit-D: 1.0 ± 0.3 g·kg-1·bw/day) or micronutrient 
intake over the immobilisation period between the three groups. Micronutrient 
intake values can be found in Table 5.3. 
Table 5.3. Average daily micronutrient intake of all participants. 
 PLA EPA Vit-D 
Retinol (µg) 267.5 ± 141.1 198.6 ± 105.6 244.4 ± 187.7 
Carotene (µg) 1737.0 ± 1245.9 1101.4 ± 1211.0 1802.9 ± 1432.5 
Vitamin B6 (mg) 1.9 ± 0.8 1.5 ± 0.5 1.9 ± 1.2 
Vitamin B12 (µg) 3.8 ± 1.4 3.1 ± 1.0 3.8 ± 3.0 
Vitamin C (mg) 83.0 ± 27.1 63.9 ± 48.3 81.5 ± 81.4 
Vitamin D (µg) 1.8 ± 0.6 1.5 ± 1.0 2.1 ± 1.7 
Vitamin E (µg) 1.9 ± 1.1 1.5 ± 1.4 1.4 ± 0.9 
Omega-3 (g) 0.37 ± 0.30 0.36 ± 0.19 0.36 ± 0.20 
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5.3.2. Circulating CK 
CV values for all colorimetry and ELISA analysis kits are shown in Table 5.4. 
Resting circulating CK levels did not significantly differ between groups at baseline 
(PLA: 261.4 ± 241.7 U/L; EPA: 477.9 ± 687.2 U/L; Vit-D: 160.7 ± 98.5 U/L; 
p=0.38). There was no significant effect of immobilisation or supplement group on 
circulating CK levels (Figure 5.1.A and 5.2.A). CK is an enzyme expressed by 
various tissues and cell types and is used as a marker of skeletal muscle damage. 
In general populations, baseline levels of serum CK are variable with ranges from 
20 to 16,000 U/L, this wide range reflects the inconsistent occurrence of genetic 
factors, subclinical disorders and minor injury, and physical activity status (Prelle 
et al., 2002). Unpublished values from our own laboratory reported resting CK 
values that were not significantly different between males and females (138 ± 140 
U/L and 80.8 ± 56.7 U/L, respectively, p=0.097). These values were reported for a 
similar study population, and, therefore, supports the mixed sex population used in 
the current chapter. A release of cellular components is thought to occur in 
response to metabolic muscle disturbance. Intracellular proteolytic enzyme activity 
is said to occur through a cascade of events, and can increase and promote 
muscle protein degradation and augment cell permeability, which allows some cell 
contents to leak into the circulation (Huerta-Alardin et al., 2005; Khan, 2009). The 
current findings of no changes in circulating CK, supports the theory that declines 
in skeletal muscle mass that occur in human response to disuse, can largely be 
attributed to decreases in protein synthesis, rather than protein degradation 
(Glover et al., 2008). This seems to be a characteristic that separates human 
atrophic response to that seen in animal models such as (Loughna et al., 1987; 
Thomason and Booth, 1990). Hence, inferring the impact of immobilisation 
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between species (such as done in some of the literature; (Bar-Shai et al., 2005)) 
does not seem advisable (Rennie et al., 2010). 
Table 5.4. Coefficient of variation values for the CK and ELISA analysis kits in the 
present study. * denotes greater than, and ** lower than the manufacturer’s 
published data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Coefficient of variation (%) 
CK 7.1 ± 6.9* 
IL-6 3.7 ± 0.6* 
IL-10 2.9 ± 1.6** 
TNF-α 3.8 ± 0.4** 
IGF-1 2.8 ± 0.6** 
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Figure 5.1. Percentage change (% ± SD) in circulating: (A) CK, (B) IL-6, (C) IL-10, 
(D) TNF-α and (E) IGF-1, from Pre-to-Post immobilisation for PLA, EPA and Vit-D 
groups. Each boxplot displays the median (middle line of the box), first quartile 
(bottom line of the box), third quartile (top line of the box), minimum (bottom 
whisker) and maximum (top whisker) values. 
 
* 
* 
† 
† † 
† 
A B 
C D 
E 
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Figure 5.2. Percentage change (% ± SD) in circulating: (A) CK, (B) IL-6, (C) IL-10, 
(D) TNF-α and (E) IGF-1, from Pre-to-Post2 immobilisation for PLA, EPA and Vit-D 
groups. Each boxplot displays the median (middle line of the box), first quartile 
(bottom line of the box), third quartile (top line of the box), minimum (bottom 
whisker) and maximum (top whisker) values. 
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5.3.3. Circulating IL-6 
Baseline circulating IL-6 levels were not significantly different between groups 
(PLA: 1.9 ± 1.2 pg/mL; EPA: 1.8 ± 1.7 pg/mL; Vit-D: 1.6 ± 1.3 pg/mL; p=0.93). 
Serum IL-6 values in the literature are similar with reports of 1.4 ± 1.0 pg/mL and 
3.0 ± 0.6 pg/mL (Klausen et al., 1997; Nishimoto et al., 2008). Percentage change 
in circulating IL-6 levels from Pre to Post immobilisation was not significantly 
different between supplement groups (Figure 5.1.B and 5.2.B). IL-6 is produced 
and released by a wide variety of cell types, including skeletal muscle and is both 
a pro-inflammatory cytokine and an anti-inflammatory myokine. There are 
observations that IL-6 either directly or indirectly mediates catabolic effects on 
skeletal muscle (Goodman, 1994) and that IL-6 can directly induce skeletal muscle 
atrophy (Haddad et al., 2005). Drummond et al. (2013)  reported increases in IL-6 
mRNA in muscle samples after seven days bed-rest, whilst systemic changes 
were absent. The results of this and the present study suggest that relatively short-
term, low total mass, disuse does not induce a change in circulating IL-6. 
5.3.4. Circulating IL-10 
Resting circulating IL-10 levels did not significantly differ between groups at 
baseline (PLA: 8.8 ± 2.2 pg/mL; EPA: 6.8 ± 2.1 pg/mL; Vit-D: 10.5 ± 6.6 pg/mL; 
p=0.28). In comparison to some values in the literature (1.1 ± 1.34 pg/mL) (Csuka 
et al., 1999), the IL-10 values reported in the present study are high. In other 
studies, however, median serum IL-10 values of 18.0 pg/mL (range, 0-1055 
pg/mL) and 9.2 pg/mL (range, 7.4-12.0 pg/mL) have been reported in healthy 
control groups, which would put the current values in line with some of the 
literature (De Vita et al., 2000; Gupta et al., 2012). There was no significant effect 
of immobilisation or of supplement group on circulating IL-10 levels (Figure 5.1.C 
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and 5.2.C). IL-10 is a predominantly anti-inflammatory cytokine that regulates the 
TNF-α-converting enzyme (Schottelius et al., 1999). Deng et al. (2012) showed 
that IL-10 plays a central role in the regulation of normal growth and regeneration 
of muscle. It is well established that shifts in macrophage phenotype coincide with 
transitions in the stage of myogenesis in regenerating muscle (Frenette et al., 
2000; McLennan, 1993; St Pierre and Tidball, 1994). That shift in macrophage 
phenotype is suggested to coincide with changes in expression of myogenic, 
regulatory transcription factors (Launay et al., 2001; McLoon et al., 1998; 
Yablonka-Reuveni and Rivera, 1994). Again, the present results do not 
demonstrate a significant change in circulating IL-10 and may suggest that IL-10 is 
not a key mechanism associated with non-injurious disuse-induced atrophy. 
5.3.5. Circulating TNF-α 
Baseline circulating TNF-α levels did not significantly differ between groups (PLA: 
16.3 ± 15.2 pg/mL; EPA: 11.3 ± 7.9 pg/mL; Vit-D: 23.7 ± 21.1 pg/mL; p=0.35). The 
reported TNF-α levels are in line with previously reported values in the literature, 
with average serum TNF-α levels ranging from 10.9 to 16.8 pg/mL in mixed control 
populations (O'Brien et al., 2007; Pavon et al., 2006). Percentage change in 
circulating TNF-α levels from Pre to Post immobilisation was not significantly 
different between supplement groups (Figure 5.1.D and 5.2.D). TNF-α is a 
cytokine involved in systemic inflammation and is one of the cytokines that make 
up the acute phase reaction. TNF-α is one of the most prominent cytokines linked 
to muscle pathophysiology, being associated with muscle catabolism and loss of 
muscle function (Li and Reid, 2001). This study does not demonstrate significant 
changes in circulating TNF-α and may support previous findings of decreased 
protein synthesis rather than increased protein degradation in disuse-atrophy 
(Glover et al., 2008). 
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5.3.6. Circulating IGF-1 
At baseline resting circulating IGF-1 levels did not significantly differ between 
groups (PLA: 184.7 ± 58.5 ng/mL; EPA: 252.2 ± 48.8 ng/mL; Vit-D: 221.0 ± 64.1 
ng/mL; p=0.12). IGF-1 serum values ranging from 114 to 538 ng/mL are reported 
in the literature for a similar aged mixed sex population (Granada et al., 2000). The 
percentage change in IGF-1 was not significantly different between supplement 
groups (Figure 5.1.E and 5.2.E). IGF-1 is a protein that has anabolic effects in 
adults, stimulating cell growth and inhibiting cell death. It has been demonstrated 
that IGF-1 induces hypertrophy by stimulating the phosphatidylinositol 3-kinase 
(PI3k)-Akt pathway, resulting in downstream activation of proteins that are 
required for protein synthesis (Bodine et al., 2001; Rommel et al., 2001). The IGF-
1/PI3K/Akt pathway, is therefore, identified as a crucial intracellular regulator of 
muscle hypertrophy (Glass, 2003b; Glass, 2003a). Several studies indicate that 
IGF-1 can induce hypertrophy and block atrophy (Barton et al., 2010; Barton-Davis 
et al., 1998; Schakman et al., 2005). The present findings do not demonstrate any 
changes in circulating IGF-1 levels. Observing no change in circulating levels does 
not rule out changes in IGF-1 in skeletal muscle itself (Sjogren et al., 1999; Yakar 
et al., 1999).  
5.4. Conclusion 
Overall, in this relatively short-term immobilisation model that utilised a small 
muscle mass, there appeared to be no change in circulating CK, cytokines or IGF-
1 in response to immobilisation. This suggests that the atrophy and strength 
declines seen in such a model (see Chapters 3 and 4) are not associated with 
changes in the specific enzyme and hormonal factors quantified here, at least not 
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at the systemic level. There may be other endocrine factors, not monitored in this 
study that may play crucial roles in skeletal muscle atrophy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
130 
 
 
Chapter 6: Impact of pre-immobilisation protein 
supplementation on the time course of immobilisation-
induced atrophy and asthenia 
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6.1. Introduction 
Previous research (summarised in Chapter 1) along with the data presented in 
Chapters 2, 3 and 4, show declines in skeletal muscle size, skeletal muscle 
strength and bone content and increases in fatty tissues content in response to 
disuse models. There are also several reports of the effects of disuse on muscle 
fatigability (Miles et al., 1994; Miles et al., 2005; Yue et al., 1997), EMG 
characteristics (Vaughan, 1989) and the cardiovascular system (Gayeski and 
Honig, 1983; Henriksson and Reitman, 1977; Shoemaker et al., 1998). The 
previous chapters support decreases in muscle size and strength and to some 
extent bone content, along with increases in fatty tissue content, with 
immobilisation. The data in Chapter 4 however, do not suggest significant changes 
in muscle fatigability, EMG characteristics or markers of cardiovascular function. 
 As suggested in the previous chapters, nutritional supplementation is 
proposed as a strong candidate for attenuating hypo-activity-induced skeletal 
muscle atrophy and declines in muscular strength. Looking back on all previous 
chapters, it is clear that the data so far highlight essential amino acid (EAA) 
supplementation as the most effective nutritional intervention to help prevent the 
deleterious changes associated with the current disuse model. Previous research 
(Paddon-Jones, Sheffield-Moore, Urban, et al., 2004; Stuart et al., 1990), along 
with Chapter 2, investigate the effects of EAA supplementation during periods of 
disuse. Physiological reserve refers to excess capacity in organs and the 
biological systems and has been defined as the buffer that allows us to cope with 
and recover from stressors (Kemp and Mosqueda, 2004). Whether building 
physiological reserve before periods of disuse (i.e. administering nutritional 
supplementation for a period before limb immobilisation) would have beneficial 
effects on the response of skeletal muscle, bone parameters and the 
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cardiovascular system to disuse however, is yet to be determined. The practical 
implications would be that for clinical orthopaedic patients, in particular those 
scheduled for joint replacement surgery, given that the period of hypo-activity (e.g. 
post-surgery) is planned, building up physiological reserve in anticipation may be 
an effective preventative measure against the expected atrophy/ asthenia. Indeed, 
previous research has shown a significant correlation between subnormal 
nutritional indices and the development of complications following orthopaedic 
surgery (Jensen et al., 1982). Similarly, in Chapter 2, there was a strong potential 
for liquid amino acid ingestion for reducing the impact of immobilisation. 
The aim of the present study, therefore, was to determine whether pre-
immobilisation supplementation with an EAA supplement before a period of limb 
immobilisation, would help to attenuate the declines in muscle morphology, muscle 
strength and bone parameters associated with upper limb immobilisation. This 
chapter utilises the same model of immobilisation as in Chapters 3, 4 and 5. 
6.2. Methods 
6.2.1. Participants 
Ten healthy, recreationally active participants were recruited from the local 
university campus, via lecture presentations, posters and word of mouth over a 
one-year period. All participants gave written informed consent to participate in this 
study before being randomly assigned to one of two groups: placebo [PLA: n = 5] 
or EAA [EAA: n = 5] (anthropometric data in Table 6.1). Participants were 
excluded if they had any medical conditions requiring the use of medication likely 
to affect muscle function or musculoskeletal health. The screening process also 
ruled out any participants with neuro-musculoskeletal disorders that could affect 
muscle function. The study was in agreement with the Declaration of Helsinki and 
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approval was obtained from the local Ethics Committee of Manchester 
Metropolitan University. 
Table 6.1. Baseline characteristics of all participants. 
 
 
 
 
 
6.2.2. Intervention 
The study used a randomised, double-blind, placebo-controlled design. At least 
one week prior to the first testing session all participants attended a familiarisation 
session. Measures of upper arm muscle and subcutaneous fat thickness, body 
composition (lean mass, bone content parameters and fat mass), upper and lower 
arm girth, isometric and isokinetic elbow torque, EMG co-contraction, muscle 
fatigability and arterial dimensions and blood flow were taken at every testing 
session. Participants attended three testing sessions in total: 
1) Baseline testing session [BASE]: participants sent away with two weeks’ 
worth of nutritional supplement 
2) Second testing session [PRE]: the non-dominant arm was immobilised in a 
sling as per Chapters 3 and 4; in short, the sling was to be worn for a 
minimum of nine waking hours a day for two continuous weeks. Participants 
sent away with two weeks’ worth of nutritional supplement 
 PLA EAA 
Age (years) 23 ± 5.5 21 ± 2.9 
Males n = 2 n = 2 
Females n = 3 n = 3 
Height (cm) 169.2 ± 15.8 167.6 ± 3.8 
Mass (kg) 75.0 ± 20.8 68.4 ± 9.6 
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3) Third testing session [POST]: post removal of the sling and final testing 
session 
During the BASE to PRE phase, the EAA group ingested 2 x 45 mL per day of 
a commercially available EAA drink (Amino Fuel Lean Muscle Liquid, Orange, 
Twinlab®, U.S.A.). During the BASE to PRE phase, the PLA group received a 
colour and taste matched placebo (Figure 6.1). Each 45 mL dose of Amino Fuel 
nutritional supplement is described by the manufacturer as containing 15 g of 
protein: 780 mg L-Leucine; 440 mg L-Isoleucine; 530 mg L-Valine; 760 mg L-
Lysine; 560 mg L-Threonine; 200 mg L-Methionine; 320 mg L-Phenylalanine; 80 
mg L-Tryptophan). Each 45 mL of the placebo mixture consisted of a homemade 
blend of water (35.3 mL), orange cordial (no added sugar) (7.9 mL), orange extract 
(1.4 mL), artificial sweeteners (0.7 Hermesetas tablets), orange and yellow food 
colouring (0.4 mL) and an over the counter thickening agent (2.6 g of Resource® 
ThickenUpTM). During the PRE to POST phase (i.e. during immobilisation) both the 
EAA and PLA group received the colour and taste matched placebo as described 
above. Participants were asked to maintain their habitual diet and not to perform 
any unaccustomed strenuous exercise during the study duration. This was 
monitored as described in more detail in Chapter 3, using a 3-day food diary, a 
daily activity log and pedometer. These were self-reported between BASE to PRE, 
and between PRE to POST. The food diaries were analysed for macronutrient and 
micronutrient average intake using Microdiet Plus 1.2 (Microdiet, Downlee 
Systems Ltd, UK).  
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Figure 6.1.Comparison of placebo (left) and EAA (right) supplements. 
6.2.3. Muscle and sub-cutaneous adipose thickness measures 
Images of biceps and triceps brachii muscle and sub-cutaneous adipose tissue 
were obtained using B-mode ultrasonography, as previously described in Chapter 
3. In short, images were obtained with the participant in an upright-seated position 
with their arm abducted square to the body and resting on the ultrasound machine. 
The midpoint (L50) and a third of the distance (L33) from the distal end of the 
biceps and triceps brachii were identified and marked on the skin. Images were 
collected in the sagittal plane at these four sites and recorded using Adobe 
Premiere 6.0 (Adobe Systems, USA). Muscle thickness was measured as the 
distance from the top of the superficial muscle aponeurosis to the bone at both 
sites along the biceps and triceps brachii. Sub-cutaneous adipose thickness was 
measured as the distance from the bottom of the epidermis to the top of the 
superficial muscle aponeurosis in the biceps and triceps at both sites. 
6.2.4. Body composition analysis 
Body composition was determined using dual-energy x-ray absorptiometry (DXA) 
scanner (Hologic Discovery; Vertec Scientific, Berkshire, UK), as previously 
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described in Chapter 3. Measures of bone mineral density (BMD), bone mineral 
content (BMC), lean mass, fat mass and fat percentage are reported for the 
immobilised arm only. 
6.2.5. Arm girths 
As previously described in Chapter 3, a measuring tape was used to measure 
upper arm girth at the mid-acromial-radial and lower arm girth at a fixed point a 
third of the way (proximal to the olecranon) along the length of the radiale-stylion. 
Arm girth measurements were taken with participants in a relaxed standing 
position with arms hanging by the sides and palms facing the hips (i.e. anatomical 
zero). 
6.2.6. Isometric dynamometry 
In depth dynamometry details are reported in Chapter 4. Briefly, isometric elbow 
torque was assessed using a Cybex dynamometer (Cybex, New York, USA). Two 
repetitions of isometric contractions were performed at six different elbow joint 
angles (60°, 70°, 80°, 90°, 100° and 110°), 60 seconds apart. Participants were 
instructed to rapidly exert maximal torque against the dynamometer lever arm over 
a 3-4 second period. First in flexion and, five seconds after return to baseline, in 
extension. The highest torque (peak torque averaged over a 500 ms period either 
side of instantaneous peak) from the repeated efforts, was recorded as the 
participant’s maximal voluntary contraction (MVC) for each angle. 
6.2.7. Isokinetic dynamometry 
Three continuous elbow extension and flexion isokinetic contractions were 
completed at six different randomised order speeds (30, 60, 90, 120, 180 and 
240°/sec), separated by 90 seconds. The highest of the three consecutive efforts 
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at each speed was recorded as peak isokinetic torque (25 ms either side of the 
instantaneous peak) for elbow extension and flexion. 
6.2.8. Electromyographic measurements 
During the isometric and isokinetic contractions, muscle recruitment level and 
patterns were assessed using electromyography (EMG) as described in Chapter 
4. Percentage biceps co-contraction was calculated (biceps EMG during extension 
/ biceps EMG during flexion) for both isometric and isokinetic contractions. 
Percentage triceps co-contraction was also calculated (triceps EMG during flexion 
/ triceps EMG during extension) again for both isometric and isokinetic 
contractions.  
6.2.9. Fatiguing contractions 
Maximal isometric contractions were performed for 30 seconds with the 
dynamometer lever arm locked at a 90° angle (where 180° is full elbow extension) 
in the direction of elbow flexion, and after 90 seconds recovery, in the direction of 
elbow extension. The mean, slope and standard deviation of the torque trace were 
recorded through the 30-second contractions. Fast Fourier transform (FFT) was 
computed for the agonist muscle during the first five and last five seconds of each 
fatiguing contraction. Median frequency values were determined for these time 
points and a change in median frequency (last 5 minutes – first 5 minutes / first 5 
minutes) was then computed as a measure of the fatigability of the muscle. 
6.2.10. Arterial resting blood flow 
Measurements of resting brachial artery diameter, heart rate (HR), resistance 
index (RI) and flow by diameter (FbD) were obtained using an echo Doppler 
ultrasound machine (AU5, Esaote, Genoa, Italy). FbD was a measure of velocity 
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(m/s). The values were obtained in the sagittal plane in line with the marker of the 
midpoint of the biceps brachii (as previously marked earlier for obtaining muscle 
ultrasound images). For more details, please refer to Chapter 4. 
6.2.11. Statistics 
Data were analysed using IBM SPSS v21 (IBM Inc, USA). The Shapiro-Wilk test 
revealed some of the data to be non-parametric (muscle and sub-cutaneous 
adipose thickness, body composition, isometric and isokinetic co-contraction, FFT 
and arterial resting blood flow). Percentage change relative to baseline values 
(BASE-to-PRE: (PRE-BASE)/BASE; and BASE-to-POST: (POST-BASE)/BASE) 
was calculated for all variables. Parametric data were analysed using a mixed 
design 2x2 ANOVA (where the within factor is time phase: BASE-to-PRE and 
BASE-to-POST; and the between factor is supplement group: PLA vs. EAA), using 
the percentage change data. Non-parametric data were analysed in two parts: a) 
within group effects was analysed using Friedman tests on raw data (BASE, PRE 
and POST) and the Wilcoxon signed rank test to compare the percentage change 
values within groups; b) between group effect was analysed using Mann-Whitney 
U tests to compare percentage change values between groups. All data are 
presented as mean ± standard deviation (SD). Statistical significance was set with 
alpha at < 0.05. 
6.3. Results 
6.3.1. Daily physical activity and nutritional intake 
There was no significant change in self-reported nutritional intake from the period 
before immobilisation compared to during immobilisation in either supplement 
group. Nutritional intake was not significantly different between groups at either 
phase (Table 6.2). EAA supplementation during the pre-immobilisation phase 
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resulted in a significantly greater protein intake before immobilisation in the EAA 
group than during immobilisation (p=0.027) and a significantly greater protein 
intake compared to the PLA group (p<0.048). There was no significant difference 
in habitual physical activity before, compared to during immobilisation or between 
supplement groups (Table 6.2). 
6.3.2. Muscle and sub-cutaneous adipose thickness measures 
Muscle and sub-cutaneous adipose thickness were not significantly different 
between groups at baseline (muscle thickness: bicep L50 p=0.144; bicep L33 
p=0.600; triceps L50 p=0.595; triceps L33 p=0.629 and sub-cutaneous adipose 
thickness: bicep L50 p=0.718; bicep L33 p=0.508; triceps L50 p=0.815; triceps L33 
p=0.962) (Table 6.3). There was a significant decrease in muscle thickness (bicep 
L50 p=0.010; bicep L33 p=0.004; triceps L50 p=0.019; triceps L33 p=0.012) and a 
significant increase in sub-cutaneous adipose thickness (bicep L50 p=0.037; bicep 
L33 p=0.020; triceps L50 p=0.044; triceps L33 p=0.033) at all sites on the biceps 
and triceps brachii POST immobilisation. There was no significant change in any 
muscle or sub-cutaneous thickness measures after supplementation from BASE to 
PRE immobilisation (muscle thickness: bicep L50 p=0.905; bicep L33 p=0.636; 
tricep L50 p=0.100; triceps L33 p=0.100 and sub-cutaneous adipose thickness: 
bicep L50 p=1.000; bicep L33 p=0.72; triceps L50 p=0.464; triceps L33 p=0.423). 
The relative change values in muscle thickness and sub-cutaneous adipose 
thickness were not significantly different between the PLA and EAA groups 
(muscle thickness: bicep L50 p=0.548; bicep L33 p=0.421; triceps L50 p=0.548; 
triceps L33 p=0.421 and sub-cutaneous adipose thickness: bicep L50 p=0.690; 
bicep L33 p=0.841; triceps L50 p=0.841; triceps L33 p=0.690) (Figure 6.2). 
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Table 6.3. Baseline biceps and triceps muscle and sub-cutaneous thickness 
measures. 
 
 
 
 
 
 
 
 
 PLA EAA 
Biceps muscle thickness (L50) (mm) 34.5 ± 5.3 30.0 ± 3.4 
Biceps muscle thickness (L33) (mm) 31.3 ± 6.1 29.6 ± 3.9 
Triceps muscle thickness (L50) (mm) 44.4 ± 4.4 43.2 ± 2.3 
Triceps muscle thickness (L33) (mm) 45.2 ± 4.7 44.0 ± 2.5 
Biceps sub-cutaneous adipose thickness 
(L50) (mm) 
5.5 ± 4.0 4.7 ± 3.2 
Biceps sub-cutaneous adipose thickness 
(L33) (mm) 
4.8 ± 1.9 3.9 ± 2.0 
Triceps sub-cutaneous adipose thickness 
(L50) (mm) 
9.5 ± 9.4 8.4 ± 2.8 
Triceps sub-cutaneous adipose thickness 
(L33) (mm) 
7.6 ± 6.3 7.4 ± 3.4 
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Figure 6.2. Percentage change (% ± SD) in, (A) muscle thickness and (B) sub-
cutaneous adipose thickness, from BASE-to-POST immobilisation for PLA (white 
bars) and EAA (grey bars) at the midpoint (L50) and a third of the distance (L33) 
along the length of the biceps and triceps brachii. 
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6.3.3. Arm girths 
Baseline upper arm girth (PLA: 29.6 ± 4.7 mm; EAA: 27.4 ± 1.9 mm) and lower 
arm girth (PLA: 25.6 ± 2.9 mm; EAA: 25.3 ± 1.4 mm) were not significantly 
different between the two groups (p=0.357 and p=0.801, respectively). There was 
a significant decrease in upper and lower arm girth POST immobilisation (p=0.001 
and p=0.003, respectively), with no significant difference between groups in the 
relative change values (p= 0.894 and p=0.523, respectively) (Figure 6.3). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.  Percentage change (% ± SD) in upper (A) and lower (B) arm girth from 
BASE-to-PRE and BASE-to-POST for PLA (white bars) and EAA (grey bars). 
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6.3.4. Body composition 
Baseline lean mass (PLA: 2364.7 ± 982.1 g; EAA: 2271.7 ± 511.0 g), BMD (PLA: 
0.8 ± 0.1 g/cm2; EAA: 0.8 ± 0.1 g/cm2), BMC (PLA: 167.1 ± 51.8 g; EAA: 169.7 ± 
38.8 g), fat mass (PLA: 1288.6 ± 583.9 g; EAA: 1180.0 ± 496.4 g) and fat 
percentage (PLA: 34.0 ± 12.7 %; EAA: 31.5 ± 10.3 %) were not significantly 
different between supplement groups (p=0.934; p=0.771; p=0.850, p=0.521, 
p=0.485, respectively). Lean mass decreased significantly POST immobilisation 
(p=0.34), with no significant difference between groups in relative change values 
(p=0.693) (Figure 6.4). There was no significant change in BMD, BMC, fat mass 
nor fat percentage throughout supplementation or immobilisation (p=0.275; 
p=0.566, p=0.125, p=0.737 respectively). Similarly, there was no significant effect 
of supplementation group on relative change values (p=0.596; p=0.654, p=0.781, 
p=0.332, for BMD, BMC, fat mass and fat percentage, respectively) (Table 6.4). 
 
 
 
 
 
 
 
 
Figure 6.4. Percentage change (% ± SD) in lean mass from BASE-to-PRE and 
BASE-to-POST for PLA (white bars) and EAA (grey bars). 
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Table 6.4. Percent changes (% ± SD) in immobilised limb composition in response 
to immobilisation and supplementation. 
 
6.3.5. Isometric dynamometry 
Isometric MVC elbow flexion and extension torque were not significantly different 
between groups at baseline (flexion: 60° p=0.909; 70° p=0.776; 80° p=0.375; 90° 
p=0.882; 100° p=0.723; 110° p=0.897 and extension: 60° p=0.386; 70° p=0.410; 
80° p=0.300; 90° p=0.360; 100° p=0.584; 110° p=0.235). Isometric MVC torque 
decreased from BASE to POST immobilisation, at every angle for elbow flexion 
(60° p=0.0002; 70° p=0.015; 80° p=0.003; 90° p=0.001; 100° p=0.035) and elbow 
extension (60° p=0.039; 80° p=0.026; 90° p=0.043), except for flexion at 110° 
(p=0.065) and extension at 70° (p=0.204), 100° (p=0.109) and 110° (p=0.173) 
(Figure 6.5). Average isometric torque decrease from BASE to POST 
immobilisation across angles for flexion were -14.0 ± 2.7 % and -12.5 ± 2.4 %, and 
for extension were -11.3 ± 3.0 %  and -10.7 ± 4.2 %, for PLA and EAA, 
respectively. There was no significant effect of supplement group on relative 
percentage change values for any of the isometric elbow torque measurements 
(flexion: 60° p=0.162; 70° p=0.965; 80° p=0.898; 90° p=0.819; 100° p=0.998; 110° 
 PLA EAA 
 BASE-to-PRE BASE-to-POST BASE-to-PRE BASE-to-POST 
BMD 0.3 ± 2.6 -0.1 ± 0.4 2.4 ± 2.8 3.1 ± 2.1 
BMC 0.2 ± 0.2 -0.3 ± 1.5 0.6 ± 1.4 -0.4 ± 1.0 
Fat mass 1.0 ± 0.6 3.2 ± 3.5 0.5 ± 1.0 1.9 ± 3.2 
Fat % 0.6 ± 2.8 1.7 ± 3.8 1.2 ± 9.0 -3.0 ± 7.7 
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p=0.974 and extension: 60° p=0.946; 70° p=0.994; 80° p=0.770; 90° p=0.751; 
100° p=0.768; 110° p=0.859). 
6.3.6. Isokinetic dynamometry 
Isokinetic MVC elbow flexion and extension torque were not significantly different 
between groups at baseline (flexion: 30°/sec p=0.971; 60°/sec p=0.764; 90°/sec 
p=0.881; 120°/sec p=0.826; 180°/sec p=0.427; 240°/sec p=0.742 and extension: 
30°/sec p=0.974; 60°/sec p=0.766; 90°/sec p=0.744; 120°/sec p=0.377; 180°/sec 
p=0.705; 240°/sec p=0.735). Isokinetic torque significantly decreased POST 
immobilisation at all speeds for both flexion (30°/sec p=0.006; 60°/sec p=0.016; 
90°/sec p=0.011; 120°/sec p=0.024; 180°/sec p=0.008; 240°/sec p=0.017) and 
extension (30°/sec p=0.009; 60°/sec p=0.006; 90°/sec p=0.042; 120°/sec p=0.004; 
180°/sec p=0.044; 240°/sec p=0.022) (Figure 6.6). Average isokinetic torque 
decrease from BASE to POST immobilisation across speeds for flexion were -9.3 
± 3.5 % and -10.5 ± 3.1 %, and for extension were -12.8 ± 3.9 %  and -7.6 ± 2.4 %, 
for PLA and EAA, respectively. There was no significant effect of supplement 
group on relative percentage change values for any of the isokinetic elbow torque 
measurements (flexion: 30°/sec p=0.209; 60°/sec p=0.919; 90°/sec p=0.806; 
120°/sec p=0.603; 180°/sec p=0.990; 240°/sec p=0.889 and extension: 30°/sec 
p=0.976; 60°/sec p=0.116; 90°/sec p=0.693; 120°/sec p=0.177; 180°/sec p=0.114; 
240°/sec p=0.129). 
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Figure 6.5. BASE (circles), PRE (triangles) and POST (squares) values for 
isometric torque (Nm ± SD) for elbow flexion (A = PLA; B = EAA) and elbow 
extension (C = PLA; D = EAA) at the six different joint angles (60-110°). * 
significant decrease from BASE to POST immobilisation. 
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Figure 6.6. BASE (circles), PRE (triangles) and Post2 (squares) values for 
isokinetic torque (Nm ± SD) for elbow flexion (A = PLA; B = EAA) and elbow 
extension (C = PLA; D = EAA) at the six different speeds (30-240°/sec). * 
significant decrease from BASE to POST immobilisation. 
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6.3.7. Electromyographic measurements 
Analysis of biceps and triceps co-contraction RMS EMG values during the 
isometric contractions showed no significant changes from BASE to PRE and 
BASE to POST immobilisation and no effect of supplement group on the relative 
percentage changes (p>0.05). Average percentage change in co-contraction RMS 
EMG values during isometric contractions decrease from BASE to POST 
immobilisation across angles for biceps were -0.22 ± 0.39 % and 0.05 ± 0.08 %, 
and for triceps were -0.09 ± 0.08 % and -0.04 ± 0.06 %, for PLA and EAA, 
respectively. Similarly, analysis of the co-contraction RMS EMG values during the 
isokinetic contractions displayed no significant effect of immobilisation nor of 
supplement group on the EMG response to the immobilisation (p>0.05). Average 
co-contraction RMS EMG values during isokinetic contractions decrease from 
BASE to POST immobilisation across speeds for biceps were 0.30 ± 0.42 % and -
0.16 ± 0.11 %, and for triceps were -0.07 ± 0.08 % and -0.02 ± 0.08 %, for PLA 
and EAA, respectively. 
6.3.8. Fatiguing contractions 
The mean, slope and standard deviation of the torque traces showed no significant 
changes with immobilisation phase for either flexion or extension fatiguing 
contractions (p>0.05) (Table 6.5). There was no effect of supplement group on 
percentage changes in the mean, slope or standard deviation of the torque trace. 
Analysis of the FFT of EMG traces of the biceps and triceps brachii revealed no 
significant effect of immobilisation or supplementation group on rate coding 
change from the beginning (first 5 sec of trace) to the end (last 5 sec of trace) of a 
fatiguing maximal isometric contraction (p>0.05). 
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Table 6.5. Fatigue characteristics in response to immobilisation and 
supplementation. 
 PLA EAA 
Flexion 
mean torque (Nm) 
BASE 27.1 ± 10.7 27.6 ± 6.4 
PRE 27.7 ± 9.8 28.2 ± 3.5 
POST 25.0 ± 9.2 25.7 ± 8.0 
Flexion 
standard deviation 
BASE 2.1 ± 0.6 2.9 ± 1.5 
PRE 2.6 ± 0.6 3.1 ± 1.9 
POST 2.1 ± 0.5 2.3 ± 1.1 
Flexion 
slope 
BASE -0.23 ± 0.11 -0.23 ± 0.25 
PRE -0.19 ± 0.11 -0.23 ± 0.22 
POST -0.20 ± 0.10 -0.20 ± 0.16 
Flexion 
agonist FFT 
1st five seconds (Hz) 
BASE 106.1 ± 8.2 106.8 ± 13.1 
PRE 107.5 ± 7.4 107.0 ± 13.1 
POST 110.2 ± 4.9 101.5 ± 11.8 
Flexion 
agonist FFT 
last five seconds (Hz) 
BASE 105.5 ± 5.7 106.1 ± 11.4 
PRE 107.0 ± 4.6 106.0 ± 11.4 
POST 111.4 ± 7.7 102.2 ± 8.6 
Extension 
mean torque (Nm) 
BASE 19.2 ± 8.6 25.2 ± 9.1 
PRE 19.9 ± 8.7 26.0 ± 10.9 
POST 19.1 ± 8.0 20.8 ± 7.0 
Extension 
standard deviation 
BASE 1.4 ± 0.7 2.8 ± 1.3 
PRE 1.2 ± 0.7 2.0 ± 1.3 
POST 1.5 ± 0.9 1.9 ± 0.8 
Extension 
slope 
BASE -0.09 ± 0.10 -0.10 ± 0.09 
PRE -0.11 ± 0.10 -0.06 ± 0.07 
POST -0.07 ± 0.06 -0.14 ± 0.09 
Extension 
agonist FFT 
1st five seconds (Hz) 
BASE 121.0 ± 14.7 123.4 ± 9.7 
PRE 118.7 ± 16.4 126.1 ± 12.1 
POST 115.2 ± 20.7 121.9 ± 7.9 
Extension 
agonist FFT 
last five seconds (Hz) 
BASE 119.1 ± 16.6 123.4 ± 9.5 
PRE 118.6 ± 15.6 123.6 ± 10.7 
POST 117.6 ± 16.7 118.8 ± 6.9 
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6.3.9. Arterial resting blood flow 
Baseline brachial artery diameter (PLA: 2.9 ± 0.5 mm; EAA: 2.6 ± 0.1 mm), HR 
(PLA: 72.5 ± 17.3 bpm; EAA: 70.0 ± 9.4 bpm), RI (PLA: 0.8 ± 0.1; EAA: 0.6 ± 0.3) 
and FbD (PLA: 0.09 ± 0.01 m/sec; EAA: 0.07 ± 0.01 m/sec), were not significantly 
different between supplement groups (Table 6.6.b). There was no significant 
change in brachial artery diameter, HR, RI and FbD from BASE to PRE nor BASE 
to POST immobilisation (p>0.05). Similarly, there was no significant effect of 
supplement group on the relative percent changes in these parameters (p>0.05) 
(Table 6.6.a). 
 
Table 6.6.a. Percent change (% ± SD) in blood kinetic parameters in response to 
immobilisation and supplementation. 
 PLA EAA 
 BASE-to-
PRE 
BASE-to-
POST 
BASE-to-
PRE 
BASE-to-
POST 
Brachial artery 
diameter 
0.2 ± 0.3 -0.6 ± 1.3 2.2 ± 3.7 0.2 ± 0.4 
HR -1.4 ± 1.5 2.8 ± 2.7 0.9 ± 3.2 4.6 ± 5.4 
RI -0.7 ± 2.2 6.2 ± 10.8 7.3 ± 11.4 19.4 ± 16.9 
FbD 3.6 ± 17.4 -6.3 ± 11.5 -1.8 ± 6.2 -7.5 ± 25.0 
 
 
 
 
152 
 
T
a
b
le
 6
.6
.b
. 
B
lo
o
d
 k
in
e
ti
c
 p
a
ra
m
e
te
rs
 (
m
e
a
n
 ±
 S
D
) 
a
t 
B
A
S
E
, 
P
R
E
 a
n
d
 P
O
S
T
 i
m
m
o
b
ili
s
a
ti
o
n
 i
n
 t
h
e
 P
L
A
 a
n
d
 E
A
A
 g
ro
u
p
s
. 
E
A
A
 
P
O
S
T
 
2
.6
 ±
 0
.2
 
7
3
.1
 ±
 1
0
.0
 
0
.7
 ±
 0
.3
 
0
.0
6
 ±
 0
.0
1
 
 
P
R
E
 
2
.8
 ±
 0
.3
 
7
1
.0
 ±
 1
3
.2
 
0
.6
 ±
 0
.3
 
0
.0
7
 ±
 0
.0
1
 
 
B
A
S
E
 
2
.6
 ±
 0
.1
 
7
0
.0
 ±
 9
.4
 
0
.6
 ±
 0
.3
 
0
.0
7
 ±
 0
.0
1
 
 
P
L
A
 
P
O
S
T
 
2
.9
 ±
 0
.5
 
7
4
.5
 ±
 1
7
.9
 
0
.8
 ±
0
.1
 
0
.0
8
 ±
 0
.0
1
 
 
P
R
E
 
2
.9
 ±
 0
.5
 
7
1
.4
 ±
 1
7
.0
 
0
.8
 ±
 0
.1
 
0
.0
9
 ±
 0
.0
2
 
 
B
A
S
E
 
2
.9
  
±
 0
.5
 
7
2
.5
 ±
 1
7
.3
 
0
.8
 ±
 0
,1
 
0
.0
9
 ±
 0
.0
1
 
 
  B
ra
c
h
ia
l 
a
rt
e
ry
 d
ia
m
e
te
r 
(m
m
) 
H
R
 (
b
p
m
) 
R
I 
F
b
D
 (
m
/s
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
153 
 
6.4. Discussion 
The purpose of this study was to determine whether pre-immobilisation 
supplementation with an EAA supplement before a period of limb immobilisation, 
would help to attenuate the declines in muscle morphology, muscle strength and 
bone parameters associated with upper limb immobilisation. As in the previous 
chapters, there was a significant change in muscle thickness, sub-cutaneous 
adipose thickness, arm girth, lean mass and isometric and isokinetic elbow flexion 
and extension torque following immobilisation. Also in line with the previous 
chapters, this immobilisation model had no impact on the assessed co-contraction 
and muscle fatigability, or on the assessed blood flow parameters. Despite 
significant immobilisation-induced changes in muscle size and strength and in 
adiposity, there was no significant impact of pre-immobilisation EAA 
supplementation.  
Pre-immobilisation supplementation with the current dosage of EAA was 
not successful at attenuating the disuse-induced changes in muscle size and 
strength. Despite the EAA supplement causing a significant increase in total 
protein intake in the EAA group (compared to that seen in the PLA group). It may 
be that the protein intake of all participants was high enough without any 
supplementation (Trumbo et al., 2002). EAAs are those that cannot be 
synthesised by the body itself. The body maintains a small reserve of amino acids 
for use as required; this is called the amino acid pool. Those lacking in dietary 
amino acid intake may not have a sufficient amino acid pool, and therefore, 
intervention is needed. The young and healthy participants used in the current 
chapter however, are less likely to have an insufficient amino acid pool. 
The dietary analysis of the participants in the current study would suggest 
that they had adequate nutritional intake and that malnutrition is unlikely 
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(Karsegard et al., 2004). It is possible that in populations where malnutrition is 
present, that pre-loading, and therefore, increasing physiological reserve, would 
be of benefit. Previous research has shown that pre-operative nutritional status 
can affect factors such as healing, rate of infection and length of hospital stay 
(Greene et al., 1991; Jevsevar and Karlin, 1993; Dempsey et al., 1988). Therefore, 
populations with malnutrition, who are known to be undergoing periods of hypo-
activity/disuse may benefit from nutritional supplementation before this event. This 
is of particular relevance for older populations in which nutritional intake is known 
to be less adequate. Future research is warranted in to the effects of pre-
immobilisation supplementation in at risk groups. 
6.5. Conclusion 
In summary, upper limb immobilisation resulted in a decrease in biceps and triceps 
brachii muscle thickness, arm girth, lean mass, and elbow isometric and isokinetic 
torque. The immobilisation model also resulted in a significant increase in biceps 
and triceps brachii sub-cutaneous adipose thickness, with no observed effect on 
co-contraction, muscle fatigability or resting blood flow. No significant effect of pre-
immobilisation EAA supplementation on any of these parameters were observed. 
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Chapter 7: Summary, conclusions and recommendations 
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7.1. Summary 
The aim of this thesis was to examine the impact of nutritional supplementation 
through essential amino acids (EAA), omega-3 (-3) or vitamin D on the 
deleterious physiologic impact of limb immobilisation. 
 The review of the current literature (Chapter 1) highlighted to the reader the 
profound changes in skeletal muscle morphology and strength with hypo-activity 
models. Losses of muscle mass and strength vary between different hypo-activity 
models, with immobilisation causing the most profound decreases. An 
immobilisation model was therefore, selected for use throughout the current thesis. 
The current literature subsequently showed that immobilisation of the upper limb 
was relatively less investigated compared to the lower limb, and therefore, 
provided an opportunity to increase research in this area. The literature review 
also highlighted the potential for nutritional supplementation as a viable 
intervention to combat muscle atrophy with hypo-activity, when exercise is not a 
practical prescription. The literature review discussed several potential nutritional 
supplements that could be used to combat muscle atrophy. It is evident that 
extensive research is needed to determine the most affective supplement and this 
lead to the choice of three supplements (EAA, -3 and vitamin D) to be 
investigated for their potential as an intervention to prevent the associated 
changes with limb immobilisation. 
 The starting point (Chapter 2) of the data section of this thesis was to 
determine the role that EAA supplementation played in attenuating atrophy 
induced through a model that would emulate relatively short-term decreased local 
mobility/activity in humans. Studies using EAA as a nutritional intervention in 
immobilisation are scarce in the literature. It was hypothesised that EAA 
supplementation during combined shoulder and arm immobilisation would 
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attenuate the deleterious changes associated with disuse models. This hypothesis 
was partly supported, in that arm girth decreased more so with the placebo 
supplement than the EAA supplement and with the suggestion of a greater 
decrease in elbow flexion and extension torque, as well as significantly further 
increased sub-cutaneous fatty tissue with the placebo supplement. The decreases 
in muscle thickness (only significant in the triceps brachii) do not explain the 
differential arm girth responses between EAA and PLA groups. The multi-
ingredient nature of the supplement makes it difficult to identify which specific 
amino acid or combination thereof, may have been responsible for the observed 
changes. Based on the literature, the likelihood is that leucine was the main 
effector (which has been reported in a recent review by Breen and Phillips (2012)). 
Elbow flexion Torque normalised by muscle thickness in the biceps decreased 
less in the EAA compared with the CON group (-6 % vs. -20 %, p<0.05). Similarly, 
normalised elbow extension torque in the triceps also changed differently in the 
EAA compared with the CON group (+15 % vs. -23 %, p<0.05). Chapter 2 
revealed that EAA supplementation impacts positively on the immobilisation-
induced changes in the structural and functional characteristic of the remaining 
muscle.  
The immobilisation model used in Chapter 2 could have relevance to both 
sporting (e.g. off-season detraining modulation) as well as clinical (e.g. 
injury/illness induced short-term immobilisation/bed-rest) populations. The current 
results warrant future research in arm immobilisation of similar duration. In this 
earlier chapter, although changes in muscle thickness were observed in response 
to sling immobilisation, the data analysis was limited to a single site ultrasound 
scan, half way along the muscle length. This partial analysis may have inflated the 
overall impact of the immobilisation as it is known that muscle immobilisation alters 
the functional length of the muscle (Tabary et al., 1972). It is therefore, proposed 
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that multiple sites be monitored along the length of the muscle, so that the overall 
impact of EAA supplementation (e.g. on elbow flexors/ extensors) may be further 
clarified. 
Following on from the effect of EAA supplementation (Chapter 2), the 
purpose of the following three chapters (Chapter 3, 4 and 5) was to determine the 
role that two potential protein-sparing modulators (-3 or vitamin D 
supplementation) may play in attenuating the deleterious physiological changes 
induced through 2 weeks of 9-waking-hours-per-day combined arm and shoulder 
immobilisation. Chapter 3 focussed on the modulation of appendicular mass 
content, composition and structure. It was hypothesised that muscle thickness, 
lean mass and arm girth would decrease with limb immobilisation. In accordance 
with this hypothesis and with previous research (Miles et al., 1994; Veldhuizen et 
al., 1993; Yue et al., 1997) muscle thickness (-5.4 ± 4.3 %), upper and lower arm 
girth (-1.3 ± 0.4 % and -0.8 ± 0.8 %, respectively) and lean mass (-3.6 ± 3.7 %) 
decreased significantly with limb immobilisation in the placebo group (p<0.05). 
Changes in bone mineral content (BMC) and bone mineral density (BMD) are 
often found in longer and more severe periods of disuse (Marchetti et al., 1996; 
Rittweger et al., 2005; Rittweger et al., 2009). Somewhat surprisingly, therefore, 
we observed a significant decrease in BMC (-2.3 ± 1.5 %) with this limited 
degree/duration of limb immobilisation (p<0.05). The BMD and BMC values 
reported in Chapter 3 may have been influenced by the observed changes in 
muscle and sub-cutaneous adipose thickness. Previous research indicates that 
BMD is affected by changes in body weight and composition (Van Loan et al., 
1998). Although a valid measure of BMD, dual-energy x-ray absorptiometry (DXA) 
may be limited in its focus to site-specific investigations, being limited to limbs 
rather than individual bones or bone regions. The value of BMD can also be 
limited by the inherent limitations of using a two-dimensional x-ray projection to 
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estimate bone area and geometrical changes (potential errors and the prevalence 
of errors with DXA are discussed in the literature (National Osteoporosis Society; 
Messina et al., 2015)).  Heilmann et al. (1998) examined a number of imaging 
techniques in relation to forearm BMD and highlighted that all techniques have 
some degree of error. However, the use of peripheral quantitative tomography 
(pQCT) may be advantageous to examine these specific changes in future 
immobilisation studies. 
It was also hypothesised that -3 would be the most effective supplement 
at minimising the effects of immobilisation. In fact, the data showed that neither -
3 nor vitamin D had any significant effect on the responses to non-injurious 
immobilisation, other than on the associated accumulation of sub-cutaneous fatty 
tissue. Interestingly, it was observed that in the case of sub-cutaneous adiposity 
on the biceps brachii, there is a protective effect of both -3 supplementation 
against limb immobilisation. A few trends towards the attenuations in deleterious 
physiological events were observed in the -3 and vitamin D treated groups which 
were discussed within the chapter. Overall, however, at the current doses, -3 
supplementation only significantly attenuated one of the changes (sub-cutaneous 
fatty tissue) associated with non-injurious limb immobilisation. These findings 
would necessitate further research into either a) supplementation linked to injury-
induced immobilisation, or b) larger doses of these supplements to confirm/refute 
their physiological reserve preservation potential. 
Chapter 4 focussed on -3 and vitamin D supplementation during 
immobilisation on the modulation of muscle functional, vascular and 
electromyographic profiles. As hypothesised, muscle elbow flexion and extension 
isometric and isokinetic torque decreased significantly with limb immobilisation. 
This is in line with the current literature that consistently demonstrates decreases 
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in strength with disuse models (Gondin et al., 2004; Hortobagyi et al., 2000; Miles 
et al., 1994; Yue et al., 1997). The decreases in maximal voluntary contraction 
(MVC) torque however, were not accompanied by any significant changes in 
biceps and triceps co-contraction RMS EMG values. EMG reliability is a general 
limitation of studies utilising longitudinal EMG monitoring (de Araujo et al., 2009; 
Fukuda et al., 2010). When drawing conclusions from EMG findings care should 
be taken, as: 1) the changes in muscle dimensions could result in a different 
population of motor units being recorded from (Clark and Fielding, 2012); 2) EMG 
data in the current studies, and previous work (Hermens et al., 2000), does not 
normalise the data for the clarity of the signal; 3) positioning of electrodes may 
differ slightly between repeated sessions. The changes in sub-cutaneous adiposity 
observed in Chapter 3 could have caused differences in the electromyographic 
signature (Solomonow et al., 1994). Similarly, the observed decrease in muscle 
thickness, arm girth and lean mass (i.e. dimensional changes) reported in Chapter 
3 could result in a different population of motor units being recorded from (Clark 
and Fielding, 2012). It was hypothesised that vascular function would deteriorate 
with limb immobilisation. Previous research suggests that a decrease in physical 
activity leads to detrimental vascular adaptations (Delp et al., 2000; Louisy et al., 
1997). The immobilisation model in this case had no impact on the assessed blood 
flow kinetics. Although resting measures of blood flow are a valid measure of 
vascular function/integrity, the use of reactive blood flow dimensions may be a 
better measure to detect the vascular adaptations with disuse. 
As described in Chapter 1 there are equivocal findings of the impact of 
disuse models on muscle fatigability (Clark et al., 2008; Miles et al., 1994; Miles et 
al., 2005; Semmler et al., 2000). In Chapter 4, there was no significant change in 
muscle fatigue parameters with immobilisation. This supports the previous findings 
of Miles et al. (1994) who demonstrated that a shorter period of immobilisation in 
161 
 
the upper limb appeared to have minimal effects on muscle fatigability. However, 
other studies investigating the effects of immobilisation in the upper limb have 
found both increased (Clark et al., 2008; Semmler et al., 2000) and decreased 
(Miles et al., 2005) resistance to fatigue. The lack of changes in muscle fatigability 
in Chapter 3, however, goes hand in hand with the absence of vascularisation-
related alterations (Sjøgaard et al., 1988; Enoka and Duchateau, 2008). The 
mechanisms that cause fatigue are specific to the task being performed (Enoka 
and Duchateau, 2008; Hunter et al., 2004). Therefore, variability between fatigue 
resistance responses to disuse models may be due to task specificity. The 
previous studies examining the response of muscle fatigability following arm 
immobilisation/suspension are of similar duration to the current chapter, ranging 
from three to four weeks. These studies all used various methods of assessing 
fatigability. They utilised time to task failure or repetition to task failure, at various 
intensities ranging from 15 to 50 % MVC. In comparison, in the current chapter, a 
maximum contraction was held for 30 seconds and fast Fourier transform (FFT) 
EMG response along with the mean, slope and Standard Deviation of the torque 
trace were utilised to assess muscle fatigability. The equivocal findings of the 
effects of disuse on muscle fatigability could be due to the duration of 
immobilisation or in the method used to test fatigue resistance. Studies 
investigating a comparison of different fatigue tasks before and after disuse are 
lacking. 
As in Chapter 3, it was hypothesised again in Chapter 4 that -3 would be 
the most effective supplement at minimising the response to immobilisation. The 
current data demonstrate that neither -3 nor vitamin D had any significant effect 
on the responses to non-injurious immobilisation. Nonetheless, a few trends 
(p<0.1) towards the attenuation of elbow isometric and isokinetic torque 
immobilisation-induced decreases were observed, in the -3 and vitamin D treated 
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groups. Despite greater relative decreases in torque than in tissue composition 
(Chapter 3), there was no significant effect of -3 or vitamin D supplementation on 
the decreases in MVC torque. It would appear that muscle function might be a less 
reliable marker of the effectiveness of a supplement against the impact of 
immobilisation than tissue composition. This is particularly relevant, considering 
the protective effect of -3 in Chapter 3 against the decrease in adiposity. 
Chapter 5 examined the systemic endocrine profile following 2 weeks of 9-
waking-hours-per-day combined arm and shoulder immobilisation, with -3 and 
vitamin D supplementation. There were no significant changes in any of the 
analysed endocrine markers either at post-immobilisation or after re-mobilisation 
(p>0.05). Similarly, there was no supplement group effect on any of the above 
data (p>0.05). The current data, therefore, suggests that the degree and duration 
of immobilisation trialled in the present study, whilst capable of inducing muscle 
atrophy and declines in elbow torque, was not in fact a strong enough signal to 
elicit measurable changes at the systemic endocrine level. This suggests that the 
atrophy and strength declines seen in such a model (see Chapters 3 and 4) are 
not associated with changes in the specific enzyme and hormonal factors 
quantified here, at least not at the systemic level. These findings would be 
reassuring to any person suffering from a minor local joint sprain necessitating 
some restraint. In that, the immobilisation is unlikely to cause further deleterious 
physiological changes, distal to the initial site of immobilisation. There may 
however, be other endocrine factors, not monitored in this study, that may play 
crucial roles in skeletal muscle atrophy. 
 The final chapter (Chapter 6) investigated the most “promising” of the three 
supplements, which was determined to be EAA supplementation, in a pre-
immobilisation supplementation model. The purpose of this study was to 
determine whether pre-immobilisation supplementation with an EAA supplement 
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before a period of limb immobilisation, would help to attenuate the declines in 
muscle morphology, muscle strength and bone parameters associated with upper 
limb immobilisation. As in the previous chapters, there was a significant change in 
muscle thickness, sub-cutaneous adipose thickness, arm girth, lean mass and 
isometric and isokinetic elbow flexion and extension torque following 
immobilisation. Also in line with the previous chapters, this immobilisation model 
had no impact on the assessed co-contraction and muscle fatigability, or on the 
assessed blood flow parameters. Despite significant immobilisation-induced 
changes in muscle size and strength and in adiposity, there was no significant 
impact of pre-immobilisation EAA supplementation. The idea behind this chapter 
was that building physiological reserve before immobilisation may better prepare 
the body for the up-coming immobilisation. In Chapter 6, there was a healthy, 
recreationally active group of participants, who reported adequate nutritional 
intake. It is still possible that in populations where malnutrition is present, that pre-
loading, and therefore, increasing physiological reserve would be of benefit. 
Previous research has shown that pre-operative nutritional status can affect 
factors such as healing, rate of infection and length of hospital stay (Greene et al., 
1991; Jevsevar and Karlin, 1993; Dempsey et al., 1988). Therefore, populations 
with malnutrition, who are known to be undergoing periods of disuse may benefit 
from nutritional supplementation before this event. 
Throughout the data chapters and as discussed in Chapter 1 the decreases 
in muscle strength often surpass those seen in muscle size in disuse models (Berg 
et al., 1997; Clark et al., 2006; Kawakami et al., 2001; Miles et al., 1994; Narici et 
al., 1989; Seynnes et al., 2008; White et al., 1984). Therefore, other alterations in 
the neuromuscular system, other than the reduction in contractile proteins must 
contribute to the excessive loss of strength. Voluntary force production is 
associated with neurological and skeletal muscle properties, thus suggesting these 
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two factors as mechanisms accounting for the loss of strength with disuse models. 
The lack of changes in co-contraction EMG values in Chapter 4 and 6, suggests 
that factors other than muscle size and muscle co-activation alone must contribute 
to the excessive loss in muscle strength. These factors could include changes in 
connective tissue, muscle fibres, neurological innervation and endocrine status. 
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7.2. Implications 
The overall aim of the current thesis was to determine the role that nutritional 
supplementation may play in attenuating hypo-activity-induced atrophy. 
Specifically, the objectives of the thesis were met in that the multi-parameter 
nature of the studies within this thesis allows for an in depth analysis of the 
numerous effects of immobilisation on skeletal muscle and the potential 
mechanisms underlying these changes. Many disuse studies only report one or 
two parameters and the current thesis adds to the literature, as it addresses 
multiple outcome parameters. 
Nutritional supplementation may be an effective and easily adhered to 
intervention programme for preventing the loss of muscle mass/function seen with 
hypo-activity. The literature is lacking in immobilisation studies examining the 
impact of different nutritional supplements. The thesis introduces different 
supplements in the context of an upper limb immobilisation model. EAA proved the 
most “promising” of supplements and this adds to the body of research on proteins 
and essential amino acid supplements during disuse models. Despite the lack of 
effectiveness of -3 and vitamin D supplementation this is not a negative result. It 
simply means that at the current dose and in the specific population these 
supplements were not effective at reducing the detrimental effects of 
immobilisation. Pre-immobilisation supplementation with EAA did not attenuate the 
changes associated with immobilisation (Chapter 6), however, this should not be 
ruled out as a nutritional intervention in other disuse models or in sarcopenia for 
example. The “healthy” population examined in this study may not have benefited 
from this intervention but other demographics, e.g. an older population more likely 
to be nutrient deficient, may have done so. 
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Despite lower limb immobilisation resulting in greater atrophy than upper limb, it 
is just as important that we examine the effects of immobilisation in the arm as well 
as the leg. Injuries and surgery for example still occur in the upper limbs and 
therefore examination of how the body responds to the sub-sequent immobilisation 
is vital. The findings of the thesis are relevant to both sporting (e.g. off-season 
detraining modulation) as well as clinical (e.g. injury/illness induced short-term 
immobilisation/bed rest) populations. It is proposed that this relatively short-term 
sling immobilisation provides a model to be used to assess other supplements and 
treatments in future studies. A short-term model such as this is relatively less 
invasive and inconvenient for participants and may allow larger participant 
numbers to be recruited for research studies.  
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7.3. Limitations 
7.3.1. Population 
Despite participant numbers throughout the chapters being in-line with other 
disuse studies (Miles et al., 1994; Yue et al., 1997; Abe et al., 1997), the numbers 
are still relatively small. The participants used throughout this thesis were 
recreationally active and healthy young adults. As such these participants were not 
likely to exhibit an adverse nutritional intake background and would not be classed 
as an at risk group (NHS Livewell, 2010). The NHS consensus (2010) on vitamin D 
states that if people achieve a sufficient supply of vitamin D in the summer, most 
should keep levels greater than the deficiency threshold of 25 nmol/L in winter, 
even without supplementation. 
7.3.2. Study design 
All of the chapters used were randomised control trials, which are considered to be 
the gold standard for grouping participants in a study. The limitations of 
randomised control trials however, must be acknowledged, for example, the 
findings are protocol driven and the results are only specific to the population 
being examined. 
7.3.3. Methodology 
Despite the obvious benefits of a short-term immobilisation model and the 
observed detrimental effects of such a model, a more stringent long-term 
immobilisation or bed-rest model, may allow for the detection of a greater impact 
of nutritional supplementation. As discussed in Chapter 1 the most dramatic 
effects of disuse come from lower limb immobilisation studies. Therefore, the use 
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of such a model could reveal a more dramatic impact of immobilisation and 
therefore allowing for a greater attenuation with any nutritional supplementation. 
 Despite the multi-parameter nature of the studies throughout the thesis, 
some additional measures could have added to the findings. Chapter 2 data 
analysis was limited to a single site ultrasound scan, half way along the muscle 
length. In the proceeding chapters, multiple sites were then monitored and DXA 
analysis also added to measure total limb lean mass. As discussed above there is 
some degree of error with all imaging techniques and specifically DXA may be 
limited in its focus to site-specific investigations, being limited to limbs rather than 
individual bones or bone regions. The value of BMD can also be limited by the 
inherent limitations of using a two-dimensional x-ray projection to estimate bone 
area and geometrical changes. Therefore, the addition of pQCT throughout the 
thesis could have ruled out some of these factors. As discussed previously, resting 
measures of blood flow are a valid measure of vascular function/integrity. Despite 
this, the use of reactive blood flow dimensions may be a better measure to detect 
the vascular adaptations with disuse. The number of endocrine factors measured 
was limited to those reported in Chapter 6, this does not rule out changes in other 
endocrine factors during atrophy and that these factors were only measured at the 
systemic level. 
7.3.4. Supplementation 
 In Chapter’s 2 and 6 a multi-ingredient EAA supplement was provided. This 
multi-ingredient nature of the supplement makes it difficult to identify which specific 
amino acid or combination thereof, may have been the effective ingredient. The 
doses of -3 and vitamin D used in Chapter 3 to 5 were not sufficient to 
dramatically attenuate the detrimental effects of immobilisation. This could be 
because an over the counter dose is simply not enough to have significant effects 
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on such changes or simply that -3 and vitamin D are not suitable for attenuating 
changes in a seemingly ‘healthy’ population. 
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7.4. Directions for future research 
The multi-parameter nature of the studies within this thesis allows for an in depth 
analysis of the numerous effects of disuse on skeletal muscle and the potential 
mechanisms underlying these changes. Future disuse studies should adopt the 
multi-parameter nature of this thesis, to increase the understanding of the complex 
processes that occur in response to disuse. 
The relatively short-term sling immobilisation used throughout the thesis 
provides a model to be used to assess other supplements and treatments in future 
studies. A short-term model such as this is relatively less invasive and 
inconvenient for participants and may allow larger participant numbers to be 
recruited for research studies. Studies 3 and 4 consisted of eight participants in 
each supplement group. Participant numbers in disuse studies are notoriously 
small due to the inconvenient nature of models such as bed-rest and 
immobilisation (Miles et al., 1994; Yue et al., 1997; Abe et al., 1997). Ideally, 
research studies should look to recruit as many participants as possible and a 
short-term model may be a good way to achieve high participant numbers. 
As discussed in the limitations section the participants used throughout this 
thesis were recreationally active and healthy young adults and as such may not 
have been likely to exhibit an adverse nutritional intake background and would not 
be classed as an at risk group. Future studies need to recruit those lacking in 
physiological reserve and those more at risk of malnutrition/deficiencies e.g. older 
and/or injured persons. Future research is warranted into the effects of nutritional 
supplementation with EAA, -3 and vitamin D in at risk groups before and/or 
during disuse models. The dosage of -3 and vitamin D may be addressed as at 
the current dosage only one parameter had a significant attenuation with -3 or 
supplementation. Despite the obvious benefits of the short-term immobilisation 
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model, a more stringent long-term immobilisation or bed-rest model, may allow for 
the detection of a greater impact of nutritional supplementation. 
Ultrasound and DXA were highly reliable techniques used throughout this 
thesis that detected significant changes in muscle thickness, sub-cutaneous 
adipose thickness and lean mass. Site-specific changes in sub-cutaneous adipose 
thickness were detected with no significant change in DXA quantified fat mass and 
percentage (Chapter 3). The use of magnetic resonance imaging (MRI) in future 
studies would allow for multi-site measurements along a limb to determine exactly 
where changes are occurring. As mentioned earlier in the discussion, BMD and 
BMC values can be influenced by changes in body weight and composition and 
can be limited by the inherent limitations of using a two-dimensional x-ray 
projection to estimate bone area and geometrical changes. Future studies could 
benefit from the addition of the use of pQCT to examine specific changes. 
Studies investigating a comparison of different fatigue tasks before and 
after periods of disuse are sparse. More research is needed to investigate the 
task-specific responses to different models of disuse and the potential 
mechanisms behind the differential responses. The lack of changes in muscle 
fatigability and resting arterial blood flow in Chapters 4 and 6 go hand in hand. 
Future studies should examine reactive blood flow rather than resting to observe 
any changes that could then be associated with fatigability. 
 The ideal treatment to help prevent declines in muscle size and strength 
with disuse would be exercise prescription with adequate nutritional intake. As 
stated previously exercise prescription is not always a practical prescription, and 
therefore, other interventions are needed. Potentially, nutrition alone will not be 
able to fully prevent the deleterious effects of disuse but if it is able to attenuate 
such changes then this is still of benefit. In particular, it may be that the “at risk” 
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groups discussed previously (i.e. aged populations) would benefit more so from 
nutritional interventions to reach adequate dietary intake. 
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7.3. Conclusions 
The main findings of this thesis demonstrate that a relatively short-term arm 
immobilisation results in a measurable decrease in muscle thickness, arm girth, 
lean mass, isometric elbow torque, isokinetic elbow torque and an increase in sub-
cutaneous adipose thickness. Muscle fatigability, resting arterial blood flow (heart 
rate, resistance index and flow by diameter), EMG co-contraction and endocrine 
markers however are unchanged following this arm immobilisation model. The 
sling immobilisation used is proposed as a suitable model for observing the effects 
of relatively short-term immobilisation. 
 At the current dosage -3 supplementation only attenuated the increase in 
sub-cutaneous adipose thickness in the biceps brachii. Despite some trends, 
neither -3 nor vitamin D supplementation attenuated any other parameters that 
were changed during immobilisation. These findings would necessitate further 
research into either: a) supplementation linked to injury-induced immobilisation, or 
b) larger doses of these supplements to confirm/refute the physiological reserve 
potential of the two supplements. 
EAA supplementation during the three weeks of immobilisation impacted 
positively on the immobilisation-induced changes in the structural and functional 
characteristic of the remaining muscle. EAA supplementation was highlighted as 
the “most promising” nutritional supplement and as such was chosen for Chapter 6 
and provided as a pre-immobilisation supplement. Providing EAA supplementation 
before immobilisation did not attenuate the immobilisation-induced changes in 
muscle structure and function. It is suggested that EAA supplementation pre-
immobilisation in a healthy population in which physiological reserve is satisfactory 
may not be beneficial. Future studies are warranted in more “at risk” populations, 
e.g. older populations and people with certain musculoskeletal wasting conditions. 
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Appendix 2: Conference proceedings 
THE EFFECTS OF 2 WEEKS ARM IMMOBILISATION ON MUSCLE 
FUNCTION MODULATORS 
Bostock E, Morse CI, Winwood K, McEwan I, Onambélé-Pearson G. 
MMU (Manchester, UK) 
Introduction: Prolonged reduction in muscle activity and mechanical loading, as seen 
with limb immobilisation, results in skeletal muscle structural and functional 
maladaptation including atrophy and asthenia (see review by Bostock et al., 2013). 
Previous research suggests that immobilisation results in a greater decrease in muscle 
strength than muscle size which may be a result of neuromuscular adaptations (Miles et al., 
1994). The aim of this study was, thus, to investigate the principal physiological 
contributors to asthenia induced through upper limb immobilisation. 
Methods: The non-dominant arm of 6 healthy, habitually active females (aged 29 ± 6 
years) was immobilised in a sling for nine waking hours a day for two continuous weeks. 
Measures of tissue thickness (B-mode ultrasonography), arm girth (anthropometry), body 
composition (DEXA), isometric (60-110° elbow angle) and isokinetic (30-240°/s) torque 
(dynamometry), vascular kinetics (Doppler ultrasonography), fatigue index (slope of 
electromyography trace) and Creatine Kinase Activity (Colorimetry at 340nm) were taken 
before immobilisation (PRE), on removal of the sling (POST), and two weeks after re-
mobilisation (POST2). 
Results: No differences existed between the immobilised and non-immobilised limbs at 
baseline for any measures (p>0.05). PRE to POST changes in the immobilised limb in arm 
girth (upper = -1.2%, lower = -1.0%), muscle thickness (biceps = -3.5 to -6.5%, triceps = -
7.1 to -10.2%), lean mass (-4.7%), sub-cutaneous adipose thickness (7.7 to 12.7%) and 
bone mineral content (-2.7%) were significantly different from those in the non-
immobilised limb (p<0.05). These changes reverted to PRE values at POST2 (except for 
adipose thickness and bone mineral content). Torque significantly decreased with 
immobilisation (-5.2 to -17.5% changes, p<0.05), with only one torque test not reverting to 
PRE values at POST2. There was a trend towards an increase in Creatine Kinase activity at 
POST (p>0.05). Immobilisation did not affect muscle fatigability or vascular kinetics. 
Discussion: Our data demonstrate that a relatively modest degree of limb immobilisation is 
sufficient to impact on muscle, adipose, and bone parameters. Whilst our results support 
the previously observed dissociation between degree of atrophy and asthenia (Miles et al., 
1994), the physiological modulator of this effect remains unclear. Indeed, neither blood 
flow, vascular dimensions nor compliance, nor muscle fatigability, changed in this cohort. 
We propose that endocrine profile changes may be key to the early response to 
immobilisation. 
References 
Bostock EL, Morse CI, Winwood K, McEwan I, Onambélé-Pearson GL. (2013). World J 
Transl 2, Med 36-48. 
Miles, MP, Clarkson PM, Bean M, Ambach K, Mulroy J, Vincent K. (1994). Med Sci 
Sports Exerc 37, 1983-1989. 
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Two nutrition supplements modulate aspects of immobilisation-induced changes in 
appendicular mass characteristics 
 
Emma L. Bostock1, Christopher I. Morse1, Keith Winwood1, Islay McEwan1 and Gladys L. 
Onambélé1 
 
1Centre for Health, Exercise and Active Living, Department of Exercise & Sport Science, 
Manchester Metropolitan University, Crewe, Cheshire, United Kingdom. 
 
Background: Muscle size and strength decrease in response to short-term limb 
immobilisation [1]. Where exercise prescription is not possible (e.g. bed rest or injury) 
other interventions are required to attenuate the atrophy and strength declines associated 
with disuse. There is a necessity to identify non-pharmacological interventions since 
polypharmacy in itself is conducive to skeletal tissue loss [2]. 
 
Objectives: To determine whether two potential protein-sparing modulators 
(Eicosapentaenoic acid (EPA) and Vitamin D (Vit-D)) would attenuate immobilisation-
induced changes in muscle characteristics.  
 
Methods: The non-dominant arm of n=24 healthy participants, aged 23 ± 5.8 years, was 
immobilised daily in a sling for a period of 9 waking hours over two continuous weeks. 
Participants were randomly assigned to one of three groups: placebo (Lecithin), EPA or 
Vit-D. Muscle and sub-cutaneous adipose thickness (B-mode ultrasonography), blood flow 
kinetics (colour Doppler ultrasound), isometric and isokinetic torque (dynamometry) were 
measured immediately before, immediately after the immobilisation period and two weeks 
after re-mobilisation. 
 
Results: There was a significant decrease in muscle thickness (-5.4%), isometric torque 
(flexion: -12.1%, extension: -15.4%) and isokinetic torque (flexion: -14.0%, extension: -
10.3%) with limb immobilisation in the placebo group (P<0.05). Despite no significant 
effect of group, EPA and Vit-D supplementation showed trends towards attenuating the 
decreases in muscle thickness and isometric and isokinetic torque observed in the 
placebo group. Sub-cutaneous adipose thickness increased in the placebo group (10.3%). 
EPA (p<0.05) and Vit-D (p>0.05) blunted this response, with EPA having a greater effect 
(p<0.05). Immobilisation had no significant effect on blood flow kinetics, including heart 
rate, brachial artery diameter, resistance index and blood flow by vessel diameter. 
 
Conclusions: Both EPA and Vit-D supplementation generally attenuated the changes 
associated with immobilisation. These findings may be applicable to both sporting (e.g. 
off-season detraining modulation) and clinical (injury/surgery induced short-term 
immobilisation) populations. 
 
References:  
1. Miles, M.P., Clarkson, P.M., Bean, M., Ambach, K., Mulroy, J., & Vincent, K. (1994). 
Muscle function at the wrist following 9 d of immobilization and suspension. Medicine 
and Science in Sports and Exercise 26: 615-623. 
2. Moylan, K.C., & Binder, E.F. (2007). Falls in older adults: risk assessment, 
management and prevention. The American Journal of Medicine 120: 493-497. 
 
Keywords: Eicosapentaenoic Acid; Vitamin D; Body Composition; Immobilisation; 
Lecithin. 
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Modulation of tissue composition and function by eicosapentaenoic acid and vitamin D in 
immobilisation 
 
Emma L. Bostock1, Christopher I. Morse1, Keith Winwood1, Islay McEwan1 and Gladys L. 
Onambélé1 
1Department of Exercise & Sport Science, Manchester Metropolitan University, Crewe, United 
Kingdom. 
 
It has consistently been demonstrated that disuse models (e.g. limb immobilisation and bed rest), 
result in skeletal muscle atrophy, decreases in maximal voluntary strength (1) and bone mineral 
density (2), and increases in intermuscular adipose content (3). Disuse models have also been 
associated with changes in electromyography (EMG) characteristics (4) and muscle fatigability (1). 
Where exercise prescription is not possible (e.g. bed rest or injury), other interventions are 
required to attenuate these changes associated with disuse. Non-pharmacological interventions 
need to be identified since polypharmacy in itself is conducive to skeletal tissue loss (5). This study 
set out to determine whether two potential protein-sparing modulators (eicosapentaenoic acid 
[EPA] and vitamin D [VitD]) would modulate the deleterious effects of immobilisation. The non-
dominant arm of 24 healthy participants, aged 23.0±5.8 years, was immobilised in a sling for a 
period of 9 waking hours a day over two continuous weeks. Participants were randomly assigned 
to one of three groups: placebo (PLA) (n=8), EPA (n=8) or VitD (n=8). Body composition (DEXA), 
arm girth (anthropometry), muscle co-contraction (EMG) and muscle fatigability (Cybex and EMG) 
were measured before, at the end of the immobilisation period and two weeks after re-
mobilisation. The effect of immobilisation and supplement group were assessed by either 
repeated measures ANOVA (parametric data), with post-hoc Bonferonni corrected 2-tailed t-tests 
or Kruskal Wallis test (non-parametric data), with post-hoc Mann-Whitney U tests. All data are 
presented as mean ± standard deviation. There were significant decreases in upper and lower arm 
girth, lean mass and bone mineral content (BMC) post-immobilisation in the PLA group (p<0.05). 
Despite no significant effect of group, EPA and VitD supplementation showed trends towards 
attenuating the decreases in upper/lower arm girths (-1.3±0.4% PLA, -0.6±0.5% EPA, -0.9±1.0% 
VitD, p=0.18 and -0.8±0.8% PLA, -0.4±0.5% EPA, -0.3±0.4% VitD, p=0.21, respectively) and BMC (-
2.3±1.5% PLA, -0.3±1.0% EPA, -0.7±1.9% VitD, p=0.47) observed in the PLA group. The EPA 
supplementation group demonstrated a non-significant attenuation of the decrease in lean mass 
observed in the placebo group (-3.6±3.7% PLA, -1.9±2.8% EPA, -4.0±2.8% VitD, p=0.95). There was 
no significant change in muscle fatigue parameters or EMG co-contraction values with 
immobilisation and no effect of supplementation group (p>0.05). All parameters had returned to 
baseline values at the re-mobilisation phase of the study. The results suggest that both EPA and 
VitD may generally attenuate the changes in muscle size and bone parameters associated with 
immobilisation. These findings may be applicable to both sporting (e.g. off-season detraining) and 
clinical (injury/surgery induced short-term immobilisation) populations. 
 
References 
1. Miles MP, Clarkson PM, Bean M, Ambach K, Mulroy J, Vincent K. Muscle function at the wrist 
following 9 d of immobilization and suspension. Med Sci Sports Exerc. 1994;26(5):615-23. 
2. Rittweger J, Frost HM, Schiessl H, Ohshima H, Alkner B, Tesch P, et al. Muscle atrophy and 
bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: 
results from the LTBR study. Bone. 2005;36(6):1019-29. 
3. Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB. Reduced physical 
activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr. 
2007;85(2):377-84. 
4. Vaughan VG. Effects of upper limb immobilization on isometric muscle strength, movement 
time, and triphasic electromyographic characteristics. Phys Ther. 1989;69(2):119-29. 
5. Moylan KC, Binder EF. Falls in older adults: risk assessment, management and prevention. Am J 
Med. 2007;120(6):493 e1-6. 
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Appendix 3: Informed consent form 
 
 
Department of Exercise and Sport Science 
 
 
Informed Consent Form 
 
   
 
(Both the investigator and participant should retain a copy of this form) 
 
 
Name of Participant:     
 
Supervisor/Principal Investigator:  Emma Bostock 
 
Project Title: Impact of nutritional supplementation on immobilisation-induced  
      atrophy 
 
Ethics Committee Approval Number: 150109(i) 
 
 
Participant Statement 
 
I have read the participant information sheet for this study and understand what 
is involved in taking part. Any questions I have about the study, or my 
participation in it, have been answered to my satisfaction. I understand that I do 
not have to take part and that I may decide to withdraw from the study at any 
point without giving a reason. Any concerns I have raised regarding this study 
have been answered and I understand that any further concerns that arise 
during the time of the study will be addressed by the investigator. I therefore 
agree to participate in the study. 
 
It has been made clear to me that, should I feel that my rights are being 
infringed or that my interests are otherwise being ignored, neglected or denied, 
I should inform the Registrar and Clerk to the Board of Governors, Head of 
Governance and Secretariat Team, Manchester Metropolitan University, All 
Saints Building, All Saints, Manchester, M15 6BH, Tel: 0161 247 1390 who 
will undertake to investigate my complaint. 
 
 
 
Signed (Participant)   Date 
 
 
Signed (Investigator)  Date 
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Appendix 4: Questionnaire 
       Participant ID code:    
 
 
MMU Cheshire 
Department of Exercise and Sport Science 
 
Impact of Nutritional Supplementation on Immobilisation-Induced Atrophy 
Questionnaire: Physical Activity & General Health 
Thank you for your interest in this research study. Prior to participation, we would like you to answer a few 
questions concerning your general health and physical activity level. Please answer the following questions 
as honestly as possible. 
 
Height (m):   m 
Weight (Kg):  Kg 
Date of birth (dd/mm/yy):        /       /         
Sex: Male  Female         
 
How would you best describe your ethnicity? 
White – British     Black or Black British – African  
Black or Black British – Caribbean   Asian or Asian British – Pakistani  
Asian or Asian British – Banglasdeshi   Chinese     
Other Asian Background    Other Ethnic Background   
If other please specify:           
 
 
Smoking Habits  Are you currently a smoker?     Yes / No 
   If yes, how many do you smoke?            ……. per day 
   Are you a previous smoker?     Yes / No 
   If yes, how long is it since you stopped?                             ……… years 
 
 
Do you drink alcohol?         Yes / No 
If you answered Yes, do you usually have:   An occasional drink        
       A drink every day         
       More than one drink a day       
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Your general health 
1. At present, do you have any health problems for which you are: 
a) on medication, prescribed (by a doctor) or otherwise               Yes  No  
b) attending (visiting) your doctor                  Yes  No  
c) on a hospital waiting list                   Yes  No  
 
2. Have you ever had any of the following? 
a) Your doctor advised you not to take vigorous exercise                Yes  No  
b) Pain in your chest when you undertake physical activity?               Yes  No  
c) Central Nervous System disease, such as Parkinson, Alzheimer, 
Convulsions/epilepsy                   Yes  No  
d) Have you any history of chest problems, such as bronchitis, asthma or 
wheezy chest                   Yes  No  
e) Major illness, such as viral hepatitis, cancer                 Yes  No  
f) Eczema                     Yes  No  
g) Diabetes                     Yes  No  
h) High blood pressure                    Yes  No  
i) A limb fracture                    Yes  No  
j) Blood disorder, such as clotting problems, thrombosis, aneurysm, 
embolus                       Yes  No  
k) Head injury                                   Yes  No  
l) Digestive problems                    Yes  No  
m) Heart problems, such as heart attack, valve disease, palpitations, 
angina                                   Yes  No  
n) Problems with bones, such as osteoporosis or osteoarthritis               Yes  No  
o) Problems with joints, such as rheumatoid arthritis, any persistent pain, 
or any surgery on your joints                                 Yes  No  
p) Back problems                    Yes  No  
q) Disturbance of balance/co-ordination, such as dizziness or balance- system 
dysfunction                                   Yes  No  
r) Numbness in hands or feet                   Yes  No  
s) Disturbance of vision                   Yes  No  
t) Physical limitations, such as visual, hearing, walking problems              Yes  No  
u) Thyroid problems, e.g. rapid loss or gain of weight                Yes  No  
v) Kidney or liver problems                   Yes  No  
w) A severe allergic reaction, e.g. swelling, breathing difficulties in response 
to an external stimulus                                Yes  No  
x) Emotional or psychiatric problems                  Yes  No  
y) Any other illness or condition that affects your general health or 
interferes with your daily activities                    Yes  No  
 
3. If you answered YES to any of the questions above, please describe the details briefly below or to the 
investigator if you wish. 
                                                                                                                                                                  
                                                                                                                                                                  
                                                                                                                                                                         
4. Are you currently involved in any other research studies at the University or elsewhere?  
Yes  No  
If YES please provide details of the study:        
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Habitual physical activity 
1. What is your main occupation?         
  
2. At work I sit Never       Seldom       Sometimes       Often       Always  
3. At work I stand Never       Seldom       Sometimes       Often       Always  
4. At work I walk Never       Seldom       Sometimes       Often       Always  
5. At work I lift heavy 
loads  Never       Seldom       Sometimes       Often       Always  
6. After work I am 
tired  Never       Seldom       Sometimes       Often       Always  
7. At work I sweat Never       Seldom       Sometimes       Often       Always  
8. In comparison with others my own age I think my work is:  
Much heavier       Heavier        As heavy       Lighter        Much lighter  
9. Do you play sport or exercise? Yes  No  
If YES, which sport do you play most frequently?       
  
How many hours             Less than 1          1 to 2          2 to 3          3 to 4          More than 4 
per week?                                                                  
Time per session 
(hours)    ½          1½          2½          3½             4½  
How many months             Less than 1          1 to 3          4 to 6          7 to 9          More than 9 
per year?                                                                    
What proportion           A few hours          A few      2 weeks       3 weeks      Most of the 
of the month?                      days                            month  
If you do a second sport (or exercise class), which is it?       
How many hours             Less than 1          1 to 2          2 to 3          3 to 4          More than 4 
per week?                                                                   
Time per session 
(hours)    ½          1½          2½          3½             4½  
How many months             Less than 1          1 to 3          4 to 6          7 to 9          More than 9 
per year?                                                                    
What proportion           A few hours          A few      2 weeks       3 weeks      Most of the 
of the month?                      days                            month  
10. Compared with other of my own age I think my physical activity during leisure time is: 
Much more         More         The same         Less         Much less  
11. During leisure Very 
time I sweat often        Often     Sometimes   Seldom      Never  
12. During leisure 
time I play sport Never     Seldom     Sometimes     Often     Always  
13. During leisure 
time I watch TV Never     Seldom     Sometimes     Often     Always  
14. During leisure 
time I walk  Never     Seldom     Sometimes     Often     Always  
15. During leisure 
time I cycle  Never     Seldom     Sometimes     Often     Always  
16. How many minutes do you walk per day to and from work, school and/or shopping? 
Less than 5  5 to 15  16 to 30  31 to 45  More than 45  
 
 
Thank you for taking the time to complete this questionnaire. All information will be kept strictly 
confidential 
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Appendix 5: Extra statistical analysis 
 
The effect of immobilisation was examined in chapters 3 and 4 by assessing the 
changes seen in the placebo group by either repeated measures ANOVA 
(parametric data) or a Friedman test (non-parametric data). The next few pages 
provide additional statistical analysis, with either repeated measures ANOVA or a 
Friedman test, on the raw data of the individual groups (placebo (PLA), EPA or 
vitamin D (Vit-D)) pre-immobilisation (Pre), post-immobilisation (Post) and post 
remobilisation (Post2). 
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Chapter 3: PLA group (data used in the text) 
 
 
 
 
 Pre to Post 
immobilisation 
Pre to Post2 
immobilisation 
Upper arm girth p < 0.05 p > 0.05 
Lower arm girth p < 0.05 p > 0.05 
Biceps muscle thickness (L50) p < 0.05 p > 0.05 
Biceps muscle thickness (L33 p < 0.05 p > 0.05 
Triceps muscle thickness (L50) p < 0.05 p > 0.05 
Triceps muscle thickness (L33) p < 0.05 p > 0.05 
Biceps sub-cutaneous adipose 
thickness (L50) 
p < 0.05 p > 0.05 
Biceps sub-cutaneous adipose 
thickness (L33) 
p > 0.05 p > 0.05 
Triceps sub-cutaneous adipose 
thickness (L50) 
p > 0.05 p > 0.05 
Triceps sub-cutaneous adipose 
thickness (L33) 
p > 0.05 p > 0.05 
Lean mass p < 0.05 p > 0.05 
BMC p < 0.05 p > 0.05 
BMD p > 0.05 p > 0.05 
Fat mass p > 0.05 p > 0.05 
Fat % p > 0.05 p > 0.05 
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Chapter 3: EPA group 
 
 
 
 
 Pre to Post 
immobilisation 
Pre to Post2 
immobilisation 
Upper arm girth p < 0.05 p > 0.05 
Lower arm girth p < 0.05 p > 0.05 
Biceps muscle thickness (L50) p < 0.05 p > 0.05 
Biceps muscle thickness (L33 p < 0.05 p > 0.05 
Triceps muscle thickness (L50) p < 0.05 p > 0.05 
Triceps muscle thickness (L33) p < 0.05 p > 0.05 
Biceps sub-cutaneous adipose 
thickness (L50) 
p > 0.05 p > 0.05 
Biceps sub-cutaneous adipose 
thickness (L33) 
p > 0.05 p > 0.05 
Triceps sub-cutaneous adipose 
thickness (L50) 
p > 0.05 p > 0.05 
Triceps sub-cutaneous adipose 
thickness (L33) 
p > 0.05 p > 0.05 
Lean mass p > 0.05 p > 0.05 
BMC p > 0.05 p > 0.05 
BMD p > 0.05 p > 0.05 
Fat mass p > 0.05 p > 0.05 
Fat % p > 0.05 p > 0.05 
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Chapter 3: Vit-D group 
 
 
 
 
 Pre to Post 
immobilisation 
Pre to Post2 
immobilisation 
Upper arm girth p < 0.05 p > 0.05 
Lower arm girth p < 0.05 p > 0.05 
Biceps muscle thickness (L50) p < 0.05 p > 0.05 
Biceps muscle thickness (L33 p < 0.05 p > 0.05 
Triceps muscle thickness (L50) p < 0.05 p > 0.05 
Triceps muscle thickness (L33) p < 0.05 p > 0.05 
Biceps sub-cutaneous adipose 
thickness (L50) 
p < 0.05 p > 0.05 
Biceps sub-cutaneous adipose 
thickness (L33) 
p < 0.05 p > 0.05 
Triceps sub-cutaneous adipose 
thickness (L50) 
p < 0.05 p > 0.05 
Triceps sub-cutaneous adipose 
thickness (L33) 
p > 0.05 p > 0.05 
Lean mass p < 0.05 p > 0.05 
BMC p > 0.05 p > 0.05 
BMD p > 0.05 p > 0.05 
Fat mass p > 0.05 p > 0.05 
Fat % p > 0.05 p > 0.05 
244 
 
Chapter 4: PLA group (data used in the text) 
 Pre to Post 
immobilisation 
Pre to Post2 
immobilisation 
Isometric torque flexion (60°) p < 0.05 p > 0.05 
Isometric torque flexion (70°) p < 0.05 p > 0.05 
Isometric torque flexion (80°) p < 0.05 p > 0.05 
Isometric torque flexion (90°) p < 0.05 p > 0.05 
Isometric torque flexion (100°) p < 0.05 p > 0.05 
Isometric torque flexion (110°) p > 0.05 p > 0.05 
Isometric torque extension (60°) p < 0.05 p > 0.05 
Isometric torque extension (70°) p < 0.05 p > 0.05 
Isometric torque extension (80°) p < 0.05 p > 0.05 
Isometric torque extension (90°) p < 0.05 p > 0.05 
Isometric torque extension (100°) p > 0.05 p > 0.05 
Isometric torque extension (110°) p > 0.05 p > 0.05 
Isokinetic torque flexion (30°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (60°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (90°/sec) p > 0.05 p > 0.05 
Isokinetic torque flexion (120°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (180°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (240°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (30°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (60°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (90°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (120°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (180°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (240°/sec) p < 0.05 p > 0.05 
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Chapter 4: EPA group 
 Pre to Post 
immobilisation 
Pre to Post2 
immobilisation 
Isometric torque flexion (60°) p < 0.05 p > 0.05 
Isometric torque flexion (70°) p > 0.05 p > 0.05 
Isometric torque flexion (80°) p > 0.05 p > 0.05 
Isometric torque flexion (90°) p < 0.05 p > 0.05 
Isometric torque flexion (100°) p < 0.05 p > 0.05 
Isometric torque flexion (110°) p > 0.05 p > 0.05 
Isometric torque extension (60°) p < 0.05 p > 0.05 
Isometric torque extension (70°) p > 0.05 p > 0.05 
Isometric torque extension (80°) p > 0.05 p > 0.05 
Isometric torque extension (90°) p > 0.05 p > 0.05 
Isometric torque extension (100°) p < 0.05 p > 0.05 
Isometric torque extension (110°) p > 0.05 p > 0.05 
Isokinetic torque flexion (30°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (60°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (90°/sec) p > 0.05 p > 0.05 
Isokinetic torque flexion (120°/sec) p > 0.05 p > 0.05 
Isokinetic torque flexion (180°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (240°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (30°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (60°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (90°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (120°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (180°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (240°/sec) p > 0.05 p > 0.05 
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Chapter 4: Vit-D group 
 
 Pre to Post 
immobilisation 
Pre to Post2 
immobilisation 
Isometric torque flexion (60°) p < 0.05 p > 0.05 
Isometric torque flexion (70°) p > 0.05 p > 0.05 
Isometric torque flexion (80°) p > 0.05 p > 0.05 
Isometric torque flexion (90°) p < 0.05 p > 0.05 
Isometric torque flexion (100°) p > 0.05 p > 0.05 
Isometric torque flexion (110°) p > 0.05 p > 0.05 
Isometric torque extension (60°) p < 0.05 p > 0.05 
Isometric torque extension (70°) p > 0.05 p > 0.05 
Isometric torque extension (80°) p > 0.05 p > 0.05 
Isometric torque extension (90°) p < 0.05 p > 0.05 
Isometric torque extension (100°) p > 0.05 p > 0.05 
Isometric torque extension (110°) p > 0.05 p > 0.05 
Isokinetic torque flexion (30°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (60°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (90°/sec) p > 0.05 p > 0.05 
Isokinetic torque flexion (120°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (180°/sec) p < 0.05 p > 0.05 
Isokinetic torque flexion (240°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (30°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (60°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (90°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (120°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (180°/sec) p < 0.05 p > 0.05 
Isokinetic torque extension (240°/sec) p > 0.05 p > 0.05 
